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XThe results obtained in these studies ai e summarised below:
SUMMARY
The work presented here represents an examination of the effects of various 
drugs on the tone of vascular smooth muscle in isolated pulmonary artery rings 
mainly from Wistar rats and an investigation of contribution of endothelium- 
derived relaxing factor (EDRF, NO).
?
1) The vasoconstrictors, 5-hydroxytryptamine (5-HT, 10"'^  to 10"^M), 
phenylephrine (PHE, 1 0 “^  to 10"^M), noradrenaline (NA, 10“i® to 10-^M), 
angiotensin II (Ang II, 10“i^  to 10"'^ M) and the thromboxane A^  (TXAj) 
analogue, U46619 (10"  ^ to 10"^M), induced concentration-dependent 
contractions in main (MPA) and branch (BPA) pulmonary artery rings from 
Wistar rats. BPA rings were more responsive than MPA rings to PHE (10”^  to 
10"^M), NA (10“^  to 10"%!) and Ang II (10"^M), whereas, there were no
significant differences between MPA and BPA rings in responses to 5-HT or
the thromboxane Ag mimetic, U46619. In some experiments, prior treatment
with Nm-nitro-L-arginine methyl ester (l-NAME, 5x10“^ M, a competitive
inhibitor of L-arginine in endothelial cells) or mechanical removal of the
.endothelium by rubbing, potentiated responses of MPA and BPA rings to 5-HT 
or PHE. Cocaine (10“%1) potentiated responses to NA (10“^  to 10"^M) in 
MPA rings but had no effect in BPA rings . .4I
2) Exposure of MPA and BPA rings for 30min or 1 hour to the concentration 
of 5-HT (10"'^M), that produced the maximum response caused a marked 
desensitisation to 5-HT. The desensitisation to 5-HT was most marked in intact 
rings. Prior treatment with l-NAME (SxIQ-'^ M, for 15min) or mechanical 
removal of the endothelium, increased contractile responses to 5-HT and
XI
reduced this desensitisation to 5-HT. Desensitisation to 5-HT in these rings,
that had an intact endothelium, was reversed by oxidised haemoglobin (HbO,
Img/ml) or l-NAME, but this did not occur in endothelium denuded rings or in
rings pretreated with l-NAME. This effect of l-NAME was inhibited by
L-arginine (r-Arg, 2xlO~'^M). For comparison, exposure of these tissues for 2
hours to a high concentration of phenylephrine (PHE, 10"^M) also produced a 
. . .desensitisation to PHE but this was less than occurred after exposure to 5-HT. 
.Also, repeated application of the concentration of Ang II (10"%1) that 
produced the maximum response, induced rapid desensitisation to Ang II in 
MPA and BPA rings. Pretreatment of the rings with a subthreshold 
concentration of KCl (10"^M, for 5min) but not with L-NAME (2xlO”M ) 
reversed the Ang Il-induced desensitisation.
3) The endothelium-dependent vasorelaxants, ACh (10"  ^ to 3xlO"M) or 
carbachol (CARB, 10"® to 10"^M) induced concentration-dependent relaxations 
in MPA rings and BPA rings, which had been precontracted with PHE 
(EC70, 1.2xlQ"M). BPA rings were more responsive than MPA rings to ACh 
and to high concentrations of CARB (10"  ^ to 10"^M). Pretreatment of these 
rings with the nitric oxide synthesis inhibitor, l-NAME (5x10"^M, for lOmin) 
or mechanical removal of the endothelium abolished ACh-induced relaxations 
to (10-9 to lO-^M) of ACh. l-NAME, also abolished CARB-induced 
relaxations to low concentrations of CARB (10"® to lO'M), but responses to 
high concentration (10"  ^to 10"M) of CARB persisted.
4) The endothelium-independent vasorelaxant, sodium nitroprusside 
(SNP, 1 0 “i2 to lO'^M) induced concentration-dependent relaxations in MPA 
and BPA rings, which had been precontracted with PHE (EC^q, 1.2x10"'^ M) or 
5-HT (EC50, fO'^M). MPA rings, which had been precontracted with PHE, 
were more responsive than BPA rings to low concentrations of SNP (10"^^M)
x n .
and also to high concentrations of SNP (1 0 ”^  to 10"%4). There was a 
significant difference between responses to SNP (10"TM) in MPA and BPA 
rings, which had been precontracted with 5-HT. Pretreatment of these rings 
with l-NAME (5x10"^M, for 20min) did not affect responses to SNP in rings 
precontracted with either PHE or 5-HT.
Comparison of concentration-response curves to ACh and SNP in MPA rings 
and BPA rings, precontracted with PHE, indicated that SNP was more potent 
than ACh.
5) The purine adenine nucleotides, ATP and ADP induced concentration- 
.dependent relaxations (10"® to 10"^M) in MPA and BPA rings, which had been 
precontracted with PHE (10"TM). There were no significant differences 
between MPA rings and BPA rings in their responses to ATP but there were 
differences in responses to high concentrations (1 0 "^  to 10"^M) of ADP.
Pretreatment of these tissues with L-NAME, (2xl0"M, for lOmin) or 
mechanical removal of the endothelium suppressed responses to all
:5:concentrations of ATP or ADP. Adenosine (AD, 3x10"^ to lO-'^M) induced 
concentration-dependent relaxations in MPA and BPA rings precontracted with
PHE (10"7M). There were no significant differences between the responses to 
AD in MPA rings and BPA rings. Pretreatment of the preparations with 
l-NAME (2x10“M , for lOmin) depressed the responses in BPA rings to AD 
(10“^  to 5xlO"^M) and in MPA rings to the lowest of AD (5xlO"%I). In MPA 
rings, the mechanical removal of the endothelium by rubbing, depressed the 
response to (3 x 10"^M) of AD.
6 ) Eüstamine (HIST, 10"^  to 10"®M) induced concentration-dependent 
.relaxations in MPA and BPA rings, which had been precontracted with PHE 
(10"M). Pretreatment of the preparations with l-NAME (2x10"^M, for lOmin) 
or with a potent Hj-receptor antagonist, chlorpheniramine (CPRA, 10"%1, for
I
„€i
__
x n i
7) The p-adrenoceptor agonist, isoproterenol (ISO, 10"^ ° to 10“^ M), induced 
concentration-dependent relaxations in MPA and BPA rings precontracted with
effect on 5-HT-induced relaxations.
lOmin), inhibited the responses to all concentrations of HIST. BPA rings were 
more responsive than MPA rings to HIST (10"  ^to 10""^ M).
PHE (10"'M). Pretreatment of these rings with l-NAME (2xlO"*M, for lOmin) 
depressed responses to low concentrations of ISO (MPA: to 10"'M;
BPA: 10“9 to 10"®M). Also, mechanical removal of the endothelium by rubbing,
,depressed the responses to low concentrations of ISO (MPA; 10“9 to 10"7M;
BPA: 10"9 to 10"®M). MPA rings with an intact endothelium were more 
responsive than BPA rings to ISO, but there was no significant difference 
between MPA and BPA in their sensititivity to ISO when the endothelium was
removed.
8 ) 5-HT (lO""^  to 5xlO"M) induced concentration-dependent relaxations in 
MPA and BPA rings, which had been precontracted with PHE 
(EC75, 1.2xlO"7M). Pretreatment of the preparations with L-NAME (5xlO“'^ M,
for 15min), or with the (3-adrenoceptor antagonist, propranolol (PROP,
for lOmin) and/or mechanical removal of the endothelium by rubbing, had no
9) The muscarinic-receptor antagonist, atropine (AT, 10"® to 5xlO"^M) 
.induced concentration-dependent relaxations in MPA and BPA rings, which
had been precontracted with PHE (10"M) or 5-HT (10"^M) but not with KCl 
3xlO"^M). Pretreatment of the preparations with the nitric oxide synthase 
inhibitors, l-NAME (5x1Q"4m, for lOmin) or No-nitro-L-arginine (l-NOARG, 
lO'^ ^M, for lOmin) or with a combination of oxy-haemoglobin (HbO, 1 mg/ml, 
for lOmin) and l-NAME (5x1Q-4m, for lOmin) together and/or mechanical 
removal of the endothelium, did not inhibit this effect of atropine. Also,
i
x rv
pretreatment of these rings with (3-adrenoceptor antagonist, propranolol 
(10"M, for lOmin) or with the phosphodiesterase inhibitor, 3-isobutyl-1- 
methylxanthine (IBMX, 10”®M, for 3min) had no effect. In intact endothelial 
rings but not in rings without endothelium, the vasorelaxant effect of atropine 
(5xlO"M) was inhibited by l-NAME (5x10“‘^ M) and this effect of l-NAME 
was reversed by L-arginine (L-Arg, 2xlO"'^M). MPA rings were more 
responsive to atropine than BPA rings.
1 0 ) Electrical field stimulation (EFS) induced frequency-dependent 
contractions in MPA rings. Pretreatment of these rings with L-NAME 
(2x1Q"4m) enhanced the maximum responses to EFS.
11) In MPA and BPA rings, which had been precontracted with PHE; 
pretreatment with standard solutions of cigarette smoke extract (CSE, 1ml, for 
10-15min), depressed vasorelaxant responses to ACh (10“9 to IQ-^M) but had 
no effect on relaxant responses to SNP (10"^  ^ to 10"^M). Also, pretreatment of 
MPA and BPA rings with CSE (2ml, for 10-15min), depressed contractile 
responses to PHE (10"® to 10"M).
12) Noradrenaline (NA) and 5-hydroxytryptamine (5-HT) induced 
concentration-dependent contractions in MPA and BPA rings of sham operated 
and heart failure rabbits. There were no significant differences between 
responses of blood vessels from sham operated and HF rabbits to these 
agonists. Acetylcholine (ACh) induced concentration-dependent relaxations in 
these rings from sham operated and HF rabbits. There were significant 
differences between the responses in BPA rings only at the lowest 
concentration of ACh (IQ-^M).
Chapter 1 
INTRODUCTION
1 INTRODUCTION
The pulmonary circulation serves many important functions. Of these, the most 
vital is the maintenance of gas exchange through the constant flow of mixed 
venous blood through the pulmonary arterial circulation to the pulmonary 
capillaries, and the return of oxygenated blood through the pulmonary venous 
circulation to the left atrium (Guyton, 1992).
1 .1  General Structure of Blood Vessels
All blood vessels have a number of structural features in common. Blood 
vessels are structurally adapted according to physiological requirements. 
Therefore, pulmonary arteries which supply a low-pressure system have thinner 
walls than do systemic arteries, such as the carotid or renal arteries, which 
supply a high-pressure system. Blood vessels form a network of tubes that 
carry blood away from the heart, transport it to the tissues of the body, and 
then return it to the heart.
1.1.1 Arteries
Arteries are the blood vessels that conduct blood away from the heart to the 
organs and tissues. They resist changes in blood pressure in their initial 
portions and regulate blood flow in tenninal portions. It is customary to 
classify arteries into elastic (conducting) arteries and muscular (distributing) 
arteries. The walls of arteries are thick and strong and consist of three coats 
(Snell, 1984);
I  ) The tunica intima (internal coat) consists of a layer of endothelial cells 
lining the vessel’s interior surface.
I I  ) The tunica media (middle coat) consists chiefly of concentric layers of 
helically-arranged smooth muscle cells. Interposed among the smooth muscle
I l l )  The tunica adventitia (outer coat) consists principally of longitudinally- 
oriented collagen and elastic fibres. The adventitial layer gradually becomes 
continuous with the enveloping connective tissue of the organ through which 
the vessel is running (Fig. 1.1).
■ f
cells are variable amounts of elastic and reticular fibres and proteoglycans. 
.In arteries the media is separated from the intima by an internal elastic lamina.
i
1 .1 .2  Pulmonary arteries
The pulmonary trunk arises from the infiindibulum of the right ventricle
through the orifice of the pulmonary valve. The pulmonary trunk passes
upward and backward into the concavity of the aortic arch, where it divides
into the right and left main pulmonary arterial branches. The right main
pulmonary arterial branch is slightly larger and longer than the left main 
.pulmonary arterial branch (Murray & Nadel, 1988). The pulmonary artery is 
thin, with a wall thickness one-third that of the aorta. The main pulmonary 
arterial branches are all very short. However, all the pulmonary arteries, even 
the smaller arteries and arterioles, have much larger diameters than their 
counterpart systemic arteries. Since the vessels are very thin and distensible, 
the pulmonary arterial tree is very compliant. This large compliance allows the 
pulmonary arteries to accommodate the stroke volume output of the right 
ventricle.
Three types of pulmonary arteries can be identified in the normal adult human 
lung (Heath, 1969):
I  ) Elastic or conducting pulmonary arteries contain distinctive layers of 
elastic fibres embedded in a coat of muscle cells. The pulmonary artery trunk, 
its main branches, and all extralobular pulmonary arteries are of the elastic 
type.
j
3
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I I  )  Muscular or distributing pulmonary arteries have a thin medial layer of 
muscle sandwiched between well-delimited internal and external elastic 
laminae. Muscular pulmonary arteries lie within lung lobules and, hence 
accompany bronchioles.
I l l )  Pulmonary arterioles are the terminal branches of the pulmonary arterial 
system; at their origin from muscular arteries they contain a partial layer of 
muscle that gradually disappears until the vessel wall consists only of 
endothelium and elastic lamina. Pulmonary arterioles supply alveolar ducts and 
alveoli.
1.2 Innervation
The pulmonary vessels are capable of reacting, by contraction or relaxation of
vascular smooth muscle to neurogenic influences. Anatomical and
histochemical techniques have demonstrated both adrenergic and cholinergic
.innervation of pulmonary arteries and adrenergic innervation of pulmonary
veins (Kadowitz et at., 1976; Knight et ah, 1981).
I
1 .2 .1  Sympathetic nerves
The pulmonary blood vessels are imiervated by sympathetic fibres, but more
sparsely than systemic vessels (Berne & Levy, 1988). The density of adrenergic
innervation and the degree of penetration of the nerve terminals into the
smooth muscle layers are of great strategic significance. In pulmonary arteries,
the adrenergic nerve terminals are localised ai ound the outside of the tunica
media at the adventitia-medial junction, whereas in veins they innervate the
deep medial smooth muscle layers (Bevan & Su, 1973; Ljung et ah, 1975).
The principal neurotransmitter released on electrical stimulation of adrenergic
nerves is noradrenaline (NA) wliich induces pulmonaiy vasoconstriction. 
.Sympathetic stimulation usually causes pulmonary vasoconstriction but
__
Endothelium ceil Internai elastic lamina
Tunica intima
Tunica media
Tunica adventitia
Fig. 1.1
Diagram showing general structure of a muscular artery
sometimes leads to a vasodilatation which is not abolished by atropine. 
Vasodilatation abolished by atropine occasionally followed vagal stimulation. 
Pharmacological studies indicate that a^, a 2 and p2-adrenoceptors are present 
in pulmonary blood vessels (Hyman et al., 1981; Hyman & Kadowitz, 1985). 
Pre-junctional a-adrenoceptors and post-junctional a-adrenoceptors differ in 
their pharmacology and function. Pre-junctional a-adrenoceptors mediate the 
regulation of transmitter release from adrenergic nerve endings, whereas 
post-junctional a-adrenoceptors mediate contraction of vascular smooth 
muscle (Somlyo & Somlyo, 1970; Stjame & Gripe, 1973; Strake et al., 1975). 
Pre-junctional a-adrenoceptors were originally classified as ag-adrenoceptors 
and post-junctional a-adrenoceptors may be either a^ or a 2-adrenoceptors or 
of both types (Langer, 1974; Starke 1975; Wikberg, 1979).
1.2.2 Parasympathetic nerves
Unlike most systemic vessels, the pulmonary blood vessels receive some 
parasympathetic innervation. Cholinergic receptors respond to parasympathetic 
nerve stimulation by causing vasodilation of a previously constricted vascular 
bed (Nandiwada et at,, 1983). Cholinergic agonists vasodilate through the 
action of an intermediary substance, endothelium-derived relaxant factor 
(EDRF), which is produced by endothelial cells and acts on adjacent smooth 
muscle in the vessel wall. (Vanhoutte et al., 1986). Although acetylcholine 
(ACh) is the principal parasympathetic neurotransmitter, there is no evidence 
that it is normally released in blood vessels to cause them to relax. Furthermore 
administration of the muscarinic receptor antagonist, atropine, to cat cerebral 
arteries does not block the neurogenic vasodilation induced by transmural 
nerve stimulation (Lee, 1980). Additionally, this model of neurogenic 
vasodilation does not require an intact endothelium, whereas ACh-mediated 
vasodilation is endothelium dependent (Lee et ah, 1984).
1.2.3 Non-adrenergic non-cholinergic (NANC) nerves 
In the early 1960s Burnstock and his colleagues were able to show that when 
the responses to both adrenergic and cholinergic nerve stimulation had been 
blocked with guanethidine and atropine in guinea-pig intestinal preparations, 
large transient hyperpolarizations and relaxation were produced. Since these 
responses were abolished by tetrodotoxin, they were established as inhibitory 
junction potentials resulting from stimulation of NANC neurones. At the end of 
the 1960s, non-adrenergic non-cholinergic nerves were recognized in a wide 
variety of organs including the respiratory and cardiovascular systems 
(Burnstock, 1969). Experiments carried out to identify the transmitter of the 
non-adrenergic non-cholinergic neurones that supply to smooth muscle of the 
gastrointestinal tract showed that among many substances examined, including 
catecholamines, 5-hydroxytryptamine (5-HT), adenosine, etc., adenosine 
triphosphate (ATP) is the principal transmitter in these nerves (Burnstock,
1986). In 1971, nerves utilizing ATP as the principal transmitter were tenned 
"purinergic" (Burnstock, 1971). Adenyl compounds cause dilatation of most 
blood vessels, but they have been found to cause both vasoconstriction of lung 
vessels and vasodilation, especially after previous vasoconstriction with 
5-hydroxytryptamine. The nature of the response is dose-dependent. Gaddum 
and Holtz (1933) showed that ATP, adenosine and AMP caused vasodilatation 
in low doses, but caused vasoconstriction in higher doses. Hauge and 
colleagues (1966) found that the initial response of the perfused rabbit lung to 
ATP injected into the pulmonary arterial tubing was vasodilation, while after 
1 0  minutes to 2  hours, this response changed to vasoconstriction.
1.2.4 Co-transmission
Some nerve cells store and release more than one transmitter (Burnstock,
1969). There is now considerable experimental support for the co-existence of 
peptides or purine nucleotides together with classical neurotransmitters i
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capillary segments become distended. Because the distension of the pulmonary 
vascular bed has a limit, the effects of pulmonary arterial pressure changes on 
resistance are greater when left atrial pressure is low (Berne & Levy, 1988).
(Bumstock et al., 1984; Bumstock, 1985; 1986). ATP and NA are released as 
CO-transmitters from the sympathetic nerves supplying some blood vessels 
(Bumstock 1984),
1.3 Regulation of Pulmonary Vascular Tone
Vascular tone is determined by the degree of contraction maintained by the 
blood vessel (Morgan, 1987) and is influenced by a multiplicity of factors 
(Vanhoutte, 1978). The high resistance of the systemic circulation is largely 
caused by the muscular arterioles, which control the distribution of blood flow
to various organs of the body. The pulmonary circulation does not have such 
thick walled small vessels. Pulmonary resistance, however, is not constant, but 
varies widely under a variety of conditions:
:1.3.1 Passive Factors:
1.3.1.1 Vascular pressure
Pulmonary vascular resistance decreases as the pressure within the vessels 
rises. As pulmonary artery pressure rises, some capillaries that are usually 
closed, begin to conduct blood, thus lowering the overall resistance (Berne & 
Levy, 1988). In addition, as the vascular pressure rises, more and more
1.3.1.2 Lung volume
With large lung volumes the resistance of the extra-alveolar vessels decreases.
In contrast, the resistance of the alveolar vessels increases. Because of the 
opposing effects of lung volume on the calibre of alveolar and extra-alveolar
_
1.3.2.2 Humoral effects
In addition to the adrenergic and cholinergic innervation, the lung itself is a
I
vessels, total pulmonary vascular resistance usually is minimal at functional 
residual capacity (Berne & Levy, 1988).
1.3.1.3 Left atrial pressure 
When the left side of the heart fails, blood beings to dam up in the left atrium. 
As a result, the left atrial pressure rises. Pulmonary arterial pressure rises when 
the left atrial pressure increases (Guyton, 1992).
1.3.2 Active Factors:
1.3.2.1 Neural effects
The pulmonary vasculature is innervated by both adrenergic and cholinergic
systems (Dawson, 1984). Neurogenic alterations in vascular tone are
predominatly produced by changes in the activity of sympathetic adrenergic
nerves (Bevan & Su, 1973). It has been established that the pulmonary vascular
bed is innervated by the adrenergic system and that stimulation of the
adrenergic nei*ves increase pulmonary vascular resistances and decreases
pulmonary vascular compliance (Ingram et al., 1968; Daly et a l, 1970;
Kadowitz & Hyman, 1973). The pulmonary vascular bed is also innervated by
the parasympathetic system (Kadowitz et al, 1976; Knight et a l, 1981), but
the influence of parasympathetic nerve stimulation is uncertain. Pulmonary
vasodilation has been demonstrated when the distal vagosympathetic trunk was
stimulated (Daly & Hebb, 1952). Despite this innervation, there is little 
.evidence that the autonomic nervous system controls vascular tone in the 
normal lung.
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source of a large number of other vasoactive substances, which influence
pulmonaiy vasomotor tone when released (Bergofsky, 1980). Neuroepithelial 
cells in the airways contain various vasoactive substances (Keith et al., 1981); 
and there are vasoactive peptides produced and/or stored within the lung (Said, 
1982). The lungs are able to convert arachidonic acid into a number of 
pulmonary vasoactive substance, including various prostaglandins, their 
intermediates and metabolites, thromboxane A ,^ and leukotrienes (Anggard & 
Samuelsson, 1965). In general, the potential effects of this large number of 
endogenous vasoactive substances on pulmonary vasomotor tone are inferred 
from their effects on the pulmonary vascular bed when infijsed as exogenous 
substances. Knowledge about their roles in the physiological responses of the 
pulmonary vasculature is relatively sparse. In some cases their potential effects 
on the pulmonary circulation may be complex. For example, 
5-hydroxytryptamine (5-HT) is a potent pulmonary vasoconstrictor and blood 
contains a considerable amount of the 5-HT, but the normal plasma 
concentrations are low because most of the 5-HT is contained in the platelets 
(Paasonen, 1956). The effect of the 5-HT on the pulmonary vascular bed may 
also depend on the condition of the pulmonary endothelial cells which are 
normally capable of inactivating 5-HT (Gillis & Pitt, 1982). The 5-HT is 
metabolized in the endothelial cell of the lung by amine oxidases (Aviado, 
1960; Gillis, 1973). Histamine is generally considered to be a pulmonary 
vasoconstrictor, but it causes vasodilation when the pulmonary vascular tone is 
abnormally elevated (Tucker et al., 1976 ). Type Hj and Hg histamine 
receptors mediate pulmonary vasoconstrictor and vasodilator responses, 
respectively (Tucker et al., 1975). Bradykinin can also be a pulmonary 
vasoconstrictor (Hauge et al, 1966) or dilator (Levine et a l, 1973). In the rat 
bradykinin appears to be a pulmonary vasoconstrictor (Hauge, 1968), and in 
humans with pulmonary hypertension it is a vasodilator (De Freitas et a l, 
1966). A major precursor of prostaglandins, arachidonic acid, is an active 
pulmonary vasoconstrictor (Okpako, 1972; Wicks et a l, 1976). PGFj^ is a
pulmonary vasoconstrictor. The mechanisms of action of PGFj^ have not been 
completely defined, but in the rodent, the excitatory action of this agent is
1.3.2.3 Hypoxia
The response of pulmonary vasculature to hypoxia has been investigated 
extensively, and it is clear that in most species, hypoxia results in an increase in
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associated with depolarization and reduction of smooth muscle cell membrane 
resistance (Kitamura et al., 1976). PGEj is a vasodilator in lung and PGE2 
seems to be a vasoconstrictor (Kadowitz et al., 1975). PGIT2 and thromboxane 
Ag (TXA2) are pulmonary vasoconstrictors. The pulmonary endothelium is a 
source of prostacyclin (PGI2 ; Gryglewski et al., 1978), which is a pulmonary 
vasodilator (Hyman & Kadowitz, 1986). Cyclo-oxygenase inhibition increases 
pulmonary vascular resistance and increases tone in isolated pulmonary arteries 
(Hadhazy et a l, 1983), thus there is speculation that prostacyclin (PGIj) may 
be involved in maintenance of the normal low pulmonary vasomotor tone. 
Polypeptides, including angiotensin II formed from angiotensin I by the 
endothelial cell-converting enzyme, is a pulmonary vasoconstrictor (Aviado, 
1960). Blood vessels are innervated by unmyelinated and thinly myelinated 
sensory neurons containing substance p (SP), neurokinin A (NKA), and 
calcitonin gene-related peptide (CGRP). Each of the sensory neuropeptides 
induces relaxation of blood vessels. The effect is mediated through receptors 
coupled to different second-messenger system, such as cyclic AMP (cAMP) 
and cyclic GMP (cGMP) and/or the release of endothelium-derived relaxing 
factor (EDRF). SP induces in precontracted rings of guinea-pig pulmonary a 
prompt but transient relaxation. In rings, in which the endothelium is removed 
beforehand, SP evokes a transient, small contraction and CGRP causes 
endothelium-independent relaxation (Maggi et al, 1990). Vasoactive intestinal 
peptide (VIP) induces relaxation in isolated pulmonary blood vessels (Hand et 
al, 1984).
I
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total pulmonary vascular resistance. Hypoxic pulmonary vasoconstriction
(HPV) is an important regulatory mechanism in matching regional blood flow
and ventilation. Although hypoxic pulmonary vasoconstriction (HPV) has been
.demonstrated in large and small pulmonary arteries, the primary site of action 
of HPV appears to be the small muscular arteries (Voelkel, 1986). Despite the 
observation that hypoxia directly stimulates contraction of pulmonary vascular 
smooth muscle, the cellular mechanisms by which alveolar hypoxia causes HPV 
are still poorly understood. The pulmonary endothelium has been suggested to ;
act as a hypoxia sensor (Holden & McCall, 1984), and both the endothelium- 
derived relaxing factor (EDRF) and contracting factor (EDCF), as well as 
other vasoactive mediators have been shown to play a modulatory role in HPV 
(Holden & McCall, 1984; Rubanyi & Vanhoutte, 1985a; Voelkel, 1986),
Bioassay studies indicated that both the hypoxic relaxation in the systemic 
circulation and contraction in the pulmonary circulation are mediated by 
diffusable factor(s) released from the endothelium (Busse et al., 1983; Rubanyi 
& Vanhoutte, 1985a). Indomethacin, a cyclo-oxygenase inhibitor had no effect 
on these responses (Rubanyi & Vanhoutte, 1985a). Methylene blue, an inhibitor
of soluble guanylate cyclase and nitro-L-arginine, an inhibitor of nitric oxide 
synthase, inhibited both hypoxia-induced relaxations and contractions (Rubanyi 
& Gi'âser, 1991). In rings without endothelium, the exogenous donor of nitric 
oxide, SIN-1, nitroglycerin, and dibutyryl cGMP inhibited hypoxic 
contractions (Graser & Vanhoutte, 1991). Hypoxia significantly decreased 
cGMP levels only in vascular preparations with endothelium (Graser &
Î
IVanhoutte, 1991). These results suggest that hypoxic relaxation is due to the 
release of EDRF (NO) from the endothelium, whereas hypoxic contraction is 
the consequence of inhibition of the effect of endothelium-derived nitric oxide 
in vascular smooth muscle. It has been suggested that ATP and 5-HT may be I
released in response to hypoxia from endothelial cells (Hopwood et ah, 1986;
Bumstock et al., 1988). These substances may also contribute to the stimulated
11 % 
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release of EDRF (NO) during hypoxia. Hypoxia can also change smooth
muscle tone by modulating adrenergic neurotransmission via the release of 
.in certain vascular preparation (Borda et al., 1980). There is now evidence that 
.in some species, especially in certain age groups, capillaries (Hakim et al.,
1983; Mazzone, 1984) and veins (Rivera-Estrada et al., 1958; Morgan et al.,
1968) may also constrict. The pulmonary vein also contracts in response to 
hypoxia (Zhao et al., 1993).
1.4 Vascular Smooth Muscle (VSM)
1.4.1 Contraction
Smooth muscle of pulmonary arteries are able to develop and maintain maximal 
contraction in response to hormones and neuromediators. The onset of the 
contraction is linked to an increase in cytosolic calcium concentration [Ca^ +]j| 
and subsequent formation of a calcium-calmodulin-myosin light chain kinase 
(MLCK) complex leading to the phosphorylation of myosin light chains 
(Adelstein & Hataway, 1979; Murphy et al., 1983). In contrast, the mechanism 
responsible for the maintenance of tone which occurs together with a decrease 
in both [Ca^+]i and phosphorylation of myosin light chains (MLC), remains 
unclear (Jiang & Morgan, 1989). The agonists produce a host of physiological 
responses in their target tissue as a result of their interaction with specific cell 
surface receptors. In addition to receptors that regulate cyclic AMP (cAMP) 
formation, there is another major type of cell surface receptor which mediates 
their effects via an increase in cytosolic Ca^ '*'. Such receptors are referred to as 
Ca^+-mobilizing receptors which affect intracellular Ca^ '^  levels via hydrolysis 
of phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate 
(IP3) and 1,2-diacylglycerol (DAG). There has been increasing interest in the 
polyphosphoinositides (PPI) as a result of two major findings: (a) that their 
hydrolysis by phospholipase C (PLC) is coupled to the activation of
'I-, I.
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Ca^^-mobilizing receptors such as cholinergic muscarinic receptors 
(Abdel-Latif et a l, 1977; Akhtar & Abdel-Latif, 1984), ai-adrenoceptors 
(Abdel-Latif c/a/,, 1978), vasopressin receptors, etc., and (b) that the products 
of the phospholipase C (PLC) hydrolysis, namely DAG and IP3, may serve as 
intracellular second messengers. Further degradation of DAG by specific 
lipases also leads to the release of arachidonic acid (AA), the precursor of 
prostaglandins (PGs), thromboxanes and leukotrienes. There is now growing 
experimental evidence which suggests that IP3 and DAG synergistically 
mediate signal transduction in receptor systems linked to Ca^^-mobilization. IP3 
has been shown to be involved in the release of Ca^ + from intracellular stores, 
such as the endoplasmic reticulum (ER), sarcoplasmic reticulum (SR), and 
DAG activates the phospholipid sensitive protein kinase C (PKC), which 
phosphorylates specific proteins. Mechanisms that increase [Ca^ +Jj include 
either Ca^ + influx, such as occurs with potassium chloride (KCl), or 
mobilization of intracellular calcium as a result of Pl-hydrolysis and generation 
of the second messengers IP3 and DAG (Berridge, 1981). Both of these 
pathways cause phosphorylation of the contractile proteins.
1.4.1.1 The phosphatidylinositol pathway
Hokin and Hokin (1955; 1958) reported that phospholipids, later identified as 
phosphatidylinositol (PI) and phosphatidic acid (PA), may have an important 
role in receptor-mediated cell responses. Several years later, Michel! (1975) 
listed a number of tissues which showed a PI effect in response to various 
stimuli, and since then, more tissues including blood vessels have been added to 
the list (Takhar & Kirk, 1981; Villalbos-Molina et al, 1982; Zeleznikar et al,
1983). The coupling factor linking receptor and phospholipase C is probably a 
GTP-binding protein. There is good experimental evidence for the involvement 
of GTP-binding proteins in the coupling of various Ca^^-mobilizing receptors 
to PIP2 hydrolysis and Ca^ + mobilization. Thus, in permeabilized cells,
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non»hydroîyzabie analogues of GTP introduced into and then trapped within 
the cytosol are able to substitute for external ligands in stimulating histamine
release of Ca^ + by IP3 is a necessary prelude to the action of IP4,
release, which is a well-defined Ca^^-dependent process (Gomperts, 1983). 
These GTP analogues also stimulate serotonin release and DAG formation in
permeabilized platelets (Haslam & Davidson, 1984). Enhanced PI or PPI 
turnover is involved in Ca^^-gating at the plasma membrane. In 1975, Michell 
suggested that PI metabolism is triggered only by those receptors that control a 
rise in [Ca^ J^j which then acts as the second messenger for stimulating the •Î
.functional response of the cell. He also suggested that PI breakdown precedes 
the entry of Ca^"*" into cells and could therefore be a universal biochemical event
a
intrinsic to the Ca^+-gating mechanism (Michell, 1975; Michell & Kirk, 1981). 
Agonist-stimulated breakdown of polyphosphoinositides regulates the plasma 
membrane Ca^+-pump. It has been suggested that IP3 might act on a 
Ca^^-channel in the plasma membrane (Kuno & Gardner, 1987). Irvine and 
Moor (1986) proposed that IP4 has a role in regulating Ca^  ^ entry. They 
reported that the Ca^^-releasing action of IP3 is insufficient to activate the sea
urchin eggs fully, and that Ca^  ^entry due to IP4 is necessary as well. Because 
IP4 did not activate the eggs when injected alone, they speculated that the
1,4.1 .2  Protein kinase C (PKC) pathway 
Another primary product of the stimulated PPI hydrolysis is diacylglycerol 
(DAG), wliich has an important second messenger function (Nishizuka, 1984; 
Hirasawa & Nishizuka, 1985; Kikkawa et al, 1986). DAG, which is formed 
transiently at the plasma membrane, stimulates C-kinase (PKC) activity, which 
is dependent on Ca^ + and acidic phospholipids, particularly phosphatidylserine, 
to catalyze the phosphorylation of serine and threonine residues of various 
cellular proteins (Nishizuka, 1984; Hirasawa & Nishizuka, 1985; Cockcroft & 
Gomperet, 1985). The Ca^Vphospholipid-dependent protein kinase was first
2:
1.4.2 Relaxation
Vascular muscle relaxes when intracellular falls below a threshold level 
The removal of from the cytoplasm is brought about by a combination of 
Ca^ + accumulation into the sarcoplasmic reticulum and extrusion from the cell 
across the plasma membrane. The major route of Ca^ + removal is probably
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purified from brain as a cyclic nucleotide-independent protein kinase which
could be activated by a Ca^+-dependent protease also present in brain (Takai,
et al., 1977). Without proteolysis, activation of the enzyme required
phospholipids. A protein kinase which required Ca^ +, phosphatidylserine, and
DAG for maximum activity has been demonstrated and named C-kinase
(Kishomoto et ah, 1980). The enzyme is both cytosolic and membranous.
Phorbol esters, such as phorbol-12-myristate-13-acetate (PMA) and
12-0-tetradecanoyl-phorbol-13 -acetate (TPA), which are potent cell activators
and co-carcinogens, are able to substitute for DAG at extremely low
concentrations and directly activate C-kinase both in vivo and in vitro
(Castagna et ah, 1982; Niedel et ah, 1983; Yamanishi et al., 1983).
. .This circumvents the physiological pathway of DAG production via receptor 
.activation of phosphoinositide hydrolysis. DAG is formed transiently in the 
stimulated cell, and under resting conditions, its concentration in the plasma 
membrane is too low to be detected. The lack of DAG accumulation in the 
plasma membrane is due both to its rapid phosphorylation to phosphatidic acid 
(PA) by DAG kinase and to its further degradation by lipases. In spite of this 
rapid metabolism, changes in DAG levels have been reported on stimulation of 
phosphoinositide breakdown in smooth muscle (Yousufzai & Abdel-Latif,
1984). PKC is present in high concentration in vascular smooth muscle (Kuo 
et ah, 1980), and induces contraction of vascular smooth muscle by 
phosphorylation of MLC at a different site from that of MLCK (Nishikawa 
et ah, 1984; Ikebe et ah, 1985; Itoh, et ah, 1986).
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activity is stimulated when cytoplasmic levels of Ca^ + rise. Smooth muscle
membrane, a G-protein which lies within the membrane is necessary to link the
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.the uptake of Ca^ + into the sarcoplasmic reticulum (Kargacin & Fay, 1991),
which is accomplished by a Ca^ +, Mg^^-ATPase (Ca^+-pump) that undergoes
Ca^^-dependent phosphorylation (Sumida et al., 1984). The activity of the
pump is regulated by phospholamban, a protein that is localized to the 
.sarcoplasmic reticulum (Ferguson et al., 1988) and is modulated by cyclic 
nucleotide-dependent phosphorylation (Eggermont et al., 1988a). The plasma 
membrane contains a distinct Ca^\ Mg^^-ATPase, which extrudes Ca^ + from
'
the cell (Eggermont et al., 1988b). This ATPase binds calmodulin so that its
membrane preparations have also been shown to contain a Na+-Ca^+ exchanger 
(Grover et al., 1983). This may contribute to Ca^  ^ extrusion in some blood 
vessels (Aaronson et al,, 1991), but it is still debated how much it contributes 
in others. The relative contribution of each of these Ca^^-removal processes 
may well vary among different vascular bed. The most important agents that 
control vascular relaxation are the cyclic nucleotides; cAMP and cGMP, which 
act through activation of cAMP-dependent protein kinase (PKA), and 
cGMP-dependent protein kinase (PKG), respectively and through 
phosphorylation of targets such as MLCK.
1.4.2.1 Cyclic AMP (cAMP)
Following the discovery of the role of the cyclic AMP by Sutherland and Rail 
(1957), cyclic AMP has been of major importance in helping to understand 
many of the mechanisms underlying the effects of neurotransmitters, hormones
and drugs on their target tissues. Cyclic AMP is synthesised within a cell by the 
action of the enzyme adenylate cyclase (AC) on ATP, following agonist- 
receptor interaction. However, because receptors lie on the outer surface of the
:î
receptor to adenylate cyclase (AC) which faces inside the cell. The cyclic
nucleotide acts within the cell on cyclic AMP-dependent protein kinase (PKA) ‘
.,1
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and is degraded by phosphodiesterases (PDE). Elevation of cyclic AMP 
produces its effect by four different methods;
(a) cyclic AMP promotes Ca^  ^ extrusion from the cell by activating pumps in 
the membrane, (fr) it promotes uptake of Ca^ + into intracellular stores, (c) it 
decreases the sensitivity of myosin light chain kinase (MLCK) to Ca^ + , and (d) 
it reduces Ca^ + entry into the cell by inactivating voltage-operated channels 
(VOC). Many smooth muscle relaxants produce their effects by stimulating 
adenylate cyclase activity with a subsequent increase in the level of cAMP and 
a reduction in [Ca^ +Jj. These agents include adenosine (Bumstock & kennedy,
1985), vasoactive intestinal peptide (VIP, Hand et al,, 1984), histamine 
(Tucker et al, 1975), prostaglandins (Bolton, 1979), and forskolin (Seamon &
Daly, 1986), as well as the p-adrenoceptor agonists such as isoprenaline 
(Bolton, 1979; Hardman, 1981). One of the actions of cyclic AMP to reduce 
free Ca^ + is by promoting extrusion mechanisms as seen in the isoprenaline- 
induced relaxation of smooth muscle (Marshall & Kroeger, 1973). This Ca^ + 
extmsion could be due to activation of Na+-Ca^+ exchange resulting from a 
cyclic AMP-dependent increase in Na^-K^-ATPase (Scheid et al., 1979).
Relaxation of smooth muscle by reduction in free [Ca^ +Jj can be achieved not 
only by Ca^  ^ extrusion from the cell but also by uptake of Ca^ + into 
intracellular stores. Cyclic AMP along with cyclic AMP-dependent protein 
kinase have been implicated in the accumulation of Ca^ + in storage sites in 
smooth muscle, mainly the sarcoplasmic reticulum. The third method by which
■  êcyclic AMP produces relaxation involves the suppression of Ca  ^*- binding by 
the contractile proteins, actin and myosin (Riiegg et al., 1981). More recently, 
a fourth method by which the second messenger, cyclic AMP, can induce 
relaxation has been noted. Cyclic AMP can modulate ion channels and is 
known to inhibit Ca^  ^entry through voltage-operated ion channels (Meisheri & 
van Breemen, 1982). Relaxation mediated by cyclic AMP is produced by many 
signal pathways, all of which involve reduction in [Ca^+]| within the cell.
. , ■ "I
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1.4.2.2 Cyclic GMP (cGMP)
The actions of cyclic GMP are much less clear than those of cyclic AMP, 
although cyclic GMP is known to promote relaxation by impairing MLCK 
activity and accelerating Ca^ + extrusion from the cells. However, the synthesis 
and function of cyclic GMP has been studied and extensively reviewed by 
Waldman and Murad (1987). A relationship between raised levels of cyclic 
GMP and relaxation in response to drugs and inhibitory NANC stimulation has 
been noted in many smooth muscles (Bowman & Drummond, 1984). Rises in 
cyclic GMP also accompany relaxation produced by a number of drugs in a 
variety of vascular and non-vascular smooth muscles (Rapoport & Murad, 
1983). A group of drugs, collectively termed nitrovasodilators, has been helpful 
in elucidating the mechanisms by which cyclic GMP may be involved in smooth 
muscle relaxation. These drugs have been used since the nineteenth century 
following the synthesis of amylnitrite (Balard, 1844). Since then, this group has 
grown to include nitroprusside, nitroglycerin, hydroxylamine and sodium 
nitrate, which produce relaxation by activation of guanylate cyclase and raised 
levels of cyclic GMP (Schultz et al., 1977). Nitrovasodilators generate nitric 
oxide either spontaneously or enzymatically and this free radical is the proximal 
activator of guanylate cyclase (Murad & Aurbach, 1977; Murad et al., 1981), 
It has been shown that EDRF and probably the inhibitory factor released from 
some inhibitory NANC nerves (Moncada et al., 1988; Gillespie & Sheng, 
1988; Martin et ah, 1988) are nitric oxide or a closely related substance. EDRF 
and the inhibitory factor produce increased levels of cyclic GMP in their target 
organs. This suggests that the actions of nitric oxide are indeed mediated by 
cyclic GMP. Furthermore agents which inhibit guanylate cyclase activity and 
hence the production of cyclic GMP, including methylene blue, cyanide and 
ferricyanide also inhibit relaxation induced by nitrovasodilators (Katsuki et al., 
1977; Holzmann, 1983). The effects of cyclic GMP were recently proposed to
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be mediated via cyclic nucleotide kinases with subsequent protein 
phosphorylation.
1.5 The Vascular Endothelium
The vascular endothelium comprises a single layer of cells, resting on a 
basement membrane, which lines the luminal side of every blood vessel within 
the body, as well as the chambers of the heart. In addition to regulating 
vascular smooth muscle tone by a number of vasoactive agents which are 
released from cells into the bloodstream from nerve terminals in the vessel wall, 
the endothelium is also able to secrete a number of vasoactive substances, 
including two vasodilator substances, endothelium-derived relaxing factor 
(EDRF; Furchgott & Zawadzki, 1980b), and prostacyclin (PGI -^ Moncada 
et al., 1976), and the endothelins, a group of vasoconstrictor peptides 
(Yanagisawa et al., 1988). The endothelium also provides a non-thrombogenic 
lining to the blood vessel both due to the nature of the endothelial cell surface 
and through the release of EDRF and prostacyclin (PGI2) which inliibit platelet 
aggregation (Azumae^a/., 1986; Radomski et al., 1987a). Additionally, EDRF 
has been shown to inhibit platelet adhesion (Radomski et al., 1987b), whilst 
prostacyclin (PGI2) has been shown to inhibit the adhesion only of activated 
platelets (Fiy etal., 1980).
1.5.1 Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO)
Furchgott and Zawadzki (1980b) demonstrated that acetylcholine-induced 
relaxation of pre-constricted rabbit aortic strips was dependent on the presence 
of the endothelium. Since that time, endothelium-dependent vasodilation has 
been elicited in vessels from a variety of mammalian species, by a number of 
pharmacological agents. These agents, including bradykinin, adenosine
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triphosphate (ATP), adenosine diphosphate (ADP), thrombin, histamine, 
substance P (SP), arachidonic acid, platelet activating factor (PAF), 
5-hydroxytryptamine (5-HT), vasopressin and calcium ionophore, A23187 
(Furchgott, 1984; Griffith et al., 1984; Vanhoutte et al., 1986) stimulate the 
endothelium to release a very labile, humoral factor referred to as endothelium- 
derived relaxing factor (EDRF). Some of these substances exhibit endothelium- 
dependent relaxation only or predominantly in some vascular beds and not in 
others. Endothelium-dependent relaxation of vascular smooth muscle has also 
been shown to be induced by hypoxia, increased blood flow and electrical 
stimulation (see Moncada et a l, 1988, for review). There is increasing 
evidence that EDRF is nitric oxide (Palmer et al, 1987, Ignarro et al., 1987b) 
or a closely related nitrosothiol (Myers et a l, 1990). Several lines of evidence 
indicate that L-arginine (n-Arg) is the physiological precursor for the formation 
of nitric oxide in vascular tissues (Moncada et al., 1989; Palmer et al., 1988a; 
Sakuma et al., 1988), following activation of the enzyme nitric oxide synthase. ■I3:
Nitric oxide appears to be derived from the terminal guanido nitrogen of L-Arg 
.by a stereospecific enzymatic process (Palmer et al,. 1988b; Schmidt et al.,
1988). The synthesis of NO is Ca^+-dependent, in particular, extracellular Ca^ +
(Singer et al., 1982; Griffith ct al., 1986). NO synthase was found to be a 
calmodulin-requiring enzyme, thereby explaining numerous reports of a crucial 
role for calcium in endothelial-dependent smooth muscle relaxation (Palmer &
Moncada, 1989; Bredt & Snyder, 1990; Bredt et a l, 1991). Neurones in the 
peripheral (Gillespie et al., 1989) and central nervous system (Garthwaite et 
al., 1988), are able to produce nitric oxide, which modulates the activity of 
other neurones. Furthermore, cells of the immune system, most notably 
macrophages, can produce massive quantities of nitric oxide (Stuehr &
Marietta, 1987; Iyengar et al., 1987), following activation by bacterial 
endotoxin or cytokines such as interleukin-1, tumour necrosis factor and 
interferon-y, and use this substance not as an intracellular messenger, but as a
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means of killing invading microorganisms. Smooth muscle cells in the vascular 
wall have a similar capacity to synthesize large quantities of nitric oxide 
following such immunological stimulation, and this is believed to account for 
the profound fall in vascular tone associated with endotoxin shock (Kilbourn 
et al., 1991; Gray et al., 1991). EDRF directly activates soluble guanylate 
cyclase of vascular smooth muscle causing an increase in guanosine 3', 5-cyclic 
monophosphate (cGMP) and thereby causing relaxation of the vascular smooth 
muscle. (Forstermann et al., 1986; Furchgott & Zawadzki, 1980b). Selective 
inhibitors of cGMP phosphodiesterase, such as M&B 22948 (Zaprinast) and 
2MY 5445, have been shown to potentiate endothelium-dependent relaxation 
(Martin et a l, 1986). Structural modification at one of the guanidino nitrogens 
of L-arginine has led to the development of a number of compounds, 
N'^-monomethyl-L-arginine (l-NMMA), N^-nitro-L-arginine (l-NOARG) and 
W-nitro-L-arginine methyl ester (l-NAMB; Rees et a l, 1989a; 1990; Moore 
et al, 1990), that competitively inhibit nitric oxide synthase. These agents 
inhibit endothelium-dependent vasodilation in vitro and have a powerful 
hypertensive effect in vivo, indicating an important role for nitric oxide in the 
regulation of systemic blood pressure (Rees et al, 1989b).
1.6 Histoiy of 5-Hydroxytryptamine (5-HT)
The endogenous vasoconstrictor substance serotonin (5-hydroxytryptamine) 
was demonstrated by Steven and Lee (1884) and later investigated by Brodie 
(1900), who proved that the serum obtained after blood clotting increased 
vascular tone. In 1933, Vialli and Erspamer found the presence of enteramine 
in the gastrointestinal tract (GIT). Rapport and colleagues (1947) reported the 
existence in serum of a vasotonic substance, which was originally called 
serotonin. The latter substance was identified as 5-HT (Rapport et a l, 1948; 
Rapport, 1949), and was found to be identical with enteramine. 5-HT was
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subsequently found in the CNS (Bogdanski et a l, 1956; Brodie & Shore, 
1957). It is believed that 5-HT plays an important role as a neurotransmitter 
and as a local hormone in the peripheral vascular system. At the peripheral 
level, 5-HT affects smooth muscle fibres, causing constriction or relaxation 
(Vanhoutte, 1985; Saxena & Villalon, 1991). 5-HT is involved in numerous 
physiological events, it affects various Sanctions of the CNS, including, sleep, 
thermoregulation, learning and memory, sex and other functions (review by 
Zifa & Pillion, 1992). 5-HT is thought to play a role in various types of 
pathological conditions (review by Zifa & Pillion, 1992).
I
1,6.1 5-HT receptors
The effects of 5-HT in the cardiovascular system differ from species to species; 
obviously this results from activation of a number of different mechanisms, 
involving more than on type of 5-HT receptor (Ruffolo et a l, 1979 ). The 
5-HT receptors have been divided into four classes: 5-HTi, S-HTj, 5-HTg and 
5 -HT4 receptors (Bradley et al, 1986; Fozard, 1990; Bockaeit et al, 1992). 
The 5-HTj class itself is heterogeneous and has been subclassified into 5-HT^^, 
5-HTib, 5-HTic and S-HT^^ subtypes which exliibit distinct pharmacological 
profiles and are coupled to different second messenger systems (Hoyer, 1989). 
In the vascular system, 5-HT activates distinct 5-HT receptors to elicit either 
contraction or relaxation of vascular smooth muscle. Contraction of isolated 
vessels is mediated by 5-HTg receptors, which are blocked by the S-HTj 
receptor antagonist ketanserin, or by 5-HTi-like receptors which are 
characterized by a high agonist activity of 5-carboxamidotryptamine (5-CT) 
(Bradley et al,, 1986; Hamel & Bouchard, 1991; Bax et al, 1992). The 5-HT- 
induced relaxation of vessels with intact endothelium or denuded of 
endothelium was shown to involve 5-HT -^like receptor subtypes (Cocks & 
Angus 1983; Molderings et a l 1989; Mylecharane 1990).
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1 .6 .2  Desensitisation o f the 5-HT2 receptors
Homologous desensitisation is a widespread phenomenon in which initial 
exposure to an agonist results in decreased cellular responsiveness on second 
exposure. 5-HT receptors, like many other receptors, are susceptible to agonist 
induced desensitisation. Thus, S-HTj receptors located on cortical neurons 
(Leysen et a l, 1989), cerebellar granule cells (Dillon-Carter & Chuang, 1989), 
facial motoneurons (Aghajanian, 1990) and platelets (Kagaya et a l, 1990) 
undergo desensitisation. As with other receptors leading to activation of 
protein kinase C (PKC), desensitisation of S-HTj receptors results from 
feedback inhibition mediated by protein kinase C (Roth et a l, 1986; 
Aghajanian, 1990). Such inhibition may serve (i) to protect cells from over 
stimulation, (ii) as a modulatory substrate by other regulators of cellular 
activity.
A second mechanism leading to loss of receptor mediated responsiveness is 
internalization or sequestration of receptors by which hydrophilic agonists are 
prevented access to receptors. Sequestration of P-adrenoceptors has been 
extensively studied (Waldo et a l, 1983; Toews et a l, 1984; Kassis et al.,
1986). Internalization of P-adrenoceptors occurs in the presence of high 
concentrations of agonist (Waldo et a l, 1983). Sequestration of 5 HT4 
receptors has been recently demonstrated (Ansanay et a l, 1992). Recently, 
multiple mechanisms of 5-HTa receptor desensitisation by Rahman and 
Neuman (1993) have been studied. They investigated mechanisms underlying 
desensitisation of S-HTj receptors in rat sensory-motor cortex and concluded 
that 5 -HT2 receptors both induce and undergo several forms of desensitisation.
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1.7 Cigarette Smoking 
. .Cigarette smoking is one of the major risk factors for the development of
atherosclerosis (Jacobs et al., 1993). One of the most important health
consequences of cigarette smoking in human subjects is the development of
diffiise vascular injury. In the past, despite the fact that cigarette smoking
caused alterations in the intima of the muscular pulmonary arteries and fibrosis 
.and wall thickening of the small pulmonary arteries and arterioles, cigarette 
smoke (CS)-related research has mainly focused on the airways and alveoli.
Nevertheless CS has been implicated in cardiovascular disease, but little 
research has been carried out to determine its implications on the pulmonary 
vasculature. This is surprising since the constituents of inlialed CS have 
immediate access to the pulmonary circulation and it is likely that these are the 
vessels most likely to be affected at an early stage. The pulmonary veins will be 
exposed to the highest concentration of CS at its site of absorption. Thereafter, 
with dilution in and diffusion from the vascular compartment and distribution 
to other sites, the concentration of CS attained in other blood vessels will be 
much lower. Therefore, it is reasonable to assume that if CS causes 
cardiovascular damage, impairment of pulmonary vascular function will be 
seen. Indeed, morphological abnormalities in endothelial cells have been 
observed in human subjects who have been smokers for fairly long periods of 
time (Rubinstein etal., 1991). The chemical composition of CS is complex and 
it is difficult to determine which compound or compounds may be involved in 
vascular injury. It is known that CS contains approximately 10"i4 free radical
Ï
per inhalation (Noronha-Dutra et al, 1993), mainly NO derived radicals in the 
gas phase and quinone radicals in the tar phase, as well as various tars, the 
vasoactive substance, CO, as well as acrolein, acetaldehyde and nicotine. 
Nicotine, being the major pharmacologically-active component of CS, has been 
considered as a mediator of vascular injury (Kershbaum et al., 1961).
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However, several studies have failed to demonstrate any consistent and 
significant vascular effects due to nicotine exposure. This project will seek to 
determine if smoking has any detrimental effects in the cardiovascular system. 
The lungs function to oxygenate the blood, but they also have a protective role 
by removing vasoactive substances from the bloodstream. Therefore, any 
impairment of lung vascular functioning caused by CS may have serious 
implications for the heart's fimctioning, since, the harmful vasoactive 
substances will not be removed and instead they will be transported directly to 
the heart with hazardous consequences, not only for the heart, but potentially 
for the rest of the systemic circulation.
1.8 Chronic Heart Failure (CHF)
Heart failure in man has been described as " the inability to deliver blood 
because of structural changes from diverse causes " (Stead, 1967). The most 
common cause is ischaemic heart disease although hypertension and genetic 
factors are also important. Heart failure may be acute or chronic. Congestive 
heart failure is the clinical syndrome which usually results from chronic heart 
failure (CHF). The congestion is caused by a build up of fluid in the 
cardiovascular system as the body attempts to compensate for a reduced blood 
pressure fi-om the failing heart. This will often manifest itself as oedema, 
engorgement of vascular beds such as the liver, and distension of peripheral 
veins, especially in the neck. The site of the congestion depends on which side 
of the heart is affected.
In left sided heart failure (HF), fluid will accumulate in the pulmonary 
circulation, leading to pulmonary oedema. This causes dyspnoea, and this is 
most noticeable on exertion. This is the classical first symptom of CHF. Right 
sided failure, which often follows on from left sided failure, gives more 
generalized systemic oedema (Davidson, 1964). The body's natural reaction to
$
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CHF is to increase sympathetic activity, which triggers a general 
neurohormonal excitation (Ferguson, 1993), leading to peripheral 
vasoconstriction, so increasing the total peripheral resistance. Unfortunately, as 
far as every other organ in the body is concerned, this is a maladaptive 
response, as it only serves to put further strain on the failing heart. Some of the 
effects of the neurohormonal responses to HF include an increase (i) in plasma 
levels of angiotensin II (Ang H), (ii) in aldosterone, (iii) in antidiuretic hormone 
(ADH) and (iv) in atrial natriuretic factor (ANF). Increased sympathetic 
activity also places extra strain on the heart by promoting fluid retention, and is 
responsible for the congestion and oedema. The modem treatment of choice 
for CHF is the angiotensin converting enzyme (ACE) inhibitors, such as 
captopril and enalapril. These drugs are indeed, amongst the only drugs which 
have been proven to prolong the life of CHF sufferers (Cohn et ah, 1986). 
Ang II is elevated during heart failure because the increased sympathetic 
activity activates p^-adrenoreceptors on the juxtaglomerular cells of the kidney, 
which in turn secrete renin to increase, eventually the production of Ang II, 
which itself is a potent vasoconstrictor that will also stimulate aldosterone 
secretion from the adrenal cortex. Aldosterone acts on the kidney to promote 
Na+, and therefore water, retention. Both of these actions put increasing strain 
on the failing heart.
1.9 The Aims of this study, which were:
i ) Investigation of mechanical responses of rat isolated pulmonary artery rings 
to both vasoconstrictor and vasorelaxant dmgs.
ii ) Investigation of the role nitric oxide (NO) in the 5-hydroxytryptamine- 
induced desensitisation in rat isolated pulmonary artery rings.
■IIÎ
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iii ) Investigation of the effects of cigarette smoke on the responsiveness of the 
pulmonary vasculature of rat to both vasoconstrictor and vasorelaxant drugs.
iv ) Investigation of the responses of rat isolated pulmonary arteiy rings to 
electrical field stimulation.
V ) Investigation of the effects of vasoconstrictor and vasorelaxant drugs in 
isolated pulmonary artery rings of sham operated and HF rabbits.
' 3 i
Chapter 2 
MATERIALS & METHODS
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2 MATERIALS & METHODS
2.1 Experimental Rats
The rats used for research purposes were kept in a control area. Their food 
was obtained from Labsure CRM diet and ordinary tap water was used for 
their drinking. The temperature and light of the animal house were controlled.
The temperature was maintained between 18-22°C and the lighting of the area 
was regulated in a cycle of twelve hours light (i.e. 6:30-18:30 h) and twelve 
hours dark.
2.2 Preparation of Artery Rings and Tension Recording
Male Wistar rats weighing 250-3OOg were killed by stunning and 
exsanguination. The heart and lungs were excised together and pinned on 
silicone rubber in a petri dish containing Krebs buffer (0°C) in an orientation 
that facilitated identification of the pulmonary arteries. The pulmonary arterial 
tree was rapidly dissected from the lung parenchyma with a small scissors and 
forceps. Segments of, the main pulmonary artery (MPA) and its first branches 
(BPA) were carefully cleared of adhering tissue and cut to obtain three rings 
(3-4mm in length); one MPA ring of approximately 3mm in diameter, and two 
BPA rings of approximately l-2mm in diameter were transferred to fresh 
ice-cold Krebs buffer. Generally, the right BPA was found to be of a slightly 
larger diameter than the corresponding left BPA. Endothelial cells were 
removed from some rings by gently rubbing the intimai surface with a moist 
wooden stick for 30-60s (Furchgott & Zawadski, 1980a). The effectiveness of 
this procedure was subsequently investigated using acetylcholine (ACh, lO’^M) 
which normally relaxed arteiy rings but had no such effect in rubbed rings 
(Furchgott & Zawadski, 1980a). Artery rings then were mounted under Ig
I
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resting tension onto two 0 .2 mm shaped stainless steel wire hooks and/or one 
shaped and one triangular, (to prevent the tissue slipping off the holder.
especially during stimulation) gently inserted into the lumen to avoid damage to
the endothelium in 25ml organ baths containing Krebs-Henseleit solution
maintained at 37°C, and containing (mM) NaCl, 118; KCl, 4.8; CaCl ,^ 2.5;
.MgSO^, 1.2; KH2PO4, 1.2; NaHCO^, 24; Glucose, 11; gassed with mixture 
95% O2 and 5% CO ,^ which gave a pH of 7.3-7.4. The top hook was 
connected by cotton [surgical silk, black braided, silk suture, EP2 (US 3/0), 
non absorbable - non sterile, 1001-40 Lot 92/43/9356] to a Grass FT03 
isometric transducer while the bottom hook was connected to a stable glass 
tissue holder. A diagram of the experimental apparatus is shown in figure (2.1)
Tension responses were recorded isometrically with Grass FT03 transducers 
and were displayed on a Grass model 7 polygraph. Before commencing each 
experiment, artery rings were allowed to equilibrate for 1 hour, during which 
time a steady resting tension was achieved. In some of the experiments, during 
the equilibration period the bathing fluid was changed regularly (every ISmin) 
and tension was reset to Ig if necessary. In some of experiments, the optimal 
preload was determined for each segment by measuring the maximal contractile 
response to 30mM KCl after incremental stretch. After each experiment, the 
tissues were then washed by changing the bathing Krebs solution 37°C three
times over a 15min period before further increasing the degree of stretch of the
.tissue. In addition, when noradrenaline (NA) was used, the Krebs solution also 
.contained 23x10"^ ethylene diaminetetra-acetic acid (EDTA) in order to 
reduce degradation of the noradrenaline. At the end of each day's experiments 
the artery strip preparations were gently blotted, dry and weighed on a 
microbalance. The contractile force was expressed in terms of mg tension per 
mg weight of tissue.
I
I.
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Water from water bath at 37°C
37°C water heats adjacent organ bath
Storage container of Krebs'
Transducer Attached to Grass polygraphHeatingcoils
Ring holders maintaining ring at 1 g tension
Gasconsistingof95%02,
5% C 02
WasteFig.2.1.
Diagiam of apparatus used to measure tension o f preparation rings
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2.3 Preparation of Cigarette Smoke Extract 
.A standard cigarette smoke extract (CSE) was freshly prepared in Krebs- 
Henseleit buffer (KHB, 4 cigarettes/100ml) for each day's experiment and was
'•used within two hours of preparation. Smoke extract from the cigarettes 
("Players Img nicotine, 14mg tar per cigarette) was obtained using a simple 
piston smoking machine (Fig. 2.2) which "inhaled" the smoke and then pumped 
it into a Woulfe bottle, where it was bubbled through the Krebs buffer (room 
temperature) to dissolve the water soluble constituents of cigarette smoke 
(CS). The smoking machine had a calibrated piston, which allowed the volume 
of smoke inhaled per puff to be controlled, and altered to a volume of between 
1 and 10ml. The rate at which the machine smoked the cigarette could also be 
controlled. Thus the rate of smoking could be varied from 20 "inhalations"
/minute to 60 "inhalations"/minute. A rate of 2 0  "inhalation"/minute was 
selected for this experiment. There was a valve between the inlet and the outlet
i
tubes so that there could be no blow back of air through the cigarette. A Scinta 
glass bubbler was attached to the end of the outlet tube and this was securely 
held and sealed in the Woulfe bottle below the level of the Krebs buffer. 
Therefore, when smoke was exhaled down the outlet tube, a very large number 
of tiny bubbles were produced with each exhalation, providing a large surface 
area for dissolving the water soluble constituents of the smoke. 3i’s"
2.4 Effect of Electrical Field Stimulation (EFS)
■I
.Some experiments were carried out in order to determine whether there was 
any evidence of the existence of a neuronally-mediated response and if so, what 
was the nature of the transmitter(s) and receptor(s) involved. Electrical field 
stimulation (EFS) was applied by two parallel wire electrodes, (one of silver;
0.5mm, thickness and the other stainless steel; 0.2mm, thickness) positioned at
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2.5 Experimental Model of Heart Failure
each end of the vessel rings and connected to a Grass S44 stimulator. 
To activate the intramural nerves without inducing a myogenic response, 
voltage-response curves were obtained in the absence and presence of 1 0  %  
tetrodotoxin. The supramaximal voltage was determined by field stimulation 
with the following parameters: 4, 8 , 16 and 32 Hz for 1, 5 and 10 seconds 
train, with a pulse width of 0.1 ms at voltages of 10, 20, 30, 40, 50, 60 and 
70V. After determining the supramaximal voltage (70V) in a preliminary study, 
control firequency-response curves (FRC), were obtained for each preparation, 
in a fiequency range of 4,8, 16 and 32 Hz, each stimulation being applied for 
10 seconds. Repetitive stimulation was applied, once every 5min, until constant 
responses were achieved. In separate experiments, to determine the origin of 
the contractile responses to EFS, the artery rings were incubated with 
tetrodotoxin (10”% ; for 10-20min) or prazosin (PRAZ, 10"%, for ISmin) and 
stimulated at 4 to 32 Hz or 16 to 32 Hz. To determine whether endogenous 
nitric oxide (NO) had any effect on the EFS-induced responses, the artery rings 
were pretreated with NO synthase inhibitor, l-NAME (10"%, for lOmin) 
before EFS.
Heart failure was induced by coronary artery ligation in male New Zealand
rabbits (Denvir, 1994). This procedure produced an area of ischaemia, and
myocardial infarct. In this respect it is very similar to a coronary atheroma,
which is a very common cause of chronic heart disease (CHD). The operation
on the rabbits was carried out by surgeons at the Royal Infirmary in Glasgow.
.Male New Zealand white rabbits weighing 2.5-3.0 kg were premedicated with 
intramuscular (i.m) Hypnorm [0.3 mg/kg fluansione (lOmg/ml): fentanyl citrate 
(0.315 mg/ml)]. The animal was further sedated with intravenous (i.v.) 
midazolam (0.25-0.5 mg/kg) to allow endotracheal intubation. The animal then
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was ventilated (0.3 - 0.4 1/min/kg), The rabbits were anaesthetized with an 
inhaled mixture of 1% halothane/ 1% nitrous oxide (NgO)/ 2 0 % oxygen (O^).
... ,vLeft lateral thoracotomy was performed to expose the heart, the pericardium 
opened and a tie placed through the cardiac apex to allow easier manipulation 
of the heart. The left marginal branch of the left circumflex coronary artery was
ligated using a 6/0 Ethicon suture at midpoint between the atrioventicular 
groove and the cardiac apex. The infarcted area rapidly became blue, and the 
position of the suture could be altered proximally or distally to obtain a 
satisfactory size of infarction. The rabbits were injected with intravenous 
quinidine (15mg/kg) into the marginal ear vein 5 minutes prior to ligation to 
reduce the incidence of arrhythmias. After ensuring that the lungs were 
properly inflated, the chest wall was closed and post-operatively, antibiotics 
were administered by intra-muscular injection (ampicilUn 25mg/kg and
cephalexidine 15mg/kg). Post operative analgesia was administered (0.2 mg/kg 
intra-muscular buprenorphine) at 30 minutes and 6 - 8  hours, and as considered 
to be required. The animals were then allowed to develop chronic heart failure 
(CHF) over the next 8 weeks. Sham operated animals underwent a similar 
procedure but the ligature was not tied round the coronaiy artery. At the end 
of 8  weeks, a catheter was inserted via the femoral artery to measure left 
ventricular ejection fraction to assess the extent of heart failure. The 
preparation of the animals was done by surgeons at Glasgow Royal Infirmary.
The heart failure rabbits were killed at 8 weeks after ligation by a lethal 
intravenous injection of pentobarbitone into the ear vein. The sham-operated 
rabbits were killed at 8  weeks by the same method. The animals were number 
coded and the experiments were performed blind; i.e. the codes were not 
broken until after each experiment. The dissection of the artery rings and the 
way they were set up in the organ baths, were the same as previously 
described, with the difference that from each rabbit two or three MPA rings
4
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■ I(3-4 mm in length) and four or six BP A rings (3-4 mm in length) were 
obtained. ■'I'
2 .6  Experimental Protocols
2.6.1 Effect o f contractile agonists
In these experiments, cumulative concentration response curves (CCRCs) to 
some of contractile agonists, such as phenylephrine (PHE), 
5 -hydroxytryptamine (5-HT), noradrenaline (NA), angiotensin II (Ang II) and 
thromboxane Ag mimetic, U46619 were obtained on endothelium-intact or 
endothelium-denuded rings and also in the absence and presence of No-nitro-L- 
arginine methyl ester (l-NAME), an inhibitor of nitric oxide synthase from 
Wistar rat main pulmonary artery and its first branch rings. Agonists were 
cumulatively added in volumes 0 .1ml (the final dilution in the organ bath) over 
the full concentration range. When the effect of l-NAME was to be examined 
on basal release of nitric oxide, it was added 1 0 -2 0 min before the addition of 
any contractile agonist. Also in experiments in which CCRCs to NA were 
obtained, cocaine was added at least lOmin prior the onset of a second CCRCs. 
EC75 values were calculated as the concentration of drag required to elicit 
75% of the maximum response.
S
2.6.2 Effect o f relaxant agonists 
.In these experiments, CCRCs were obtained in the presence of the EC75 or the 
EC70 for PHE or the EC50 for 5-HT to vasorelaxants, such as the endothelium- 
dependent relaxants, acetylcholine (ACh), carbachol (CARB), histamine 
(HIST) or the endothelium-independent relaxants, sodium nitroprusside (SNP) 
or purinoceptor agonists, such as adenosine (AD), adenosine 5 -triphosphate 
(ATP), adenosine 5'-diphosphate (ADP) or the p-adrenoceptor agonist, 
isoprenaline. These vasorelaxant responses were obtained in the absence or
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presence of l-NAME or in the presence of antagonists or in endothelium 
denuded rings. Vasorelaxant agonists were added cumulatively in volumes of 
0.1ml (the final dilution in the organ bath), when the contractions to PHE 
(EC75 or EC7Q) or 5-HT (EC50) reached a stable plateau. When the effects of 
l-NAME or antagonists were to be examined, these drugs were added 
10-20min before the addition of any relaxant agonists. Relaxant effects were 
expressed as a percentage (%) relaxation of the PHE- or 5-HT-induced tone.
2.6.3 Desensitisation to 5-hydroxytryptanüne (5-HT) or phenylephrine 
(PHE)
In these experiments, pulmonary artery rings and its first branch rings were
exposed either to 5-HT (10"%, for 30min or 1 hour) or to PHE (lO'^M, for
2 hours), which produced desensitisation. Responses to standard submaximal
concentrations of 5-HT and PHE or concentration response curves (CRC)
were then obtained and compared with control responses obtained prior to the
desensitisation. In some experiments, the part played by the endothelium in
agonist-induced desensitisation was examined using rings in which the
endothelial cells had been removed by rubbing. In addition, the role of NO in
desensitisation was examined by studying the effects of L-NAME, L-arginine
(L-Arg) and oxy-haemoglobin (HbO), which were administered according to
two protocols. First, HbO or L-NAME was added after desensitisation had 
.been induced by prolonged exposure either to 5-HT or PHE. The reversibility
of the effect of l-NAME was then investigated by adding L-arginine. In the 
second protocol, the L-NAME was added befor 
and again after desensitisation had been induced.
e the desensitisation procedure
1;
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2.6.4 Effects o f cigarette smoke extract
2.7 Drugs
After having obtained control concentration-response curves for PHE, 
concentration-response curves to ACh and SNP were also obtained. In 
subsequent experiments, increasing amounts of cigarette smoke extract (CSE)
in Krebs buffer were administered to the baths as a pretreatment (10»15min), 
ensuring that a final volume of 25ml was maintained after each CSE addition, 
and the concentration-response curves to PHE, ACh and SNP repeated. The 
contractile response curves to PHE and also the relaxant response curves to 
ACh and SNP were obtained in the absence and presence of CSE. The 
contractile response curves to PHE were expressed as tension mg mg tissue 
and the dilator responses to ACh and SNP were expressed as % inhibitions of 
the contractile response to the EC^o of the precontracting agonist PHE 
(10-7M).
a
5-hy droxytryptamine creatine sulphate, L-phenylephrine hydrochloride, 
acetylcholine chloride, carbamylcholine chloride (carbachol), 
NcD-nitro-L-arginine methyl ester (l-NAME), L-arginine HCl, sodium 
nitroprusside (SNP), haemoglobin, DL-propranolol HCl, atropine sulfate, 
(-)-isoprenaline, adenosine, adenosine 5'-diphosphate (ADP), adenosine 
5'-triphosphate (ATP), angiotensin II, mianserin HCl, indomethacin, histamine, 
prazosin HCl, theophylline, cocaine HCl, (~)-artemolol, (+)-chlorpheniramine, 
bradykinin, idazoxan HCl, substance P, U46619, 3-isobutyl-1 -methylxantine 
(IBMX), Nco-nitro-L-arginine (l-NOARG), glybenclamide (glyburide), were 
obtained from Sigma (Dorset); di sodium ethylendiaminetetra-acetate from 
M&B (May & Baker LTD); potassium chloride from Fisons; sodium chloride 
from BDH. All drugs were dissolved in saline (0.9%) or in Krebs buffer.
_
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2.8 Statistical Analysis
The results are expressed as means ± standard errors of the means (S.E.M). 
Comparisons were made using the paired Student's t-test and where 
appropriate, the unpaired t-test were used. A probability of less than 0.05 was 
considered to be significant.
B
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3 RESULTS
3.1 Investigation of Contractile Responses to Agonists in Isolated Main 
Pulmonary Artei-y (MPA) Rings and in its First Branches (BPA) from 
Wistar Rats
3.1.1 Contractile responses to 5-hydroxytryptamine (S-HT)
5-Hydroxytryptamine (5-HT, 10”'^  to 10"^M), administered non-cumulatively, 
produced concentration-dependent contractions in Wistar rat isolated main 
pulmonary artery (MPA) rings and in its first branches (BPA) (Fig. 3.1 to 3.2). 
The MPA and BPA rings were equally responsive to 5-HT (1 0 "^  to 10""*M), 
but BPA rings were more responsive to high concentrations (lO'^M) of 5-HT 
than MPA rings (0.05 > P > 0.01; Fig. 3.3). In endothelium-intact rings, 
Nco-nitro-L-arginine methyl ester (L-NAME, 5x10"%) caused a slowly- 
developing increase in resting tone but not in all of the preparations (data not 
shown) and potentiated responses in both MPA and BPA rings to high 
concentrations (10"  ^ to 10"^M) of 5-HT (Fig. 3.1 to 3.2), but not in 
endothelium-denuded rings. In comparison between contractile response curves 
to 5-HT, in intact rings pretreated with l-NAME, BPA rings were more 
responsive than MPA rings to 5-HT (10"^M) (0.05 > P > 0.01; Fig. 3.4). The 
mechanical removal of the endothelium by rubbing potentiated concentration- 
response curves to 5-HT in these rings. The effects of incubation with 
l-NAME (5x10"%, for 20min) and removal of the endothelium in MPA rings 
on the concentration response curves to 5-HT were very similar (Fig. 3.1 to 
3.2. In endothelium-denuded rings, l-NAME was without effect on either 
resting tone or on the contractile responses to 5-HT. The ECjo values and the 
maximum contractile responses to 5-HT, in the absence and presence of 
l-NAME, are summarized in Tables 3.1 and 3.2. l-NAME did not affect the
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ECjo of 5-HT. There were no significant differences between the ECg@ values 
to 5-HT, in MPA and BPA rings, whether in the absence or presence of
curves were obtained in the absence and presence of 5 -HT2-antagonist,
in completely inhibite*
response curves to 5-HT (10"  ^to 10“^ M).
,
l-NAME (Table 3.2). In one series of the experiments, cumulative response
f 
.mianserin (10"%I; for lOmin). Mianser i ited cumulative
vEy
500  1
400  -
0)3(nUîh-
300  -T
enE 200  “ ++coenc0)h-
- 5 4—  8 - 6 3 - 2
I
4
5 -H T  (Log M)
Fig. 3.1
Non-cumulative concentration-response curves to 5-hydroxytryptamine (5-HT, 
1 0 ”'^  to 10"3M) in the absence (open square) and presence (closed square) of 
l-NAME (5x10"^M) in MPA rings and/or in endothelium-denuded (open 
circle) rings of Wistar rats. Tension was recorded (mg mg"i tissue) and 5-HT- 
induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n- 8  rings from 8 animals. 
The vertical bars show ± S.E.M. Significant difference between means is 
indicated by p  values'. * P < 0.05; ** P < or ^  P < 0.01; *** P < or 
P < 0 . 0 0 1  (paired and unpaired Student's t test).
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Fig. 3. 2
Non-cumuîative concentration-response curves to 5-hydroxytryptamine (5-HT, 
to 10"^M) in the absence (open diamond) and presence (closed diamond) 
of l-NAME (SxlO'^^M) in BPA rings and/or in endothelium-denuded (open 
circle) rings of Wistar rats. Tension was recorded (mg mg"i tissue) and 5-HT- 
induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n= 8  rings from 6  animals. 
The vertical bars show ± S.E.M. Significant difference between means is 
indicated by p  values: ** P < or ++ P < 0.01; P < 0.001 (paired and 
unpaired Student's t test).
t
i
:::Z
!
Ï
I.T
a-
__
(D 3 (0 M i—
IcnE
coMc
CO
500 n
400
300
200
100  -
V  VS
6 - 5  - 4
5 -H T  (Log M)
Fig. 3. 3
Comparison between non-cumulatlve concentration-response curves to 
5-hydroxytryptamine (5-HT, 10"'^  to 10"^M) in MPA (open symbol) or BPA 
(closed symbol) rings of Wistar rats. Tension was recorded (mg mg"^  tissue) 
and 5-HT induced concentration-dependent contractions were obtained in these 
preprations. The results are expressed as means of n=6 - 8  rings from 6 - 8  
animals. The vertical bars show ± S.E.M. Asterisk indicates significant 
difference between means by p value: * P < 0.05 (unpaired t test). 1
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Fig. 3. 4
Comparison between non-cumulative concentration-response curves to 
5-hydroxytryptamine (5-HT, 10~'^  to lO'^M) in the presence of l-NAME 
(5xlO"^M) in MPA (open symbol) or in BPA (closed symbol) rings of Wistar 
rats. Tension was recorded (mg mg~^  tissue) and 5-HT induced concentration- 
dependent contractions were obtained in these preprations. The results are 
expressed as means of n=6 - 8  rings from 6 - 8  animals. The vertical bars show 
± S.E.M. Asterisk indicates significant differences between means by: p value 
* P < 0.05 (unpaired t test).
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Pulmonary Artery T h eE ^ a x
(mg mg"l tissue)
P values
MPA (control) 
V
MPA (treated)
146.60±25.80
V
224.70±36.74
0.01 > * * P >  0.001
BPA (control) 
V
BPA (treated)
212.13±26.98
V
324.08db32.28
0.01 > * * P >  0.001
MPA (control) 
V
BPA (control)
146.60i25.80
212.13i26.98
P > 0.05
MPA (treated) 
V
BPA (treated)
224.70±36.74
V
324.08±32.28
P > 0.05
(+EC) MPA (treated) 
V
(-EC) MPA (control)
224.70±36.74
V
228.27±4.28
P > 0.05
(+EC) BPA (treated) 
V
(-EC) BPA (control)
324.08i32.28
V
360.62±19.31
P > 0.05
Table 3.1
Comparison between the maximum responses induced by 5-HT in the
absence (control) and presence (treated) of l-NAME (5xlO""*M, for 2 0 min) in 
MPA and BPA rings or in endothelium-denuded (-EC) rings and/or in MPA 
rings versus (V) BPA rings fiom Wistar rats. The results are expressed as 
means of n- 8  rings from 6 - 8  animals. Asterisks indicate significant differences 
between means, p  values: ** P < 0.01 (Student's t test).
Pulmonary Artery The EC5 0  (Molar) P values
MPA (control) 10.61 xlO-^M
V V P > 0.05
MPA (treated) 9.38x10-6m
(+EC) MPA (treated) 9.38xlO-^M
V V P > 0.05
(-EC) MPA (control) 9.22xlO-^M
(+EC) BPA (treated) 6.29xlO-^M
V V P > 0.05
(-EC) BPA (control) 5.65xlO-^M
BPA (control) 9.37xlO'^M
V V P >0.05
BPA (treated) 6.29x1Q-6m
MPA (control) 10.61x10"6m
V V P > 0.05
BPA (control) 9.37x1Q-6m
MPA (treated) 9.38x10'^M
V V P > 0.05
BPA (treated) 6.29xlO-^M
Table 3.2
Comparison between the ECjq values for 5-HT in the absence (control) and 
presence (treated) of l-NAME (2x10“^ M) in MPA and BPA rings or in 
endothelium-denuded (-EC) rings and/or in MPA rings versus (V) BPA rings 
from Wistar rats. The results are expressed as means of n= 8  rings from 6 - 8  
animals.
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3,1,2 Contractile responses to phenylephrine (PHE)
Phenylephrine (PHE; 10"® to 10”'^ M) administered non-cumulatively also 
produced concentration-dependent contractions in isolated MPA rings and in 
BPA rings of rat vasculature (Fig. 3.5 to 3.6). l-NAME (5x10"^M, for 20min) 
also potentiated responses of MPA to all of concentrations of PHE (Fig. 3.5),
as well as potentiating responses of BPA to low concentrations (10"® to
10"^M) of PHE (Fig. 3.6). The BPA rings were more responsive to all of
concentrations of PHE than were MPA rings. Also, BPA rings pretreated with
l-NAME were more responsive than MPA rings to PHE (10"  ^ to 10"'*M)
(Fig. 3.7 to 3.8). The mechanical removal of the endothelium by rubbing
potentiated concentration-response curves to PHE in MPA rings and in BPA
rings. The effects of incubation with l-NAME or removal of the endothelium in
MPA rings on the PHE concentration response curves were very similar
(Fig. 3.5 to 3.6). l-NAME had no effect on either resting tone or contractile
responses to PHE in endothelium denuded rings of MPA. The EC30 values and
the maximum contractile responses to PHE in the absence and presence of
l-NAME, are summarized in Tables 3.3 and 3.4. In comparison between the
maximal contractile responses to PHE, BPA rings were more responsive than
MPA rings, whether rings were pretreated with L-NAME or not (Table, 3.3).
In comparison between the EC50 values to PHE, l-NAME increased the
sensitivity of rings to PHE (respectively, MPA: 10.43 fold; BPA: 6.57 fold).
.BPA rings were more sensitive than MPA rings when the rings were not 
pretreated with l-NAME (1.9 fold; Table 3.4).
I
%I1
J'iIn other experiments, prazosin (10"®M, for lOmin) inhibited contractile 
responses to PHE. In comparisons between the contractile responses to PHE 
and 5-HT, expressed as percentages of the maximum response, the former was 
more potent than the latter in both MPA and BPA rings (Fig. 3.9 to 3.10).
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Fig. 3. 5
Non-cumulative concentration-response curves to phenylephrine (PHE, 10“® to 
10"^M) in the absence (open triangle) and presence (closed triangle) of 
l-NAME (SxlO'^^M) in MPA rings and/or in endothelium-denuded (open 
diamond) rings of Wistar rats. Tension was recorded (mg mg"  ^ tissue) and 
PHE-induced concentration-dep endent contractions were obtained in these 
preparations. The results are expressed as means of n= 6  rings from 6  animals. 
The vertical bais show ± S.E.M. Significant difference between means is 
indicated byp  values: * P < or ^ P < 0.05; ** P < or ^  P < 0,01; *** P < or 
P < 0 . 0 0 1  (paired and unpaired Student's t test).
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Fig. 3. 6
Non-cumulative concentration-response curves to phenylephrine (PHE, 10"^  to 
10"4m) in the absence (open diamond) and presence (closed diamond) of 
l-NAME (5x10"^M) in BPA rings and/or in endothelium-denuded (open circle) 
rings of Wistar rats. Tension was recorded (mg mg"i tissue) and PHE- induced 
concentration-dependent contractions were obtained in these preparations. The 
results are expressed as means of n= 6  rings firom 6  animals. The vertical bars 
show ± S.E.M. Significant difference between means is indicated by p  values: 
* P < or + P < 0.05; * * P < o r + + P <  0.01; *** P < or +++ P < 0.001 (paired 
and unpaired Student's t test).
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Fig. 3. 7
Comparison between non-cumulative concentration-response curves to 
phenylephrine (PHE, 10"^  to 1 0 in MPA (closed symbol) or BPA 
(open symbol) rings of Wistar rats. Tension was recorded (mg mg"^  tissue) and 
PHE-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n= 6  rings from 6  animals. 
The vertical bars show ± S.E.M. Asterisks indicate significant differences 
between means, p values'. * P < 0.05; ** P <0.01 (unpaired t test)
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Fig. 3. 8
Comparison between non-cumulative concentration-response curves to 
phenylephrine (PHE, 10"^  to 10"^M) in the MPA (open symbol ) or BPA 
(closed symbol) rings pretreatment with l-NAME (5><10"4M). Tension was 
recorded (mg mg"^  tissue) and PHE-induced concentration-dependent 
contractions were obtained in these preparations. The results are expressed as 
means of n= 6  rings from 6  animals. The vertical bars show ± S.E.M. Asterisks 
indicate significant difference between means, p values: * P < 0.05 
(unpaired t test).
Pulmonary Artery
The Ejuju 
(mg mg"^ tissue)
P values
MPA (control) 
V
MPA (treated)
286.46±24.95
V
362.86±38.37
0.01 > * * ? >  0.001
(+EC) MPA (treated) 
V
(“EC) MPA (control)
362.86±38.37
V
370.36±42,10
P > 0.05
BPA (control)
V
BPA (treated)
459.56±54.90
V
316.49±34.82
P > 0.05
(+EC) BPA (ü-eated) 
V
(-EC) BPA (control)
516.49134.82
V
500.25142.10
P > 0.05
MPA (control) 
V
BPA (control)
286.46±24.95
V
459.56^54.90
0.05 > * P > 0.01
MPA (treated)
V
BPA (treated)
362.86138.37
V
516.49134.82
0.05 > * P > 0.01
■i
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Table 3.3
Comparison between the maximum responses (E^ax) induced by PHE in the 
absence (control) and presence (treated) of l-NAnSe (SxlO'^^M, for 2 0 min) in 
MPA and BPA rings or in endothelium-denuded (-EC) rings and/or in MPA 
rings versus (V) BPA rings from Wistar rats. The results are expressed as 
means of n= 6  rings from 6  animals. Asterisks indicate significant differences 
between means, p  values: * P < 0.05; ** P < 0.01 (Student's t test).
Pulmonary Artery The EC5 0  (Molar) P values
MPA (control) 9.5x10"%
V V *** P < 0.001
MPA (treated) 9.1x10"%
(+EC) MPA (treated) 9.1x10"% 1V V P > 0.05
(-EC) MPA (control) 9 .28x10'%
BPA (control) Sx lO -%
V V 0.01 > * * P >  0.001
BPA (treated) 7 .6 x 1 0 '%
(+EC) BPA (treated) 7.6x10"%
V V P > 0.05
(-EC) BPA (control) 7.84x10"%
MPA (control) 9.5x10"%
V V 0.01 > * * P >  0.001
BPA (control) 5x10"%
MPA (treated) 9.1x10”%
V V P > 0.05
BPA (treated) 7.6x10"%
Table 3.4
Comparison between the EC50 values induced by PHE in the absence (control) 
and presence (treated) of L-NAME in MPA and BPA rings or in endothelium- 
denuded (-EC) rings and/or in MPA rings versus (V) BPA rings from Wistar rats. 
The results are expressed as means of n= 6  rings from 6  animals. Asterisks indicate 
significant differences between means, p values: ** P < 0.01; *** P < 0.001 
(Student's t test).
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Fig. 3. 9
Comparison between concentration-response 
(PHE, 10"^  to 10"4M; open symbol)
(5-HT, 10"'^  to 10"^M; closed symbol) in MPA rings of Wistar rats. PHE and 
5-HT induced concentration-dependent contractions in these preparations. 
The results are expressed as means and as a percentage of the maximum 
response to PHE or 5-HT of n= 8  rings from 8  animals. The vertical bars show 
± S.E.M.
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Fig. 3. 1 0
Comparison between concentration-response curves to phenylephrine 
(PHE, 10"^  to open symbol) or 5-hydroxytryptamine
(5-HT, 10"^  to 10"^M; closed symbol) in BP A rings of Wistar rats. PHE and 
5-HT induced concentration-dependent contractions in these preparations. 
The results are expressed as means and as a percentage of the maximum 
response to PHE or 5-HT of n= 8  rings from 8  animals. The vertical bars show 
± S.E.M.
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3.1.3 Contractile responses to noradrenaline (NA)
Noradrenaline (NA, 1 0 " to 10"^M), administered cumulatively, induced 
concentration-dependent contractions in MPA rings and in BPA rings 
(Fig. 3.11 to 3.12). The MPA rings were less responsive than the BPA rings to 
NA (10-9 to 10-7M) (Fig. 3.13). Cocaine (IQ-^M, for 10-15min) slightly 
enhanced responses to some concentrations (10"  ^ to lO'^M) of NA in MPA 
rings, but had no effect in BPA rings (Fig. 3.11 to 3.13). Cocaine did not affect 
the maximum contractile responses to NA in either the MPA or BPA rings. 
The ECjo values and the maximum contractile responses to NA in the absence 
and presence of cocaine are summarized in Tables 3.5 and 3.6. There were no 
significant differences between the maximum responses to NA in MPA or BPA 
rings whether cocaine was absent or present. In comparisons between the EC^q 
values to NA, cocaine caused an increase in the sensitivity of MPA rings 
(1.75 fold) but not of BPA rings to NA (Table 3.6; Fig. 3.11 to 3.12). In other 
experiments, prazosin (10"^M) completely inhibited contractile responses to 
NA (data not shown).
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Fig. 3. 11
Concentration response curves to noradrenaline (NA, 10"^ ° to 10"^M) in the 
absence (closed symbol) and presence (open symbol) of cocaine (10"^M) in 
MPA rings of Wistar rats. NA induced concentration-dependent contractions in 
these rings. The results are expressed as means and as a percentage of the 
maximum response to NA of n=7 rings from 7 animals. The vertical bars show 
± S.E.M. Asterisks indicate significant differences between means, p values: 
* P < 0.05; ** P < 0.01 (paired Student's t test).
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Fig. 3. 12
Concentration response cui-ves to noradrenaline (NA, to 10"^M) in the 
absence (closed symbol) and presence (open symbol) of cocaine (10"^M) in 
BPA rings of Wistar rats. NA induced concentration-dependent contractions in 
these rings. The results are expressed as means and as a percentage of the 
maximum response to NA of n=7 rings from 7 animals. The vertical bars show 
± S.E.M.
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Fig. 3. 13
Comparison between concentration response curves to noradrenaline (NA, 
10"i® to 10"%[) in MPA (open symbol) and or BPA (closed symbol) rings of 
Wistar rats. Tension was recorded (mg mg"^  Tissue) and NA induced 
concentration-dependent contractions in these rings. The results are expressed 
as means of n=7 rings from 7 animals. The vertical bars show ± S.E.M. 
Asterisks indicate significant differences between means, p  values’. * P < 0.05; 
** P < 0.01; *** P < 0.001 (unpaired t test).
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Pulmonary Artery
The
(mg mg"i tissue)
P values
MPA (control) 
V
MPA (treated)
298.89±6.03
V
304.92±6.10
P > 0.05
BPA (control) 
V
BPA (treated)
282.50±18.45
V
288.133=20.32
P > 0.05
MPA (control) 
V
BPA (control)
298.893:6.03
V
282.503=18.45
P > 0.05
MPA (treated) 
V
BPA (treated)
304.923=6.10
V
288.133:20.32
P > 0.05
Table 3.5
Comparison between the maximum responses to NA (10"^M) in MPA
and BPA rings and/or in MPA rings versus (V) BPA rings and in the absence 
(control) and presence (treated) of cocaine (10"%1). The results are expressed 
as means of n=7 rings from 7 animals.
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Pulmonary Artery The ECgo (Molar) P values
MPA (control) 
V
MPA (treated)
6.4xlO-^M
V
3.51x10“9m
***P <0.001
BPA (control) 
V
BPA (treated)
8 x 1 0 " 10m
V
7.1x10“10M
P>0.05
MPA (control) 
V
BPA (control)
6.4x10-9m
V
8 x1 0 " 10m
***P< 0.001
MPA (treated) 
V
BPA (treated)
3.51x10"9M
V
7.1x10"10m
***P< 0.001
Table 3.6
Comparison between the ECjq values induced by NA in MPA and BPA rings 
and/or in MPA rings versus (V) BPA rings and in the absence (control) and 
presence (treated) of cocaine (10”^ M). The results expressed as means of n=7 
rings from 7 animals. Asterisks indicate significant differences between means. 
p  values’. *** P < 0 . 0 0 1  (Student's t test).
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3.1.4 Contractile responses to angiotensin II  (Ang II)
5
iAngiotensin II (Ang II, 10"i° to 10“'^ ), administered cumulatively, induced 
concentration-dependent contractions of MPA and BPA rings (Fig. 3,14). BPA 
rings were more responsive than the MPA rings to Ang II (10~^M). The ECjq 
values for Ang II in intact MPA and BPA rings were (respectively, 1.7xlO"M; 
n=9 and 7xlO"i‘^ M). Comparison of the EC^g values for Ang II, indicates that 
BPA rings were more responsive than MPA rings (2.42 fold; P < 0.001). 
Maximal responses to Ang II, expressed as percentages of the initial maximal 
contraction to KCl (3xlO"^M) in these rings were (MPA; 130.133=3.84% and 
BPA: 131.073=5.56%; P > 0.05; Fig. 3.14). Comparison of the maximal 
responses to Ang II obtained in MPA rings and BPA rings, indicated no
significant differences.
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Fig. 3. 14
Concentration-response curves showing contraction to angiotensin II 
(Ang II, to 1 0 -%I) in MPA (closed symbol) and BPA (open symbol) rings 
of Wistar rats. Tension was recorded as a percentage of the maximum 
contraction to KCl (SxlO'^M). The results are expressed as means of n-9-10 
from 9-10 animals. The vertical bars show ± S.E.M. Asterisks indicate 
significant difference between means, p  values: ** P < 0.01 (unpaired t test).
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3.1.5 Contractile responses to the thromboxane A2 mimetic, XJ46619
The thromboxane (TXAg) mimetic, U46619 (10“® to 10"%[), administered 
cumulatively, induced large concentration-dependent contractions in isolated 
MPA (EC50; 8.5X10-9M) and BPA (EC50; 7.2x10"%; P > 0.05) rings of 
Wistar rats (Fig. 3.15). The maximum contractions to U46619 (10"%) 
expressed as percentages of the initial maximum contraction to KCl (SxlQ-^M) 
in MPA rings and BPA rings were (respectively, 165.16±5.66% and 
178.62±31.03%; P > 0.05). There were no differences between the responses 
to U46619 in the MPA and BPA rings.
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Fig. 3. 15
Concentration-response curves showing contraction to U46619 
(10"  ^ to in MPA (closed symbol) and BPA (open symbol) rings of
Wistar rats. Tension was recorded as a percentage of the maximum contraction 
to KCl (3x10"2M). The results are expressed as means of n=7-9 
from 7-9 animals. The vertical bars show ± S.E.M.
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loss of responsiveness to agonists with time. This phenomenon, which has been
3,2 Investigation of Agonist-Induced Desensitisation of Isolated 
Pulmonary Artery Rings of Wistar Rats
3.2.1 S'‘Hydroxytryptamine (5-HT)4nduced desensitisation
Prolonged exposure of a variety of cells to drugs or hormones may result in
termed desensitisation, leads to a loss in agonist potency and/or ability to 
induce a maximal biological response in the tissue. Prolonged exposure of 
MPA rings and BPA rings with or without endothelium, in the absence and 
presence of l-NAME (5x10"^M, for 20min) to 5-HT for 30min or Ihr)
produced marked desensitisation to 5-HT (Fig. 3.19A). Standard responses to I
5-HT before tachyphylaxis, in intact MPA and BPA rings were enhanced by 
.l-NAME, but not in endothelium-denuded rings. Also, l-NAME enhanced the
standard responses to 5-HT after tachyphylaxis, in intact MPA and BPA rings,
but not in endothelium-denuded rings (Table 3.7 to 3.8; Figs. 3.16 to 3.17 and
3.19B). The mechanical removal of the endothelium by rubbing, enhanced
standard responses to 5-HT in MPA rings, but not in BPA rings (Figs. 3.16 to
3.17 and 3.19A). Comparing the maximal responses to 5-HT, before
tachyphylaxis, there were no significant differences between MPA and BPA 
.rings, in the absence and presence of l-NAME, whether the endothelium was 
present or not (Table 3.7). In comparisons between the maximal responses to
■V.
5-HT, after tachyphylaxis, there were significant differences between intact 
MPA and BPA rings, in the absence and presence of l-NAME. There were also 
differences between denuded MPA and BPA rings in the presence of l-NAME, 
but not in its absence (Table 3.8). l-NAME depressed the percentage of 
tachyphylaxis to 5-HT in MPA rings, whether the endothelium was present or 
not, and in BPA rings when the endothelium was intact (Table 3.7, Fig. 3.18).
Prior treatment of MPA and BPA rings with l-NAME (5x10”'^ M, for 20min)
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reduced desensitisation to 5-HT (10""^ M). The desensitisation to 5-HT (10“'^ M) 
in the absence and presence of l-NAME was more marked in MPA rings than 
in BPA rings, whether the endothelium was present or not (Table 3,7). The 
addition of oxidised haemoglobin (HbO, I mg/ml) or L-NAME (5xlO""*M) to 
desensitised rings with an intact endothelium during prolonged exposure to 
5-HT, completely reversed this desensitisation. This effect of l-NAME was 
inhibited by L-arginine (L-Arg, 2xlO"4M), but not in desensitised rings, in which 
the endothelium had been removed or in rings pretreated with l-NAME. In 
contrast, prior treatment with l-NAME (5xlO""^M, for 20min) or the 
mechanical removal of the endothelium by rubbing, increased standard 
contractile responses to 5-HT (lO’^M) and reduced but did not prevent the 
development of desensitisation to 5-HT (Fig. 3.19C). In some experiments, 
during prolonged exposure to 5-HT (10"'^M) or PHE (10"^M) and before the 
desensitisation had hilly developed, the addition of acetylcholine (1 0 "%I) 
produced relaxations that were reversed by l-NAME (5xiO""^M). This action 
of l-NAME was unaffected by L-arginine (L-Arg, 2xlO~^M; Fig. 3.19D). In one 
series of the experiments, cumulative concentration response curves to 5-HT 
(10"'^  to 10“‘^ M) and PHE (10"  ^ to 10“^ M), were obtained after tachyphylaxis 
induced by 5-HT (10""^ M) and were compared with those that were obtained 
before tachyphylaxis. Whereas responses to all of concentrations to 5-HT were 
inhibited after prolonged exposure to 5-HT, only responses to low 
concentrations of PHE (10“^  to 10"*M) were depressed after tachyphylaxis to 
5-HT (Fig. 3.19C; data not shown). Prolonged exposure of MPA rings to PHE 
(10"^M, for 2 hrs) also produced a desensitisation to PHE. The desensitisation 
to the a^-adrenoceptor agonist, PHE, was most marked in MPA rings with an 
intact endothelium (data not shown). Cumulative response curves to 5-HT 
before and after tachyphylaxis to PHE were obtained. After tachyphylaxis to 
PHE only responses to high concentrations of 5-HT (10"'^M) were reduced. In 
comparisons between the percentage of tachyphylaxis to PHE (lO'^M) or
I44
5-HT (10~^M), tachyphylaxis to PHE was less than to 5-HT in MPA rings 
whether in the absence (PHE: 49.71±3.53%, 5-HT: 85.37±5.09%; P < 0.001) 
or presence of l-NAME (PHE: 26.303=2.65%; 5-HT: 65.853=4.63%; P < 0.001) 
(Fig. 3.19). Prior treatment MPA rings with L-NAME (5xlO""*M, for 20min) or 
mechanical removal of the endothelium by rubbing, increased maximal
contractile responses to PHE (data not shown) and reduced the percentage 
tachyphylaxis to PHE (from 49.713=3.53% to 26.303=2.65%; P < 0.001; 
Fig, 3.19). The addition of l-NAME (5x 10"‘^ M) to desensitised rings during the 
prolonged exposure to PHE, produced a contraction which was partially 
inhibited by L-Arg (2xlO"4M).
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Fig. 3. 16
Histograms showing standard responses of MPA rings to 5-HT before and 
after prolonged exposure to 5-HT for 30min or Ihr) in intact control
rings (+EC) and in rings denuded of their endothelium (-EC) in the absence 
(open columns) and presence (hatched columns) of l-NAME (5X10“'^ M). The 
results are expressed as means of n= 6  rings from 6  animals. The vertical bars 
show ± S.E.M. Asterisks indicate significant differences between means. 
p values'. * P < 0.05; ** P < 0.01; ns = non-significant (Student's t test).
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Fig. 3.17
Hüstograms showing standard responses of BPA rings to 5-HT before and after 
prolonged exposure to 5-HT (lO-^M, for 30min or Ihi) in intact control rings 
(+EC) and in rings denuded of their endothelium (-EC) in the absence 
(open columns) and presence (hatched columns) of l-NAME (5x10“^ M). 
The results are expressed as means of n= 6  rings from 6  animals. The vertical 
bars show ± S.E.M. Asterisks indicate significant differences between means. 
p  values'. * P < 0.05; *** P < 0.001; ns = non-significant (Student's t test).
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Fig. 3. 18
Histograms showing extent of the tachyphylaxis that occurred in MPA and 
BPA rings, with and without the endothelium (+EC and -EC) and in the 
absence (open columns) and presence (hatched columns) of l-NAME 
(5xlO"4M) after prolonged exposure to 5-HT (lO'^ ^M, for 30min or Ihr). The 
results are expressed as means of n= 6  rings from 6  animals. The vertical bars 
show + S.E.M. Asterisks indicate significant differences between means. 
p  values'. * P < 0.05; ** P < 0.01; *** P < 0.001; ns= non-significant 
(paired Student's t test).
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Fig. 3. 19
Histograms showing greater tachyphylaxis to 5~hydroxytryptamine 
(5-HT, 10"4M) than to phenylephrine (PHE, 10"^M) in MPA rings after 
prolonged exposure to 5-HT (10""^ M, for 30min or Ihr) in the absence 
(open columns) and presence (hatched columns) of l-NAME (SXlQ-^M). 
The results are expressed as means of n= 6  rings from 6  animals. The vertical 
bars show ± S.E.M. Asterisks indicate significant differences between means. 
p  values: * P < 0.05; *** P < 0.001 (Student's t test).
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Pulmonary Artery
The
(mg mg"^  tissue) 
(Before tachyphylaxis) P values
(+EC) MPA (control) 
V
(+EC) MPA (treated)
153.4U I1.59
V
238.79±30.38
0.05 > * P >  0.01
(+EC) BPA (control) 
V
(+EC) BPA (treated)
182.504:14.93
V
279.444:32.38
0.05 > * P >  0.01
(4-EC) MPA (control) 
V
(4-EC) BPA (control)
153.4U11.59
V
182.504:14.93
P > 0.05
(4-EC) MPA (treated) 
V
(4-EC) BPA (treated)
238.794=30.38
V
279.444:32.38
P > 0,05
(4-EC) MPA (control) 
V
(-EC) MPA (control)
153.4U11.59
V220.544=10.36 0.01 > * * ? >  0.001
(4-EC) BPA (control) 
V
(-EC) BPA (control)
182.504=14.93
V
208.894:13.27
P > 0.05
(-EC) MPA (control) 
V
(-EC) BPA (control)
220.544:10.36
V
208.894:13.27
P > 0.05
(-EC) MPA (treated) 
V
(-EC) BPA (treated)
204.124=18.20
V
254.444:17.86
P > 0.05
Table 3.7
Comparison between the maximum responses induced by 5-HT (10“'^ M) before 
tachyphylaxis in MPA and BPA rings and/or in MPA rings versus (V) BPA rings 
with endothelium (+EC) or without endothelium (-EC) and in the absence (control) 
and presence (treated) of l-NAME (5x10"^M). The results are expressed as means 
of n= 6  rings from 6  animals. Asterisks indicate significant differences between 
means, p  values: * P < 0.05; ** P < 0.01 (Student's t test).
Pulmonary Artery The Bmax (mg mg”^  tissue) 
(After tachyphylaxis)
P values
(4-EC) MPA (conti'ol) 
V
(4-EC) MPA (tieated)
12.754=2.49
V
91.084=17.76
0.05 > * P >  0.01
(4-EC) BPA (control) 
V
(4-EC) BPA (treated)
70.004=7.58
V
166.674=11.79
♦ * * P <  0.001
(4-EC) MPA (treated)
V(-EC) MPA (treated)
91.084=17.76
V
118.964=11.51
P > 0.05
(4-EC) BPA (treated) 
V
(-EC) BPA (treated)
166.674=11.79
V
170.834=10.49
P > 0.05
(4-EC) MPA (control) 
V
(4-EC) BPA (control)
12.754=2.49
V
70.004=7.58
0.01 > * * P >  0.001
(4-EC) MPA (tieated) 
V
(4-EC) BPA (treated)
91.084=17.76
V
166.674:11.79
0.05 > * P > 0.01
(-EC) MPA (control)
V
(-EC) BPA (control)
90,754=17.80
V
108.334=20.97
P > 0.05
(-EC) MPA (treated) 
V
(-EC) BPA (treated)
118.964:11.51
V
170.83dbl0.49
0.05 > * P >  0.01
Table 3.8
Comparison between the maximum responses induced by 5-HT (10"'*M) after 
tachyphylaxis in MPA and BPA rings and/or in MPA rings versus (V) BPA rings 
with endothelium (+EC) or without endothelium (-EC) and in the absence 
(control) and presence (treated) of L-NAME (SxlO'^^M). The results are 
expressed as means of n= 6  rings from 6  animals. Asterisks indicate significant 
differences between means, p  values: * P < 0.05; ** P < 0.01; *** P < 0.001 
(Student's t test).
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Pulmonary Artery % Tachyphylaxis 
to 5-HT
P values
(+EC) MPA (control) 85.37±5.09
V V 0.05 > * P > 0.01
(+EC) MPA (treated) 65.85±4.63
(+EC) BPA (control) 59.27±5.42 '
V V * * * P <  0.001
(+EC) BPA (treated) 22.334=2.77
(+EC) MPA (control) 85.374:5.09
V V O . O K * * P <  0.001
(+EC) BPA (control) 59.27±5.42
(+EC) MPA (treated) 65.854:4.63
V V * * * P <  0.001
(4-EC) BPA (treated) 22.374=2.77
(4-EC) MPA (control) 85.374:5.09
V V P > 0.05
(-EC) MPA (control) 74.784=3.00
(4-EC) BPA (control) 59.274=5.24
V V P > 0.05
(-EC) BPA (control) 51.564=6.53
(4-EC) MPA (treated) 65.854=4.63
V V P > 0.05
(-EC) MPA (treated) 61.094=2.30
(4-EC) BPA (treated) 22.334=2.77
V V P > 0.05
(-EC) BPA (treated) 34.834=5.83
Table 3.9
Comparison between the percentage of tachyphylaxis to 5-HT (10“^ M) in MPA and 
BPA rings and/or in MPA rings versus (V) BPA rings with endothelium (+EC) or 
without endothelium (-EC) and in the absence (control) and presence (treated) of 
L-NAME (5xlO"^M). The results are expressed as means of n= 6  rings from 6  
animals. Asterisks indicate significant differences between means, p values: 
* P < 0.05; ** P < 0.01; *** P < 0.001 (Student's t test).
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3,2.2 Rapid desensitisation to Angiotensin I I  (Ang II)
Exposure to the maximum concentration (10"TM) of Ang H produced rapid 
desensitisation in MPA and BP A rings. The control maximum contractions 
induced by Ang II in MPA rings and BPA rings were respectively, 
257.67±20.94 and 250±22.66; mg mg“^  tissue (P > 0.05) and after 
desensitisation produced by Ang H, were 141.67±22.28 (MPA) and 
140db23.14 (BPA) mg mg"  ^ tissue (P > 0.05). There were significant 
differences between the standard responses to Ang II (10"^), in control MPA 
rings and in desensitised MPA rings (P < 0.001; Fig. 3.20) and also between 
control BPA rings and desensitisised rings of BPA (P < 0.001; Fig. 3.20). 
Following pretreatment of desensitisised rings with a subthreshold 
concentration of KCl (lO'^M, for 5min), responses to Ang II were enhanced. 
The maximum contractions to Ang II (10"'M) in MPA, and BPA rings, 
pretreated with KCl after desensitisation, were 226.67±20.70 (MPA) and 
242.92^24.77 (BPA) mg mg"* tissue. In comparisons with control (before Ang 
n-induced tachyphylaxis), there were significant differences between responses 
to Ang II in MPA rings ( 0.01 > P > 0.001) but not in BPA rings. In other 
experiments, pretreatment of rings with l-NAME (2><10"'*M), or the 
mechanical removal of the endothelium by rubbing, did not prevent 
tachyphylaxis to Ang II. In other experiments, in which MPA or BPA rings had 
been desensitised by repeated exposure to 5-HT (10""*M), subthreshold 
concentration of KCl (10"^M, for 5min) also enhanced responses to 5-HT 
(10"'*M) (data not shown).
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Fig. 3. 20
Histograms showing extent of the maximum response to angiotensin II 
(Ang II, lO-'M) before (C) and after the desensitisation (D) and the facilitation 
(F) (pretreated with KCl, lO'^M, for 10-15min)] in MPA and BPA rings of 
Wistar rats. Tension was recorded (mg mg"* Tissue). The results are expressed 
as means of n=9-10 from 9-10 animals. The vertical bars show ± S.E.M. 
Asterisks indicate significant differences between means, p values: ** P < 0.01; 
*** P < 0.001; ns= non-significant (paired Student's t test).
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«(respectively, 81.79±3.74% and 64.26±3.66%; 0.01 > P > 0.001). In another
3.3 Investigation of vasorelaxant responses to agonists in main 
pulmonary artery (MPA) and branch pulmonary artery (BPA) rings of 
Wistar rats
■ ^  ji. "5';
3.3.1 Vasorelaxant responses to acetylcholine (ACh), carbachol (CARB) 
and sodium nitroprusside (SNP)
.The endothelium-dependent vasorelaxant acetylcholine (ACh, 1 0 “^  to 
3xlO"%[) induced concentration-dependent relaxations in MPA and in BPA 
rings precontracted with PHE (EC^q, 1.2xlO“'^ M). ACh-induced relaxations in 
BPA rings were significantly larger than those obtained in MPA rings 
(Fig. 3.21). The maximum relaxations in BPA and MPA rings were
series of experiments, the endothelium-dependent relaxant, carbachol, (CARB,
10“® to 10“"*M) induced concentration-dependent relaxations in
.PHE-precontracted (10“'^ M) MPA and BPA rings (Fig, 3.22). The maximum 
relaxations in MPA rings and BPA rings were (respectively, 44.33±3.86% and 
75.50±3.35%; P < 0,001). The BPA rings were more responsive than MPA 
rings. Pretreatment of the rings with L-NAME (SxlO'^M, for lOmin) abolished 
CARB-induced relaxations to low concentrations (10“® to 10“7M), but high
concentrations (10“^  to 10“^ M) of CARB produced concentration-dependent 
contractions (data not shown). Similarly, the endothelium-independent relaxant 
sodium nitroprusside (SNP, 10“^^  to 10“^ M) induced concentration-dependent 
relaxations in PHE-precontracted MPA rings and BPA rings In comparisons 
between concentration-response curves, MPA rings were more responsive than 
BPA to SNP (Fig. 3.23). The maximum relaxations in these rings were (MPA; 
99.40±0.60% and BPA: 94.61±2%; P < 0.05).
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i :In other experiments, concentration response curves to SNP to 10”^ M)
were obtained in control rings and in rings pretreatead with l-NAME 
(5xiO"4M). L-NAME had no significant effect on concentration-dependent 
relaxations to SNP (Fig. 3.24 to 3.25).
I
.In another series of experiments, concentration-response curves to SNP 
( 1 0 " 12 to 10"2M) were obtained in MPA and BPA rings precontracted with 
5-HT (ECjo, 10"^M; Fig. 3.26). In comparisons between concentration- 
response curves, MPA rings were only more responsive than BPA rings to 
SNP (10"7M) (0.05 > P > 0.01; Fig. 3. 26). The maximum responses to SNP in 
these rings were (MPA; 97.62^=2.38% and BPA; 86.43±3.64%;
0.05 > P > 0.01). Pretreatment of the rings with L-NAME (5xlO"'iM, for 
2 0 min) had no significant effect on concentration-dependent relaxations ■
to SNP (Fig. 3.27 to 3.28).
In comparisons between concentration response curves to the vasorelaxant 
agonists, the endothelium-independent agonist SNP, was more potent than 
endothelium-dependent agonist ACh in both MPA rings and BPA rings, 
precontracted with PHE (EC70; 1.2x10"%!; Fig. 3.29 to 3.30).
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Fig. 3. 21
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10"^  to 3xlO"<^ M) in MPA (open circle) and BPA (closed 
circle) rings precontracted with phenylephrine (EC^g; 1.2xlO"'^M). The results 
are expressed as means of percentage relaxation of PHE-induced tone. n=10 
rings from 10 animals, vertical bars show ± S.E.M. Asterisks indicate 
significant differences between means, p values'. * P < 0.05; ** P < 0,01 
(unpaired t test).
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Fig. 3. 22
Comparison between concentration-response curves showing relaxation to 
carbachol (CARB, 10"® tolO'^^M) in MPA rings (open circle) and in BPA rings 
(closed circle) precontracted with PHE (IQ-'^ M). The results are expressed as 
means of percentage relaxation of PHE-induced tone. n= 6  rings from 6 
animals, vertical bars show ± S.E.M. Asterisks indicate significant difference 
between means, p  values'. ** P < 0.01; *** P < 0.001 (unpaired t test).
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Fig. 3. 23
Comparison between concentration-response curves showing relaxation to 
sodium nitroprusside (SNP, lO"^  ^ in MPA (open symbol) and BPA
(closed symbol) rings precontracted with PHE (ECy ;^ 1.2xlO’'^M). The results 
are expressed as means of percentage relaxation of PHE-induced tone. n= 6  
from 6  animals, vertical bars show ± S.E.M. Asterisks indicate significant 
difference between means, p value'. * P < 0.05; *** P < 0.001 (unpaired t test).
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Fig. 3. 24
Concentration-response curves showing relaxation to sodium nitroprusside 
(SNP, to 10”^ M) in the absence (closed symbol) and presence
(open symbol) of l-NAME (5x10“^ M) in MPA rings precontracted with PHE 
(ECy ;^ 1 .2 x1 0 "%!). The results are expressed as means of percentage 
relaxation of PHE-induced tone. n= 6  rings from 6  animals, vertical bars show 
± S.B.M.
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Fig. 3. 25
Concentration-response curves showing relaxation to sodium nitroprusside 
(SNP, 10"^  ^ to 10"^M) in the absence (closed symbol) and presence 
(open symbol) of l-NAME (5x10“4M) in BPA rings precontracted with PHE 
(ECjq; 1.2x10"^ TM). The results are expressed as means of percentage 
relaxation of PHE-induced tone. n= 6  rings from 6  animals, vertical bars show 
± S.E.M.
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Fig. 3. 26
Concentration-response cui'ves showing relaxation to sodium nitroprusside 
(SNP, 1 0 “ to 10“'^M) in the absence (open symbol) and presence 
(closed symbol) of l-NAME (SxlO’^M) in MPA rings precontracted with 
5-HT (ECj^; 10"^M). The results are expressed as means of percentage 
relaxation of 5-HT-induced tone. n= 6  rings from 6  animals, vertical bars 
show±S.E.M.
:
■J
3
I
4
a
i1 0 0  -1
co 6 0  -
oXa<DCH 4 0  -
20  -
13 - 1 2 10 - 7 61 1 9 - 8
SNP (Log M)
Fig. 3. 27
Concentration-response curves showing relaxation to sodium nitroprusside 
(SNP, 10" to 10"'^M) in the absence (open symbol) and presence 
(closed symbol) of l-NAME (SxlG'^^M) in BPA rings precontracted with 
5-HT (ECjo; 10"^M). The results are expressed as means of percentage 
relaxation of 5-HT-induced tone. n= 6  rings from 6  animals, vertical bars 
show± S.E.M.
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Fig. 3. 28
Comparison between concentration-response curves showing relaxation to 
sodium nitroprusside (SNP, to 10"'^M) in MPA .(open symbol) and 
BPA (closed symbol) rings precontracted with 5-HT (ECj^; 10“^ M). The 
results are expressed as means of percentage relaxation of 5-HT-induced 
tone. n= 6  rings from 6  animals, vertical bars show ± S.E.M. Significant 
difference between individual means is indicated by p  value: * P < 0.05 
(unpaired t test)
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Fig. 3. 29
Comparison between concentration-response cui*ves showing relaxation to 
sodium nitroprusside (SNP, 1 0 "^  ^ to closed symbol) and acetylcholine
(ACh, 10"* to 3xlO"<5M; open symbol) in MPA rings precontracted with PHE 
(ECy ;^ 1 .2 x10“7]vi). The results are expressed as means of percentage 
relaxation of PHE-induced tone. n=6-10 rings from 6-10 animals, vertical bars 
show ± S.E.M.
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Fig. 3. 30
Comparison between concentration-response curves showing relaxation to 
sodium nitroprusside (SNP, 10"^  ^ to 10"^M; open symbol) and acetylcholine 
(ACh, 10"® to 3xlO“^ M; closed symbol) in BPA rings precontracted with PHE 
(ECjqI L2x1Q-7M). The results are expressed as means of percentage 
relaxation of PHE-induced tone, n-6-10 rings from 6-10 animals, vertical bars 
show ± S.E.M.
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3.3.2 Vasorelaxant responses to the purine adenine nucleotides, adenosine 
5^-triphosphate (ATP), adenosine 5 ''-diphosphate (ADP) and adenosine 
(AD)
Adenosine 5'-triphosphate (ATP, 10"® to 10"^M) induced concentration- 
dependent relaxations in MPA and BPA rings precontracted with PHE (10"'^M) 
The maximum relaxant responses to ATP (10"^M) in rings which had been 
precontracted with PHE were MPA; 80.48±1.93% and BPA: 74.76±3.48% 
(P > 0.05; Fig. 3.31 to 3,32). The mechanical removal of the endothelium by
rubbing, reduced relaxant responses to 10"%î of ATP in MPA rings
__(P < 0.001) and to 10"? to lO'^M of ATP in BPA rings (P < 0.001). 
Pretreatment of artery rings with l-NAME (2x10"'*M, for 10-15min) reduced
i
responses to ATP (10"? to 10"^M) in both MPA and BPA rings (P < 0.001). 
There were no significant differences between responses to ATP (10"® to 
lO’^M) in intact MPA and BPA rings (P > 0.05; Fig. 3.33). In other 
experiments, in which the artery rings were pretreated with the blocker of 
ATP-sensitive potassium channels, glibenclamide (10"%I, for lOmin) or with 
the PDE inhibitor, theophylline (10"%4, for lOmin) the relaxant responses to 
ATP were unaffected (data not shown).
Concentration-dependent relaxations to ADP (10"® to 10"^M) were obtained in
MPA and BPA rings precontracted with PHE (10"%I). The maximum relaxant
responses to ADP (10"^M) in intact rings precontracted with PHE were MPA:
78.393=2.68% and BPA: 68.453=2.29% (0.05 > P > 0.01) (Fig. 3.34 to 3.35).
The mechanical removal of the endothelium by rubbing, or pretreatment of the 
.artery rings with l-NAME (2xlO"'*M, for lOmin) reduced responses to all 
concentrations of ADP (10"® to 10"^M) in both MPA and BPA rings. There 
were significant differences between responses to high concentrations of ADP 
(10"* to 10"^M) in intact MPA and BPA rings, with MPA rings being more
responsive to ADP than BPA rings (0.05 > P > 0.01) (Fig. 3.36).
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The p-adrenoceptor antagonist, propranolol (10"*M, for lOmin) had no affect 
on relaxant responses to ADP.
Concentration-dependent relaxations to adenosine (AD, 3x10"* to lO'^M) 
were obtained in MPA and BPA rings which had been precontracted with PHE 
(10"7M). The maximum relaxations produced by AD (10""^ M) in the artery 
rings which had been precontracted with PHE were MPA: 72.22±3.0% and 
BPA: 62.533=3.71% (P > 0.05) (Fig. 3.37 to 3.38). Mechanical removal of the 
endothelium by rubbing or pretreatment of the artery rings with l-NAME 
(2xlO""*M, for lOmin) did not affect relaxant responses to AD (Fig. 3.37 to 
3.38 ). There were no significant differences between concentration response 
curves to AD in MPA and BPA rings (Fig. 3.39). In some experiments, 
pretreatment of MPA and BPA rings with the PDE inhibitor, theophylline 
(10"*M, for lOmin), completely abolished relaxant responses to AD (3x10"* to 
10"^M) (data not shown).
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Fig. 3. 31
Comparison between concentration-response curves showing relaxation to 
adenosine 5'-triphosphate (ATP, 10"^  to 10"^M) in MPA rings with 
endothelium intact in the absence (closed triangle) and presence (open square) 
of l-NAME (2x10"^M) and in endothelium denuded (closed square) rings 
precontracted with PHE (10"'^M). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=5-9 rings from 5-9 animals, 
vertical bars show ± S.E.M. Significant difference between means is indicated 
byp  values: P or *** P < 0.001 (unpaired t test).
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Fig. 3. 32
Comparison between concentration-response curves showing relaxation to 
adenosine 5 -triphosphate (ATP, 10"^  to in BPA rings with endothelium
intact, in the absence (open triangle) and presence (closed triangle) of l-NAME 
(2xlO"4M) and in endothelium denuded (open diamond) rings precontracted 
with PHE (10"'TvI). The results are expressed as means of percentage relaxation 
of PHE-induced tone, n-5-8 rings from 5 animals, vertical bars show ± S.E.M. 
Significant difference between means is indicated by p  values: P <
*** P < 0.001 (unpaired t test).
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Fig. 3. 33
Comparison between concentration-response curves showing relaxation to 
adenosine 5 -triphosphate (ATP, 1 0 "^  to in MPA (open symbol) and
BPA (closed symbol) rings precontracted with PHE (10"^M). The results are 
expressed as means of percentage relaxation of PHE-induced tone. n=8-9 rings 
from 9 animals, vertical bars show ± S.E.M,
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Fig. 3. 34
Comparison between concentration-response curves showing relaxation to 
adenosine 5'-diphosphate (ADP, 10"^  to 10"^M) in MPA rings with 
endothelium intact, in the absence (closed triangle) and presence (open square) 
of l-NAME (2><10'4M) and in endothelium denuded (closed square) rings 
precontracted with PHE (lO'TM). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=6 - 1 0  rings from 6-10 animals, 
vertical bars show ± S.E.M. Significant difference between means is indicated 
by p  values: + P < or * P < 0.05; P < or ** P < 0.01; P < or
*** p < 0 . 0 0 1  (unpaired t test).
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Fig. 3. 35
Comparison between concentration-response curves showing relaxation to 
adenosine 5'-diphosphate (ADP, 10"^  to lO'^M) in BPA rings with endothelium 
intact, in the absence (open circle) and presence (closed circle) of l-NAME 
(2xlO"4M) and in endothelium denuded (open triangle) rings precontracted 
with PHE (10"%). The results are expressed as means of percentage relaxation 
of PHE-induced tone. n=5-10 rings from 5-10 animals, vertical bars show ± 
S.E.M. Significant difference between means is indicated by p  values: P < or
* P < 0.05; +++P < or *** P < 0.001 (unpaired t test).
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Fig. 3. 36
Comparison between concentration-response curves showing relaxation to 
adenosine 5'-diphosphate (ADP, 10"^  to 10"^M) in MPA (open symbol) and 
BPA (closed symbol) rings precontracted with PHE (lO'lVi). The results are 
expressed as means of percentage relaxation of PHE-induced tone. n=6-7 rings 
from 6  animals, vertical bars show ± S.E.M. Significant difference between 
means is indicated by p  values: * P < 0.05 (unpaired t test).
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Fig. 3. 37
Comparison between concentration-response curves showing relaxation to 
adenosine (AO, 3x10"^ to lO'^M) in MPA rings with endothelium intact, in the 
absence (closed circle) and presence (open triangle) of l-NAME (2x10"'^M) 
and in endothelium denuded (closed triangle) rings precontracted with PHE 
(IQ-^M). The results are expressed as means of percentage relaxation of PHE- 
induced tone, n -6 - 8  rings, vertical bars show ± S.E.M. Significant difference 
between means is indicated by: p values: + P < or * P < 0.05 (unpaired t test).
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Fig. 3. 38
Comparison between concentration-response curves showing relaxation to 
adenosine (AD, 3x10"^ to lO'^M) in the absence (open symbol) and presence 
(closed symbol) of l-NAME (2x10-4M) in BPA rings precontracted with PHE 
(10“^ M). The results are expressed as means of percentage relaxation of PHE- 
induced tone. n=6-7 rings from 4animals, vertical bars show ± S.E.M. 
Significant difference between means is indicated by: p values: * P < 0.05 
(unpaired t test).
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Fig. 3. 39
Comparison between concentration-response curves showing relaxation to 
adenosine (AD, 3x10“^  to in MPA (open symbol) and BP A
(closed symbol) rings precontracted with PHE (10“'^ ) .  The results are 
expressed as means of percentage relaxation of PHE-induced tone, n-7-8 rings 
from 7 animals, vertical bars show ± S.E.M.
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3.3.3 Vasorelaxant and contractile responses to histamine (HIST)
Î
SO
aHistamine (HIST, 10“^  to 10"^M) induced concentration-dependent relaxations 
in MPA and BP A rings precontracted with PHE (Figs. 3.40 and 3.42). The 
maximum relaxations to HIST (10“^ M) in the rings were MPA: 69.52^:4.02% 
and BP A; 78.32±2.92% (P > 0.05). The BPA rings were more responsive than 
MPA rings to HIST (10'^ to 10"^M) (P < 0.05; Fig. 3.44). Pretreatment of the 
rings with H^-receptor antagonist, chlorpheniramine (CPRA, 10"%!, for 
lOmin) reduced relaxant responses to all concentrations of FUST (Figs. 3.40 
and 3.42). l-NAME (2x10”'^ M, for lOmin) also, reduced relaxant responses in 
these rings to all concentrations of HIST (Figs. 3.41 and 3.43). The inhibitory 
responses to HIST in these tissues was reversed by l-NAME (2x10”^ M) and 
this effect was not inhibited by L-Arg (10"^M). In some experiments, the effects 
of HIST (10"'^  to 10"^M) were examined in the absence of PHE-induced tone in 
resting MPA and BPA rings, which produced small contractile responses to 
HIST (10""^  to lO’^M) in these circumstances (data not shown).
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Fig. 3. 40
Comparison between concentration-response curves showing relaxation to 
histamine (HIST, 10"^  to lO'^M) in the absence (closed symble) and presence 
(open symble) of chlorpheiramine (10~^M, for lOmin) in MPA rings 
precontracted with PHE (10"TM). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=6-10 rings from 10 animals, 
vertical bars show ± S.E.M. Asterisks indicate significant difference between 
mems. p  values: * P < 0.05; *** P < 0.001 (unpaired t test).
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Fig. 3. 41
Comparison between concentration-response curves showing relaxation to 
histamine (HIST, 10"^  to 10"^M) in the absence (open symble) and presence 
(closed symble) of l-NAME (2x10"4M, for lOmin) in MPA rings precontracted 
with PHE (10"%[). The results are expressed as means of percentage relaxation 
of PHE-induced tone. n=4-10 rings from 10 animals, vertical bars show ± 
S.E.M. Asterisks indicate significant differences between means, p values: 
* P < 0.05; *** P < 0.001(unpaired t test).
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Fig. 3. 42
Comparison between concentration-response curves showing relaxation to 
histamine (HIST, 10"^  to 10"^M) in the absence (open symbol) and presence 
(closed symbol) of chlorpheniramine (10~%I, for lOmin) in BPA rings 
precontracted with PHE (lO-^M). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=6-10 rings from 10 animals, 
vertical bars show ± S.E.M. Asterisks indicate significant differences between 
means, p  values: ** P < 0.01; *** P < 0.001 (unpaired t test).
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Fig. 3. 43
Comparison between concentration-response curves showing relaxation to 
histamine (HIST, 10"^  to lO'^M) in the absence (open symbol) and presence 
(closed symbol) of l-NAME (2x10“^ M, for lOmin) in BPA rings precontracted 
with PHE (10”'^ M). The results are expressed as means of percentage relaxation 
of PHE-induced tone. n=4-10 rings from 10 animals, vertical bars show ± 
S.EM. Asterisks indicate significant differences between means, p  values: 
** P < 0.01; *** P < 0.001 (unpaired t test).
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Fig. 3. 44
Comparison between concentration-response curves showing relaxation to 
histamine (HIST, 10“^  to 10"^M) in MPA (open symbol) rings and in BPA 
(closed symbol) rings precontracted with PHE (10"'^M). The results are 
expressed as means of percentage relaxation of PHE-induced tone. n=10 rings 
from 10 animals, vertical bars show ± S.E.M. Asterisks indicate significant 
differences between means, p  values', * P < 0.05; ** P < 0.01 (unpaired t test).
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3.3.4 Vasorelaxant responses to the p-adrenoceptor agonist, isoproterenol 
(ISO)
■■I
;
The P-adrenoceptor agonist, isoprenaline (ISO, lO'i® to lO'^M) induced 
concentration-dependent relaxations in MPA and BPA rings precontracted 
with PHE (10"%I; Fig. 3.45 to 3.46). The maximum relaxant responses to ISO 
(10"^M) in the preparations were MPA: 93.04±1.25% and BPA: 77.21±2.80%
(P < 0.001). The MPA rings were more responsive than BPA rings to all 
concentrations of ISO (Fig. 3,47). Mechanical removal of the endothelium by 
rubbing, or pretreatment of the rings with l-NAME (2x10“'*M, for lOmin)
depressed responses to low concentrations of ISO in these rings (MPA: 10” ®^ 
to lO’TM and BPA: 10”^  to 10"^M) (Fig. 3.45 to 3.46). The p-adrenoceptor 
antagonist, propranolol (PROP, lO’^M) abolished responses to ISO (data not 
shown ). l-NAME (2x10“^ M, for lOmin) partially reversed the inhibitory
effects produced by ISO (IQ-ic to 10"^M) in MPA and BPA rings. This effect 
of L-NAME was slightly inhibited by L-Arg (10"^M).
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Fig. 3. 45
Comparison between concentration-response curves showing relaxation to 
isoproterenol (ISO, 10-^  ^to 10‘^M) in MPA rings with endothelium intact, in 
the absence (closed circle) and presence (open triangle) of l-NAME 
(2X1Q-4M, for lOmin) and in endothelium denuded (closed triangle) rings 
precontracted with PHE (10"TM). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=6 - 8  rings from 6  animals, 
vertical bars show ± S.E.M. Significant difference between means is indicated 
by p  values: ^ P < or * P < 0.05; ** p < 0.01; P < or *** P < 0.001 
(unpaired t test).
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Fig. 3. 46
Comparison between concentration-response curves showing relaxation to 
isoproterenol (ISO, lO-i® to 10"^M) in BPA rings with endothelium intact, in 
the absence (open square) and presence (closed square) of l-NAME 
(2xlO”'*M, for lOmin) and in endothelium denuded (open triangle) rings 
precontracted with PHE (10"'^M). The results are expressed as means of 
percentage relaxation of PHE-induced tone. n=7-8 rings from 4 animals, 
vertical bars show ± S.E.M. Significant difference between means is indicated 
by p values: + P < 0.05; ** P < 0.01; +++ P < or *** P < 0.001 
(unpaired t test).
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Fig. 3. 47
Comparison between concentration-response curves showing relaxation to 
isoproterenol (ISO, 10“^  ^to lO'^M) in MPA (closed symbol) rings and in BPA 
(open symbol) rings precontracted with PHE (IQ-^M). The results are 
expressed as means of percentage relaxation of PHE-induced tone. n=7-8 rings 
from 8  animals, vertical bars show ± S.E.M. Significant difference between 
means is indicated byp  values: * P < 0.05; *** p < 0.001 (unpaired t test).
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3.3.5 Vasorelaxant responses to 5-hydroxytryptamine (5-HT)
(5xlO"'^M, for 15min) or with propranolol for 15min) did not abolish
5-HT-induced relaxations in these rings.
5-HT (10”'^  to 5xlO"^M) produced concentration-dependent relaxations in 
isolated MPA and BPA rings precontracted with PHE (EC70, 1.2xlO"%[) 
(Fig. 3.48). The maximum relaxations were 84.37±5.24% (MPA) and
74,12±7.92% (BPA) (P > 0.05). Pretreatment of the rings with l-NAME I
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Fig. 3. 48
Comparison between concentration-response curves showing relaxation to 
5-HT (10"'^  to 5x10"%) in MPA rings (open symbol) and in BPA 
(closed symbol) rings precontracted with PHE (ECjq, 1.2x10"%). The results 
are expressed as means of percentage relaxation of PHE-induced tone. n= 6  
rings from 6  animals, vertical bars show ± S.E.M.
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3.3.6 Vasorelaxant effects o f atropine
Atropine (AT, 10"% to 5x10"%) induced concentration-dependent 
relaxations in MPA and BPA rings precontracted with either PHE (10"TM; 
3.49) or 5-HT (10"^M), but did not produce relaxations in artery rings 
precontracted with potassium chloride (KCl, 2x10"%; Fig. 3.49A). 
The maximum inhibitions produced by AT in MPA rings and BPA rings, 
precontracted with PHE, were MPA: 65.87±3.72% and BPA: 51.11±3.33% 
(0.05 > P > 0.001) and when MPA and BPA rings were precontracted with 
5-HT, the AT-induced inhibitions were MPA: 62.70±6.2% and BPA: 
63.83±6.17% (P > 0.05). There were no significant differences between 
responses to AT in MPA and BPA rings precontracted either with PHE or 
5-HT. Pretreatment of these tissues with the nitric oxide synthase inhibitors, 
l-NAME (5xl0”^ M, for lOmin), or l-NOARG (10"^M, for lOmin) and also 
L-NAME (5xlO"^M) in the presence of HbO (1 mg/ml) did not abolish
AT-induced relaxations (Fig. 3.49B to 3.49C). In one series of experiments the 
inhibitory effects of AT on contractile responses to PHE in MPA rings with 
intact endothelium, were completely inhibited by L-NAME (5xlO"^M) or HbO 
(1 mg/ml). However, this did not occur in intact rings, which had been 
pretreated with l-NAME (5xlO"^M, for lOmin) or in endothelium denuded 
rings (Fig. 3.49B). This effect of l-NAME was partially reversed by L-arginine 
(L-Arg, 2xlO"'^M). The ability of atropine to inhibit PHE-induced tone in MPA 
rings, with or without the endothelium, was unaffected by P-adrenoceptor 
antagonist, propranolol (PROP, 10"%, for lOmin; Fig. 3.49C) or with the 
phosphodiesterase (PDE) inhibitor, 3 -isobutyl-1 -methylxanthine (IBMX,
10"%, for 3min). The inhibitory effects of AT on contractile responses to PHE 
persisted in MPA rings in which the endothelium had been removed, and in the 
presence of ACh (10“% ). The ACh-induced relaxation (10"%) was obtained 
in intact MPA rings which had been precontracted with PHE and these
     _ _
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relaxations were antagonised by AT Also, ACh (10"^M) reversed AT-
induced relaxation (5xlO"%; Fig. 3.49D). Comparisons between the 
concentration response curves to AT in MPA rings and BPA rings which had 
been precontracted with PHE, revealed that the MPA rings were more 
responsive than BPA rings to AT (10"  ^to 3x10"%). II
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Fig. 3. 49
Comparison between concentration-response curves showing relaxation to 
atropine (AT, 10"* to 5xlO“^ M) in MPA (open symbol) and in BPA 
(closed symbol) rings precontracted with PHE (ECy ;^ 1.2x10"%!). The results 
are expressed as means of percentage relaxation of PHE-induced tone. n=10 
rings from 10 animals, vertical bars show ± S.E.M. Asterisks indicate 
significant differences between means, p values: ** P < 0 .0 1 ; *** P < 0.001 
(unpaired t test ).
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Fig. 3. 49B
Individual traces showing the inhibitory effects of atropine (AT, 10"^  to 
5xlO“^ M) in main pulmonary artery (MPA) rings, with (+EC) and without 
(-EC) the endothelium, in the presence of L-NAME (5xlO"^M) or l-NOARG 
(10""^ M) and in the absence and presence of oxy-haemoglobin (HbO, Img/ml), 
Symbol (•) indicates drug addition and (WO) indicates wash off.
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Fig. 3. 49C
Individual traces showing the inhibitory effects of atropine (AT, 10"^  to 
5xl0“^ M) in main pulmonary artery (MPA) and branch pulmonary artery 
(BPA) rings, with (+EC) and without (-EC) the endothelium, in the presence of 
IBMX (10"^M) or propranolol (10~^M) and in the absence or presence of oxy- 
haemoglobin (HbO, Img/ml). Symbol (•) indicates drug addition and (WO) 
indicates wash off.
a
I1a
3
llî
If'-a
"i;
Atropine (5xlO"‘^’M) WO
# ACh (10 % )  
5-HT (lQ-%)
MPA
i
Atropine
m c
HbO+L-NAME
(Img/ml) (5x10"'%)
Fig. 3. 49D
Individual traces (A and B) showing responses of intact main pulmonary artery 
(+EC, MPA) rings, precontracted with 5-HT (10"^M) to atropine (AT, 
5x10“% ) in the absence and presence of HbO (lmg/mi)+L-NAME (SxlO'^M) 
and the effects of acetylcholine (ACh, 1 0 "^  and 10"%) on AT-induced 
responses. Symbol («) indicates drug addition and (WO) indicates wash off
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3.4 Frequency-response studies to electrical field stimulation (EFS) in 
MPA rings o f Wistar rats
A
Î
I
Electrical field stimulation (EFS; 70V, pulse width of 0.1 ms, 4, 8 , 16 and 
32 Hz, 10 seconds) induced a fi*equency-dependent contraction of the Wistar 
rat pulmonary artery rings at resting tension. These contractions were 
abolished by pretreatment of rings with tetrodotoxin (10”7M) and antagonized 
by a-adrenoceptor antagonist, prazosin (PRAZ, 10"^M), suggesting that this 
response was due to the activation of a^-adrenoceptors by neurally-released 
noradrenaline (NA) from peiivascular sympathetic nerves. The EFS-elicited 
contractions are expressed as means and as a percentage of the maximum 
response were respectively, 4 Hz ; 48.56±5.54, 8 Hz : 70,63^3.48, 16 Hz : 100 
and 32 Hz ; 94.07 (n=10; Fig. 3.50). Nco-nitro-L-arginine methyl ester 
(l-NAME, 2x10"%, for 15min) increased the EFS responses, but this effect 
was only significant at the frequency which produced the maximal response 
(16 Hz; 0.05 > P > 0.01, compared with control, n=8 . Fig. 3.50A). 
Pretreatment of rings with cocaine (10"%, for 10-15min) had no significant 
effect on the EFS-induced contractions (Fig. 3.50B).
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Fig. 3. 50
Histograms showing frequency-dependent responses to electrical field 
stimulation in the absence (solid column) and presence (open column) of 
l-NAME (2x 10"%, for 15min) in MPA rings from Wistar rats. The results are 
expressed as means and as a percentage of the maximum response to EFS of 
n=8-10 rings from 8-10 animals. The vertical bars show ± S.E.M. Asterisk 
indicates significant difference between means, p value'. * P < 0.05 
(paired t test).
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3.5 Investigation of the effects cigarette smoke extract (CSE)) on the 
responsiveness of the pulmonary artery (MPA and BPA) rings of Wistar
rats
3.5.1 Contractile responses
The cumulative concentration response curves to phenylephrine (PHE, 10"^  to 
10“5M) were obtained in MPA and BPA rings pretreated with cigarette smoke 
extract (CSE) and compared with the control responses to PHE in MPA and 
BPA rings (Fig. 3.51 to 3.52). Pretreatment of rings with CSE (0.1 or 1ml; for 
lOmin) had no effect on contractile responses to PHE in MPA and BPA rings. 
Whereas, pretreatment of artery rings with 2ml of CSE depressed contractile 
responses to PHE (10"  ^ to lO'^M) either in MPA or in BPA rings. 
The cumulative effects of CSE (0.1, 0.2, 0.5, 1 and 2ml) in MPA and BPA 
rings, which had been precontracted with PHE were performed. The CSE at 
high concentration (2ml) induced a slight relaxation in some of MPA and BPA 
rings which precontracted with PHE (10"%f) but not in all of the rings 
(data not shown). Also, the CSE (2ml) produced a small, time-dependent 
contraction in some of resting rings.
3.5.2 Relaxant responses
The cumulative response curves to acetylcholine (ACh) were obtained in MPA 
and BPA rings pretreated with cigarette smoke extract (CSE; l~2ml, for 
lOmin), which had been precontracted with PHE (10"'nvi) and compared with 
the control responses to ACh in MPA and BPA rings (Fig. 3.53 to 3.54). The 
CSE (2ml) reduced relaxant responses to ACh at concentrations (10“^  to 
10"TM) in MPA rings and at concentrations (10"? to 3xlO“^ M) in BPA rings 
(Fig. 3.53 to 3.54), but was unaffected by 1ml of the CSE. The CSE had no
57
effect on relaxant responses to sodium nitroprusside (SNP, to 10"^M) in 
MPA and BPA rings, which had been precontracted with PHE (10‘"^ M). (Fig. 
3.55 to 3.56).
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Fig. 3. 51
Cumulative concentration-response curves to phenylephrine (PHE, 10“^  to 
10"^M) in the absence (open symbol) and presence (closed symbol) of CSE 
(2ml) in MPA rings of Wistar rats. Tension was recorded (mg mg"i tissue) and 
PHE-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n= 6  rings from 6  animals. 
The vertical bars show ± S.E.M. Asterisks indicate significant differences 
between means, p  values'. * P < 0.05; ** P < 0.01 (paired Student's t test).
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Fig. 3. 52
Cumulative concentration-response curves to phenylephrine (PHE, 10“^  to 
10"^M) in the absence (open symbol) and presence (closed symbol) of CSE 
(2ml) in BPA rings of Wistar rats. Tension was recorded (mg mg"^  tissue) and 
PHE-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n= 6  rings from 6  animals. 
The vertical bars show ± S.E.M. Asterisks indicate significant differences 
between means, p  values: * P < 0.05; ** p < 0.01; *** P < 0.001 
(paired Student's t test).
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Fig. 3. 53
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10"^  to 3xlO"%T) in the absence (open symbol) and 
presence (closed symbol) of CSE (2ml) in MPA rings precontracted with PHE 
(10‘TM). The results are expressed as means of percentage relaxation of PHE- 
induced tone. n=7 rings from 7 animals, vertical bars show ± S.E.M. Asterisks 
indicate significant differences between means, p values: * P < 0.05 
(paired Student's t test).
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Fig. 3. 54
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10“^  to 3xlO"^M) in the absence (open symbol) and 
presence (closed symbol) of CSE (2ml) in BPA rings precontracted with PHE 
(IQ-^M). The results are expressed as means of percentage relaxation of PHE- 
induced tone. n=5 rings from 5 animals, vertical bars show ± S.E.M. Asterisks 
indicate significant differences between means, p  values: * P < 0.05 
(paired Student's t test).
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Fig. 3. 55
Comparison between concentration-response curves showing relaxation to 
sodium nitroprusside (SNP, to 10"'^ M) in the absence (open symbol) and 
presence (closed symbol) of CSE (2ml) in MPA rings precontracted with PHE 
(10“'^ M). The results are expressed as means of percentage relaxation of PHE- 
induced tone. n= 6  rings from 6  animals, vertical bars show ± S.E.M.
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Fig. 3. 56
Comparison between concentration-response curves showing relaxation to 
sodium nitroprusside (SNP, 10“^^ to in the absence (open symbol) and
presence (closed symbol) of CSE (2 ml) in BPA rings precontracted with PHE 
(10“'^ ) .  The results are expressed as means of percentage relaxation of PHE- 
induced tone, n-7 rings from 7 animals, vertical bars show ± S.E.M,
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3.6 Investigation of the effects of chronic heart failure on the 
responsiveness of the pulmonary vasculature: in main pulmonary artery 
(MPA) and branch pulmonary artery (BPA) rings of sham and heart 
failure rabbits
3.6.1 Effects o f contractile responses
3.6.1.1 Contractile responsese to 5-hydroxytryptamine (5-HI)
In this set of experiments, after 1 hour equilibration period, artery rings were 
contracted with the maximum concentration ofKCl (SxlO'^M) twice, at 20min 
intervals, to assess tissue viability and provide a reference contraction for 
subsequent data analysis. In addition, when experiments with noradrenaline 
(NA) were performed, the Krebs solution also contained 2.3xlO"^M ethylene 
diaminetetra-acetic acid (EDTA) in order to reduce degradation of the NA. 
5-Hydroxytryptamine (5-HT, 10“"^ to 10"^M) induced concentration-dependent 
contractions in MPA and BPA rings of 8 weeks sham or of heart failure (HF) 
rabbits. The maximum contractions to 5-HT (expressed as mg mg“i tissue) in 
MPA rings were repectively, 54.22±4.54 (n=7 rings from 7 animals) and 
58.91±16.53 (n=3 rings from 3 animals) (Fig. 3.57). There were no significant 
differences between contractile responses to 5-HT in MPA rings of sham and 
of HF rabbits. Also, 5-HT produced concentration-dependent contractions in 
BPA rings of sham and of HF rabbits. The maximum contractions (expressed 
as mg mg-i tissue) were respectively, 195.89±37.27 (n= 8  rings from 8  animals) 
and 135.72±18.62 (n=3 rings from 3 animals), which were not significantly 
different (Fig. 3.58). BPA rings were more responsive than MPA rings to 5-HT 
both in sham and HF rabbits (P < 0.05; Fig. 3.59 to 3.60).
f
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3.6.1.2 Contractile responses to noradrenaline (NA)
3.6.2 Vasorelaxant responses to acetylcholine (ACh)
Noradrenaline (NA, 1 0 " to 10"^M) induced concentration-dependent 
contractions in MPA and BPA rings, both in sham operated and HF rabbits 
( 8  weeks). There were no significant differences between responses to NA both 
in MPA and in BPA rings of sham operated and of HF rabbits (Fig. 3.61 to 
3.62). The maximum contractions (expressed as mg mg"  ^ tissue) in MPA rings 
of sham operated rabbits were 82.79±6.06 and of HF rabbits were 83.88±2.85, 
which were not significantly different. The maximum contractions in BPA rings 
of sham operated rabbits were 158.50±3.03 and of HF rabbits were 
195.85±27.13, which were not significantly different. In comparisons between 
responses to NA in MPA and BPA rings of sham operated rabbits, the latter 
were more responsive than the former to NA (10"  ^ to lO'^M; Fig. 3.63), also 
BPA rings of HF rabbits were more responsive than MPA rings to NA (10"'^  to 
10"^M; Fig. 3.64). Cocaine (10"^M) slightly enhanced responses to NA 
(10"7M) in MPA and to NA (lO'^M) in BPA rings of sham rabbits (Fig. 3.65 to 
3.66).
:=v
In pulmonary artery rings of sham operated and heart failure (HF) rabbits, 
which had been precontracted with NA (10"%[), acetylcholine (ACh, 1 0 "^  to 
10"%[) induced concentration-dependent relaxations. The maximum 
relaxations to ACh (expressed as the percentage of the PHE-induced tone) in 
MPA rings were respectively, 73.89±3.89% (in sham) and 69.23±8.24%
(in HF), which were not significantly different (Fig. 3.67). Also, the maximum 
relaxations to ACh in BPA rings were 57.99±8.68 (in sham) and 46.27±4.61 
(in HF), which were not significantly different. There was a significant 
difference between the responses only at lowest concentration of ACh (10"^M)
  __ _
“ 3(Fig. 3.68). Comparisons of concentration response curves to ACh in MPA and
,BPA rings whether from the heart failure and or from sham rabbits, showed
that there were no significant differences (Fig. 3.69 to 3.70). I
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Fig. 3. 57
Cumulative concentration-response curves to 5-hydroxytryptamine (5-HT, 
10"'^  to in MPA rings of 8  weeks sham (open symbol) or HF (closed
symbol) rabbits. Tension was recorded (mg mg"i tissue) and 5-HT-induced 
concentration-dependent contractions were obtained in these preparations. The 
results are expressed as means of n=3-7 rings from 3-7 animals. The vertical 
bars show ± S.E.M.
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Fig. 3. 58
Cumulative concentration-response curves to 5-hydroxytryptamine (5-HT, 
10“'^  to in BPA rings of 8  weeks sham (open symbol) or HF (closed
symbol) rabbits. Tension was recorded (mg mg"i tissue) and 5-HT-induced 
concentration-dependent contractions were obtained in these preparations. The 
results are expressed as means of n=3-8 rings from 3-8 animals. The vertical 
bars show ± S.E.M.
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Fig. 3. 59
Comparison between cumulative concentration-response curves to 
5-hydroxytryptamine (5-HT, 10"'^  to 10"^M) in MPA (open symbol) and BPA 
(closed symbol) rings of 8 weeks HF rabbits. Tension was recorded 
(mg mg"  ^tissue) and 5-HT-induced concentration-dependent contractions were 
obtained in these preparations. The results are expressed as means of n~3 rings 
from 3 animals. The vertical bars show ± S.E.M. Asterisks indicate significant 
differences between means, p  values'. * P < 0.05 (unpaired t test).
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Fig. 3. 60
Comparison between cumulative concentration-response curves to 
5-hydroxytryptamine (5-HT, 10"^  to lO’^M) in MPA (closed symbol) and BPA 
(open symbol) rings of 8 weeks sham rabbits. Tension was recorded (mg mg”  ^
tissue) and 5-HT-induced concentration-dependent contractions were obtained 
in these preparations. The results are expressed as means of n=7-8 rings from 
7-8 animals. The vertical bars show ± S.E.M. Asterisks indicate significant 
differences between means, p  values: * P < 0.05 (unpaired t test).
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Fig. 3. 61
Comparison between cumulative concentration-response curves to 
noradrenaline (NA, 10"^  ^ to 10“^ M) in MPA rings of 8 weeks sham (open 
symbol) or HF (closed symbol) rabbits. Tension was recorded (mg mg"i tissue) 
and NA-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n=7-9 rings from 7-9 
animals. The vertical bars show ± S.E.M.
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Fig. 3. 62
Comparison between cumulative concentration-response curves to 
noradrenaline (NA, 10"i® to 10"^M) in BPA rings of 8 weeks sham (open 
symbol) or HF (closed symbol) rabbits. Tension was recorded (mg mg"i tissue) 
and NA-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n=3 rings from 3 animals. 
The vertical bars show ± S.E.M.
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Fig. 3. 63
Comparison between cumulative concentration-response curves to 
noradrenaline (NA, lO-^ ^^ to 10"^M) in MPA (open symbol) and in BPA (closed 
symbol) rings of 8  weeks sham rabbits. Tension was recorded 
(mg mg“i tissue) and NA-induced concentration-dependent contractions were 
obtained in these preparations. The results are expressed as means of n-7-9 
rings from 7-9 animals. The vertical bars show ± S.E.M. Asterisks indicate 
significant differences between means, p  values: * P < 0.05; ** P < 0.01; 
*** P < 0.001 (unpaired t test).
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Fig. 3. 64
Comparison between cumulative concentration-response curves to 
noradrenaline (NA, lO’^^to 10"^M) in MPA (closed symbol) and in BPA (open 
symbol) rings of 8 weeks HF rabbits. Tension was recorded (mg mg"i tissue) 
and NA-induced concentration-dependent contractions were obtained in these 
preparations. The results are expressed as means of n-3 rings from 3 animals. 
The vertical bars show ± S.E.M. Asterisks indicate significant differences 
between means, p  values: * P < 0.05 (unpaired t test).
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Fig. 3. 65
Cumulative concentration-response curves to noradrenaline (NA, to
lO'^ lVQ in the absence (open symbol) and presence (closed symbol) of cocaine 
(10"%[) in MPA rings of 8 weeks sham rabbits. Tension was recorded 
(mg mg“  ^ tissue) and NA-induced concentration-dependent contractions were 
obtained in these preparations. The results are expressed as means of n=9 rings 
from 9 animals. The vertical bars show ± S.E.M. Asterisk indicates significant 
difference between means, p value: * P < 0.05 (paired t test).
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Fig. 3. 66
Cumulative concentration-response curves to noradrenaline (NA, 1 0 “io to 
10“^ M) in the absence (open symbol) and presence (closed symbol) of cocaine 
(10"%T) in BPA rings of 8 weeks sham rabbits. Tension was recorded 
(mg mg"i tissue) and NA-induced concentration-dependent contractions were 
obtained in these preparations. The results are expressed as means of n=7 rings 
from 7 animals. The vertical bars show ± S.E.M. Asterisks indicate significant 
difference between means, p value: *<0.05;**P<0.01 (paired t test).
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Fig. 3. 67
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10“^  to 10“^ M) in MPA rings precontracted with PHE 
(10"^M) of 8  weeks sham (closed symbol) or HF (open symbol) rabbits. The 
results are expressed as means of percentage relaxation of PHE-induced tone. 
n=3 rings from 3 animals, vertical bars show ± S.E.M.
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Fig. 3. 68
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10“^  to 10"^M) in BPA rings precontracted with PHE 
(10"^M) of 8 weeks sham (closed symbol) or HF (open symbol) rabbits. The 
results are expressed as means of percentage relaxation of PHE-induced tone. 
n=3 rings from 3 animals, vertical bars show ± S.E.M. Asterisk indicates 
significant difference between means, p value. * P < 0.05 (unpaired t test).
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Fig. 3. 69
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10"® to 10'%t) in MPA (closed symbol) and in BPA rings 
(open symbol) precontracted with PHE (10‘^M) of 8 weeks sham rabbits. The 
results are expressed as means of percentage relaxation of PHE-induced tone. 
n=3 rings from 3 animals, vertical bars show ± S.E.M.
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Fig. 3. 70
Comparison between concentration-response curves showing relaxation to 
acetylcholine (ACh, 10"^  to 10"%[) in MPA (closed symbol) and in BPA rings 
(open symbol) precontracted with PHE (10"®M) of 8 weeks HF rabbits. The 
results are expressed as means of percentage relaxation of PHE-induced tone. 
n-3 rings from 3 animals, vertical bars show ± S.E.M.
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4 DISCUSSION
The calibre of blood vessels is dependent on vascular smooth muscle (VSM) 
tone, which is influenced by the adrenergic innervation, and by circulating or 
locally- produced humoral substances. It is also modulated by the endothelium. 
The role of endothelium-derived vasoactive substances in the control of 
vascular tone have been documented widely (Furchgott & Zawadzki, 
1980a; 1980b; Moncada et al., 1976; Yanagisawa et al., 1988; Palmer et al., 
1987; Ignarro et al., 1987b). The vascular endothelium in addition to its other 
important functions, which include capillary transport, regulation of plasma 
lipids, and participation in the control of haemostasis, modulates the reactivity 
of vascular smooth muscle. This regulatory role is accomplished through 
several mechanisms: I) The endothelial layer interposes a physical barrier 
between the vascular smooth muscle and hormones and other vasoactive 
substances circulating in blood; II) it extracts or metabolically degrades 
vasoactive substances such as noradrenaline (NA), 5-hydroxytryptamine 
(5-HT), and kinins and thereby prevents or diminishes their activity in vascular 
smooth muscle; III) it converts precursors (e.g. angiotensin I) into vasoactive 
products; IV) it may store, synthesis/release inhibitory and excitatory 
vasoactive substances, including, (PGIg, EDRF, EDHF, EDCF). The 
pulmonary artery rings were selected for examination since the pulmonary 
vascular bed is notable for its large surface area and the important contribution 
that the endothelial cells make to the metabolic activation and/or degradation 
of a variety of vasoactive compounds. On the other hand, the pulmonary 
circulation differs markedly from the systemic circulation in several respects; 
the different response to acute hypoxia, which causes contraction in 
pulmonary, but relaxation in systemic vessels (Staub, 1985) is well known; also 
there are differences in other control mechanisms (Fishman, 1990), the 
distribution (Hyman et al., 1989) and affinities of adrenoceptors (Shaul et al..
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1990), and in the response to some peptides, such as vasoactive intestinal 
polypeptide (Sata et ah, 1986).
4.1 Vascular efTects of contractile agonists and the role of the 
endothelium
5-Hydroxytryptamine (5-HT) exerts complex effects on the cardiovascular 
system. 5-HT is a potent vasoconstrictor in many vascular tissues. However, 
the action of 5-HT and related agents vary greatly, depending on the species, 
the specific vessels under study and the sympathetic tone (Pertz, 1993; 
Growcott et al., 1992; Corsi et al., 1991). 5-HT can cause either 
vasoconstriction or vasodilation and these effects have been explained by the 
wide variety of 5-HT receptors involved and by the different cell types 
activated by the amine (Feniuk & Humphrey, 1989; Feniuk & Humphrey, 
1990). 5-HT inhibits the release of noradrenaline (NA) from sympathetic 
nerves (Rang & Dale, 1991; Done & Sharp, 1992), and releases nitric oxide 
(NO) from endothelial cells via the 5-HT; receptor in the canine coronary 
artery (Cocks & Angus, 1983; Cohen et al., 1983; Vanhoutte, 1987). The 
complexity of the effects of 5-HT is indicated by the fact that vasoconstrictor 
responses to 5-HT usually show desensitisation, which has been attributed to 
the vasorelaxant effect of NO, released during 5-HT-induced responses 
(Wakabayashi, 1993). The effects of 5-HT in the pulmonary vessels are further 
complicated by the fact that 5-HT is taken up by and inactivated in the 
endothelial cells (Murray, 1986). The main findings of this study of the effects 
of 5-HT on pulmonary artery rings can be summarized as follows. 1) 5-HT 
produced concentration-dependent contractions in isolated rings of main 
pulmonary artery (MPA) and its first branches (BPA), but at high 
concentration (lO'^M), contractile responses to 5-HT in these rings decreased. 
2) Branch pulmonaiy arteiy (BPA) rings and main pulmonary artery (MPA)
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rings were equally responsive to 5-HT. 3) Contractile responses to 5-HT in 
endothelium-intact rings, were enhanced by the nitric oxide synthase inhibitor, 
Nco-nitro-L-arginine methyl ester (l-NAME, SxlO'^^M, for 20min) or when the 
endothelium had been removed by rubbing. The augmentation of the contractile 
responses to 5-HT in endothelium-denuded rings was very similar to that in 
endothelium-intact rings incubated with l-NAME. 4) 5-HT produced 
concentration-dependent relaxations in endothelium-intact artery rings and also 
in endothelium denuded artery rings, which had been precontracted with 
phenylephrine (PHE). 5) Prolonged exposure of MPA and BP A rings to 5-HT 
produced marked desensitisation to 5-HT. The present study demonstrated that 
5-HT produced concentration-dependent contractions in MPA and BP A rings. 
It has been shown that contractile responses to 5-HT in both arteries and veins 
are usually mediated via 5-HT; receptors but 5-HTj-like receptors or a mixture 
of 5-HT;-like and S-HTj receptors may also be involved, depending upon 
tissues and species examined (Roth et al, 1986; Saxena & Villalon, 1990). To 
characterize the 5-HT-mediated contractile responses, the aitery rings (MPA 
and BP A) were pretreated with the 5-HTg receptor antagonist, mianserin (10" 
®M), which inhibited cumulative contractile responses to 5-HT (10"  ^to 10"^M). 
This observation suggested that 5-HT-induced contractile responses in these 
rings are mediated via 5-HTg receptors. Surprisingly, the contractile responses 
to 5-HT in MPA and BPA rings were similar, indicating that contractile 
responses to 5-HT in these rings did not correlate with artery size in the 
pulmonary vasculature. N©-nitro-L-arginine methyl ester (l-NAME, SxIQ-^m, 
which inhibited the maximum responses to endothelium-dependent relaxant, 
ACh), enhanced responses of intact artery rings to high concentrations of 
5-HT, without significantly affecting the EC^g values. 5-HT normally has little 
apparent effect in the pulmonary circulation when it is perfused with Krebs' 
buffer but in the presence of the nitric oxide synthase inhibitor, 
N©-nitro-L-arginine methyl ester (l-NAME), 5-HT produced large
13* ■
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pressor responses (Shaw et al., 1992). One explanation of the ability of 
l-NAME to enhance the pressor effect of 5-HT in the pulmonary circulation is 
that l-NAME inhibits the synthesis of NO, which acts as a physiological 
antagonist of 5-HT and normally masks its pressor effects. Another explanation 
is that l-NAME potentiates the vasoconstrictor effects of 5-HT in the §
pulmonary circulation by increasing the sensitivity of the S-HTj receptor to the 
vasoconstrictor action of 5-HT rather than by inhibiting NO synthesis (Lippton 
et al, 1992). Mechanical removal of the endothelium in MPA and BPA by Î
rubbing, caused little reduction of KCl-induced responses. The effectiveness of 
this procedure was subsequently investigated using ACh, which normally 
relaxed artery rings but had no effect in rubbed rings. Rubbing also enhanced 
responses to 5-HT in MPA rings and BPA rings. l-NAME had no effect on 
5-HT-induced responses in denuded rings. Interestingly, the concentration- 
response curves to 5-HT in intact rings, pretreated with l-NAME, was 
superimposable on the curves to 5-HT in denuded rings, which were not 
pretreated with l-NAME. These results are consistent with those obtained in 
the rabbit basilar artery by Trezise and colleagues (1992). Thus, removal of the 
endothelium or pretreatment artery rings with l-NAME had almost identical 
effects on the responses to 5-HT. These data collectively suggest that the 
depressant effect of the endothelium can be fully accounted for by the release 
of an L-NAME-sensitive endothelium-derived relaxing factor (EDRF). Since 
l-NAME is an inhibitor of the formation of nitric oxide (NO) from its 
precursor L-arginine (L-Arg) in vascular endothelial cells (Rees et al., 1990), it 
seemed probable that the NG/r-Arg pathway was involved. To determine the 
involvement of the NO/r-Arg pathway, the effect of L-Arg (2 x1 0 ’  ^and 10“^ M) |
was investigated in endothelium-intact pulmonary artery rings and in denuded 
rings. Following incubation in the response of a submaximal concentration of 
5-HT, addition of l-NAME (5x1Q-4M) resulted in an augmentation of tone in 
intact artery rings, but not in denuded rings and this effect of l-NAME was
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endothelium-intact artery rings, which had been relaxed with ACh. These
endothelium-derived relaxing factor (EDRF). Similar experiments were carried
■;|
completely inhibited by L-Arg (lO'^M), whereas L-Arg had no such effect in
intact rings precontracted with 5-HT and in the absence of L-NAME. These
.observations are consistent with those reported in the guinea-pig pulmonary
artery by Sakuma and colleagues (1988), and in rat aorta by Frew and
colleagues (1993). When the tone was raised in intact pulmonary artery rings
with a submaximal concentration of 5-HT (10“^ M), ACh (10"<*M)-induced
relaxations were inhibited by l-NAME (SxlO’^^ M) but these inhibitions were
not reversed by L-Arg (10”^ M). These observations are consistent with those
reported by Randall and Griffith (1991) in rabbit perftised ear arteries. These
observations strongly suggest 1) The endothelium-derived nitric oxide formed
from L-Arg fully accounts for the depression of 5-HT-induced contractions in
these vessels. 2) The depression of contractions to 5-HT was a consequence of
.the basal release of nitric oxide (NO) from the endothelium, and not of 5-HT- 
stimulated release. This seems likely since first, l-NAME induced contractions 
in endothelium-intact artery rings which had been precontracted with 5-HT, but 
not in endothelium-denuded rings and this effect of l-NAME was reversed by 
L-Arg; secondly, L-Arg failed to reverse the inhibitoiy effect of l-NAME in
■
results therefore support the hypothesis that the vascular endothelium regulated 
resting pulmonary vascular tone through the synthesis and release of
out using the a^-adrenoceptor agonist, phenylephrine (PHE), in endothelium- 
.intact rings of MPA and of BPA and in endothelium-denuded rings, in the
■:s:absence and presence of L-NAME, (i) to investigate responses of MPA and 
BPA rings to this agonist and (ii) to compare responses induced by 5-HT and
PHE in MPA and BPA rings. These experiments demonstrated that 
phenylephrine (PHE) produced concentration-dependent contractions in MPA 
rings and BPA rings. MPA rings were less responsive than BPA rings to PHE. 
Contractile responses to PHE were enhanced in MPA and BPA rings
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pretreated by l-NAME (5x10"^M, for 20min) and this effect l-NAME was 
inhibited by L-Arg. Removal of the endothelium by rubbing in MPA rings, 
enhanced and potentiated contractile responses to PHE. The augmentation of 
the contractile responses to PHE were very similar in intact MPA rings 
pretreated by L-NAME to that seen in endothelium-denuded rings. These
iresults indicate that the endothelium exerts a depressant effect on the
contractility of these rings to PHE. Contractile responses to high
concentrations of PHE (10""*M) in these preparations were poorly maintained.
Pretreatment of the preparations with propranolol (10"%1, for lOmin)
prevented this reduction in the contractile response which occurred with high
concentrations of PHE (10"^M), without having any other effect on the
contractile responses to PHE. This suggests that at high concentrations of
PHE, a p-adrenoceptor mediated response occurs and that this P-
adrenoceptor-mediated relaxation overcomes the a^-adrenoceptor mediated
vasoconstriction at this point. It has been shown that contractile responses to
PHE are mediated via a^-adrenoceptors (Langer & Hicks, 1984). In some
experiments concentration response curves to PHE were obtained in MPA 
.rings pretreated with the a-adrenoceptor antagonist, prazosin (PRAZ, 10"®M). 
PRAZ, which inhibited completely the contractile responses to PHE (10“^  to 
10"^M), indicating that contractile responses to PHE are mediated via ttj- 
adrenoceptors in these artery rings. Comparisons between contractile responses 
to PHE, in MPA and BPA rings demonstrated that BPA rings were more 
responsive than MPA rings to PHE, indicating that the contractile response to 
PHE is correlated with artery size in the pulmonary vasculature, and smaller 
arteries were more sensitive than bigger arteries. The results obtained are not 
consistent with the results reported by Leach and colleagues (1992). There may 
be a biochemical explanation of the greater ability of BPA rings to respond to 
this vasoconstrictor. I) It is possible that basally-released NO acts as a 
physiological antagonist of PHE in rat isolated BPA rings and this occurs to a
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lesser extent than in MPA rings. II) It is possible that BPA rings were less 
sensitive to basally-released NO than MPA. This view seems likely since there 
were significant differences between MPA and BPA rings after treatment of the 
rings with the nitric oxide inhibitor-synthase, N©-nitro-L-arginine methyl ester, 
ni) It is possible that BPA rings have either more a^-adrenoceptors than MPA 
rings or that their contractile mechanisms were more responsive to this agonist. 
Consequently, activation of a^-adrenoceptors in BPA rings was perhaps more 
likely to induce more Pl-hydrolysis and in turn increase Ca^ + from intracellular 
stores, and presumably, produce larger contractile responses. Comparisons 
between contractile concentration response curves to 5-HT and PHE in MPA
and BPA rings, reveal that the latter agonist was more potent than the former. 
There are several explanations of the greater ability of PHE to contract these
.rings. I) It is possible that 5-HT^-receptor-mediated response was more
susceptible than the -adrenoceptor-mediated response to NO and/or there 
was less NO released by the tt;-agonist than by 5-HT. II) It is possible that the 
aj-adrenoceptors were more numerous than the 5 -HT2-receptors and/or more 
G-proteins participate to promote receptor-phospholipase C coupling in a^- 
adrenoceptor-mediated responses than in 5-HT induced responses. To 
determine which explanation is correct will require the use of techniques which 
would involve e.g. measurement of cGMP levels, receptor cloning and 
radioligand studies. In another series of experiments, the effects of other 
vasoconstrictors (noradrenaline, angiotensin II and the thromboxane A^  
mimetic, U46619) were examined (i) to determine the effects of these agonists 
on pulmonary artery rings and (ii) to compare their effects in MPA and BPA 
rings and to determine whether there were any significant differences. All of 
these agonists produced concentration-dependent contractions in MPA and 
BPA rings. As with the results obtained in BPA rings with PHE, responses to 
noradrenaline (NA) in BPA rings were larger than in MPA rings. The 
explanations given previously for the greater ability of BPA rings to respond to
•Î.
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the a;-adrenoceptor agonist, PHE may also apply to NA. In addition, BPA 
rings were more responsive than MPA rings to angiotensin II (AH) but only at 
a concentration of 10"^M. Whereas, there were no significant differences 
between MPA and BPA rings in responses to thromboxane A^  mimetic, 
U46619. Generally, the results obtained showed that the smaller pulmonary 
arteries (BPA) were more responsive and sensitive than the larger MPA to 
vasoconstrictors.
5-HT also induced concentration-dependent relaxations in the rings, which had 
been precontracted with PHE (lO-TH). 5-HT-induced relaxations were 
unaffected either by pretreating the preparations with L-NAME (5xlO"^M) or 
by mechanical removal of the endothelium by rubbing. The vasorelaxant effect 
of 5-HT was therefore unlike that of ACh which also relaxed PHE-induced 
tone in these vessels. Unlike 5-HT-induced relaxations, ACh-induced 
relaxations were inhibited by l-NAME (5xlO""*M) and this effect was not 
reversed by L-arginine (lO’^M). The results obtained with ACh in the 
pulmonary artery rings are consistent with those of Randall and Griffith (1991), 
who suggested that different mechanisms may be involved in basal and agonist- 
stimulated release of NO. The synthesis of NO involved in both types of release 
was inhibited by l-NAME, but the effect of l-NAME was only reversed by 
L-arginine when the NO was basally-released. By this criterion, ACh released 
NO in pulmonary artery rings but 5-HT did not, since its ability to relax rings 
which had been precontracted with PHE was reversed by l-NAME and this 
action of l-NAME was then antagonised by L-Arg. However, this distinction 
between basally-released and stimulation-release may be spurious since there is 
evidence that l-NAME can also block muscarinic receptors (Buxton et ah, 
1993). Thus l-NAME would block the vasorelaxant effect of ACh for two 
reasons. First, by inhibiting nitric oxide synthase and secondly, by antagonising 
the action of ACh at its receptor. L-Arginine would be able to reverse the 
action of L-NAME on the synthesis of NO but would not affect the action of
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l-NAME at the muscarinic receptors and so L-arginine would not restore the 
vasorelaxant response to ACh. Since muscarinic receptors are not involved in 
basal release of NO, the effect of l-NAME would be readily reversed by 
L-arginine. Furthermore, since l-NAME does not block the action of 5-HT at 
its receptor, its ability to reverse any NO-mediated vasorelaxation that 
occurred in the presence of 5-HT, would be exclusively due to blockade of NO 
synthesis. Thus contraction produced by l-NAME in the presence of 5-HT 
would be reversed by L-arginine irrespective of whether the NO was basally- 
released or released by 5-HT. The ability of L-arginine to reverse l-NAME 
induced contractile responses, obtained in the presence of 5-HT, merely 
confirms that NO is present and reduces contractile response to 5-HT and also, 
it is thought that the NO is basally-released and is not released by 5-HT.
Therefore, it is possible that the vasorelaxant action of 5-HT is mediated either 
by relaxant receptors which are only susceptible to high concentrations of 
5-HT or it is a non-specific effect of 5-HT and/or it is that desensitisation 
occurred.
Homologous desensitisation is a widespread phenomenon in which initial 
exposure to an agonist results in decreased cellular responsiveness on second 
exposure to the same agonist. This study also investigated the maximum 
contractile effects of 5-HT in the absence and presence of l-NAME in 
endothelium-intact rings of MPA or of BPA and in rings with denuded- 
endothelium to determine if desensitisation occurred and whether it was 
specific to 5-HT and if it could be explained by the release of nitric oxide (NO).
For comparison, responses to phenylephrine (PHE) were also examined. In 
some experiments artery rings were exposed to high concentration of 5-HT 
(10"^M) for 30 minutes or 1 hour, after which cumulatively administered
'Ssubmaximal responses to 5-HT and PHE were examined. The effect of this 
treatment were also examined in the presence of L-NAME, and in rings in 
which the endothelium had been removed by rubbing. This study has shown
%
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that l-NAME statistically enhanced the maximum contractile responses to 
5-HT in main pulmonary artery rings and in its branches. This result suggests
that endogenous nitric oxide (NO) acts as a physiological antagonist of 5-HT in 
the pulmonary vasculature. Two possible explanations of the ability of
l-NAME to potentiate responses to 5-HT in the pulmonary vessels exist. First,
l-NAME may have prevented desensitisation to 5-HT occurring. This is more
likely to occur with high concentrations of 5-HT and so this is a plausible
explanation of the ability of l-NAME to enhance responses to high 
.concentration of 5-HT in pulmonary artery rings. A second possibility is that
5-HT can release NO and its ability to do this is, like its ability to contract the
artery rings, concentration-related. The maximum contractile responses to
.phenylephrine (PHE) were enhanced also by l-NAME in pulmonary artery
rings and its first branches. Prolonged exposure of pulmonary artery rings to
5-HT for periods of up to an hour produced desensitisation, which was
characterised by abolition of contractile responses to 5-HT and inhibition of
responses to low concentrations of PHE. This desensitisation to 5-HT was
most marked in pulmonary artery rings in which the endothelium was intact.
Investigation of the effects of 5-HT in pulmonary artery rings in which the
endothelium had been removed by rubbing and in which ACh had no relaxing
effect, showed that the extent of 5-HT-induced desensitisation was reduced but
not abolished. Pretreatment with l-NAME also reduced but did not abolish
5-HT-induced desensitisation and even the combination of l-NAME and
removing the endothelium did not abolish the phenomenon. It is clear that the
desensitisation produced by prolonged exposure to 5-HT is complex and is
produced by several mechanisms. One component could be physiological
.antagonism caused by NO derived from the endothelium. This seems likely 
since removing the endothelium reduced the extent of the desensitisation.
However, the possibility that endothelial PGIg was responsible for this 
component of the desensitisation can be excluded; since indomethacin s
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pretreatment of artery rings had no effect. The involvement of NO is suggested 
by the effect of l-NAME , which when administered before exposure of the
artery to 5-HT, also reduced but did not abolish the desensitisation. In some 
prolonged experiments, artery rings were exposed to 5-HT and then, during the
desensitisation and in the presence of 5-HT, were exposed to haemoglobin or 
L-NAME. In these experiments haemoglobin or L-NAME rapidly reversed the 
desensitisation and this effect of L-NAME was opposed by L-arginine. This 
observation suggests that during prolonged experiments, in which the artery 
rings were exposed only to 5-HT, NO was entirely responsible for the 
desensitisation, which was due to physiological antagonism of the contractile 
effect of 5-HT by NO, released mainly from the endothelium. In contrast, when
the l-NAME was administered prior to exposure to 5-HT, the result obtained
was very different. In this situation there was still desensitisation to the
contractile response to 5-HT but the administration of haemoglobin or
l-NAME during the desensitisation had no effect. This result indicates that in
the presence of l-NAME and presumably in the absence of NO, prolonged
exposure to 5-HT still causes subsensitivity to 5-HT. This subsensitivity may
be due to (i) alterations in the 5-HT receptor or its coupling mechanism; whose
integrity may normally be maintained by nitric oxide; however, attenuation of
5 -HT2 receptor-mediated phosphatidylinositol turnover via an activation of
protein kinase C has been reported (Roth et a l, 1986; Aghajanian, 1990); such 
.inhibition may serve (a) to protect cells from over stimulation, (b) as a 
modulatory substrate by other regulators of cellular activity, (ii) internalisation 
or sequestration of receptors by which hydrophilic agonists are prevented
access to receptors; sequestration of p-adrenoceptors has been extensively 
studied (Waldo et a l, 1983; Toews et a l, 1984; Rassis et a l, 1986).
4.2 Vascular effects o f relaxant agonists and the role of the endothelium
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Studied extensively (Furchgott & Zawadzki, 1980b; Chand & Altura, 1981;
A number of agents have been shown to elicit relaxation of the pulmonary
artery either through the release of nitric oxide (NO) or by promoting (NO) 
synthesis, through stimulation of specific endothelial cell receptors. This study
investigated the effects of various vasorelaxants including acetylcholine (ACh), 
carbachol (GARB), adenosine 5'4riphosphate (ATP), adenosine 5'-diphosphate 
(ADP), histamine (HIST), isoprenaline (ISO), adenosine (AD), bradykinin 
(BK), substance P (SP) and sodium nitroprusside (SNP) in MPA and BPA |
rings with or without endothelium and in the absence and presence of l-NAME
(2 xlO"%I). The purpose of this study was : (i) to examine the effects of these 
vasorelaxants in MPA and BPA rings (ii) to determine the contribution of nitric
oxide on the agonist-induced endothelium-dependent or -independent 
relaxations and (iii) to investigate agonist-induced relaxant responses in the M
presence of their specific antagonists. The vascular endothelium regulates the 
tone of the underlying vascular smooth muscle through the release of two
important nonprostanoid agents, these are EDRF, which is likely to be nitric 
oxide (NO), and EDHF, which has yet to be identified (Palmer et oL, 1987; 
Ignarro et ah, 1988; Feletou & Vanhoutte, 1988; Chen et ah, 1988; Keef & 
Bowen, 1989; Brayden, 1990; Nagao & Vanhoutte, 1991; Chen et ah, 1991). 
These are likely to be distinct factors because NO does not alter membrane 
potential (Huang et ah, 1988; Komori et ah, 1988) and also because inhibitors 
of nitric oxide do not alter endothelium-dependent hyperpolarization (Chen &
Cheung, 1992; Chen et ah, 1991). Acetylcholine and related cholinomimetics 'i
cause both vasorelaxation and hyperpolarization in vascular smooth muscle 
cells by endothelium-dependent mechanisms (Bolton et a l ., 1984; Chen et ah.
1988; Feletou & Vanhoutte, 1988). The mechanism of the vascular smooth .#1muscle relaxation to acetylcholine (ACh) and other muscarinic agents has been
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De Mey & Vanhoutte, 1981; Cocks & Angus, 1983) and shown to be 
dependent upon the presence of the endothelium (Furchgott & Zawadzki,
1980b). Now, it is understood that acetylcholine and other muscarinic agents
:'S:Tcause a diffusible factor namely endothelium-derived relaxing factor (EDRF)
(Angus & Cocks, 1989) which is released from endothelial cells following the
binding of ACh to muscarimc receptors (Hynes et al., 1986; Dauphin & Hamel,
1990). EDRF is thought to be nitric oxide (NO) (Palmer et al., 1987; Ignarro,
1989) which is formed from the conversion of L-arginine to L-citrulline (Palmer
et al, 1988b) or a derivative, since relaxation to acetylcholine is blocked by
compounds including haemoglobin (Angus & Cocks, 1989), or the L-arginine
analogues, N®-monomethyl-L-arginine (l-NMMA), N^-nitro-L-arginine
(l-NNA) and N®-nitro-L-arginine methyl ester (l-NAME) (Sakuma et al.,
1988; Moore et al., 1990; Rees et al., 1990). NO diffuses into the adjacent
.vascular smooth muscle cells where it causes activation of guanylyl cyclase 
(GC), the enzyme that catalyzes the production cGMP from guanosine 
5 -trisphosphate (GTP) within the smooth muscle (Griffith et al., 1985;
Waldman & Murad, 1987; Ignarro, 1989; Moncada et al., 1991). In turn, 
cGMP probably inhibits contraction of vascular smooth muscle through 
activation of cGMP-dependent protein kinase (PKG). Both the relaxation and 
enhanced guanylyl cyclase activity produced by ACh can be mimicked by 
addition of authentic NO (Gruetter et al, 1981; Ignarro et al, 1987a). The 
present experiments demonstrated that ACh (1 0 ~® to 3xlO"^M) induced 
concentration-dependent relaxations in MPA and BPA rings. The maximum 
relaxation to ACh in MPA rings and BPA rings which had been precontracted 
with PHE (EC70, 1.2x10"%) were respectively, (64,26±3.66% in MPA and 
81.79±3.74% in BPA). In comparisons between relaxant response curves to 
ACh, BPA rings were more responsive than MPA rings. This observation is 
consistent with that reported in rabbit ear artery resistance vessels and in 
central ear arteries to ACh by Owen and Bevan (1985). There were significant
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(CARB, 10"* to 10"'^ M). Thus, it is possible that the smaller pulmonary arteries
differences between MPA and BPA rings to the maximum effect of ACh 
(0.01 > P > 0.001). Moreover, in another series of experiments, similar results
were obtained between MPA and BPA rings in relaxant responses to carbachol
Iproduce higher cGMP levels than large arteries in relaxant responses to
::
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muscarinic agonists. This view is supported by the results obtained in bovine 
pulmonary arteries of different sizes by Ignarro and colleagues (1987). 
Pretreatment of isolated rings with blockers of the NO pathway, l-NAME or 
l-NOARG (5x10"'^ M, for lOmin) or mechanical removal of the endothelium by 
rubbing completely abolished relaxant responses to ACh or CARB in 
pulmonary artery rings. The inliibitory effect of ACh was reversed by l-NAME 
and this action of l-NAME was not antagonised by L-Arg (lO'^M). These 
results indicate that (i) vascular smooth muscle relaxation induced by ACh or
(ii) ACh- or CARB-induced relaxations were mediated by agonist-stimulated 
endothelial-release EDRF, since the L-Arg failed to reverse the contractile 
action of l-NAME, whereas the contractile effect of l-NAME was inhibited by 
L-Arg when the NO was basally-released and (iii) ACh or CARB are unlikely to 
have produced hyperpolarization in pulmonary artery rings, since, L-NAME 
completely abolished relaxant responses both to ACh and CARB, thus 
suggesting that EDRF was the sole inhibitory mediator released from 
endothelium cells. In blood vessels, the release of EDRF evoked by ACh is 
mediated via the activation of different muscarinic receptors. The M3 
muscarinic receptors mediate endothelium-dependent relaxation in the rat 
pulmonary artery (McCormack ei al., 1988). This study demonstrated that the 
relaxant effect ACh (10"%) was antagonized by atropine (10"*M), indicating 
relaxant responses to ACh mediated via muscarinic receptors in pulmonary 
artery rings. It has also been demonstrated that nitro-vasodilators such as 
sodium nitroprusside (SNP) induce endothelium-independent relaxation
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through formation of cGMP and activation of soluble guanylate cyclase 
(Rapoport & Murad, 1983). Nitro-vasodilators probably lead to the formation 
of nitric oxide (NO) which activates guanylate cyclase (Katsuki et ah, 1977). 
In present experiments, concentration-response curves to SNP were obtained 
in MPA rings and its first branches (BPA), which were precontracted either 
with PHE (10"%) or with 5-HT (10“^ M). MPA rings were more responsive 
than BPA rings especially those which had been precontracted with PHE. 
Pretreatment of the preparations with L-NAME (5xlQ-4M) or mechanical 
removal of the endothelium had no significant effect on SNP-induced 
relaxations, whether in artery rings (MPA and BPA) which were precontracted 
with PHE or with 5-HT. These results confirm that relaxant responses to SNP 
are endothelium-independent. In comparing relaxation response curves to ACh 
or SNP, the latter was able to induce greater relaxation than the former in these 
tissues.
Extracellular adenosine and adenine nucleotides, adenosine 5'-triphosphate 
(ATP) and adenosine 5'-diphosphate (ADP) play an important part in the 
regulation of many biological processes including the control of vascular tone 
and haemostasis by interaction with specific receptors on the cell surface. 
The cellular responses to ATP and ADP are mediated by ? 2  purinoceptors as 
opposed to P; purinoceptors which interact preferentially with adenosine 
(Bumstock, 1978; Bumstock & Kennedy, 1985; Gordon, 1986; Olsson & 
Pearson, 1990). ATP and ADP can be liberated into the extracellular space as a 
consequence of vessel wall damage and local platelet aggregation (Gordon, 
1986), after which they are rapidly sequentially dephosphorylated to adenosine 
by ectonucleotidases of endothelium and circulating blood cells (Coade & 
Pearson, 1989). The endothelium-independent effect of ATP can be either 
vasodilation or vasoconstriction, depending on the subclass of the P2 
purinoceptor in question (Kennedy et ah, 1985; Houston et ah, 1987). 
The endothelium-dependent effect of ATP is vasodilation and this is due to its
76
action at Pjy purinoceptors, releasing the endothelium-derived relaxing factor 
(EDRF-NO) and/or prostacyclin (PGIj) (De Mey & Vanhoutte, 1981; Gordon 
& Martin, 1983; Needham et a l, 1987; Boeynaems & Pearson, 1990).
The responses of vascular endothelial cells to adenine nucleotides are generally 
attributed to the stimulation of Pjy receptors. However, the possibility of a 
heterogeneous population of ATP-sensitive receptors on vascular endothelial cells 
has recently been reported and two types of ATP receptors (P^y and P^u) 
might coexist on endothelial cells (O'Connor et al., 1991; Motte et al., 1993).
The role of EDRF in the relaxations to ATP and ADP was demonstrated in 
canine arteries (De Mey & Vanhoutte, 1981), and in the rat aorta (Olsson & 
Pearson, 1990; White etal., 1985). It has also been demonstrated that ATP- or 
ADP-induced relaxations are prevented by inhibitors of nitric oxide synthase 
(Dominiczack et al., 1991; Koga et al., 1992). It is suggested that vasodilator 
action of adenosine (AD) is mediated via the Ag subclass of P; purinoceptors, 
leading to stimulation of adenylate cyclase (AC) in smooth muscle (Collis & 
Brown, 1983; Ramagopal et al., 1988). The location of adenosine receptors 
has not been well-defined and both endothelium-dependent (Gordon & Martin, 
1983; Rubanyi & Vanhoutte, 1985b) and endothelium-independent (Kennedy 
et al., 1985; White & Angus, 1987) responses have been described. A variety 
of evidence indicates a key role for ATP-sensitive potassium channels in certain 
of the cardiovascular effects induced by activation of adenosine A; or Ag 
receptors. It has been suggested that the xanthines, such as theophylline and 
caffeine, are P; receptor antagonists (Olsson & Pearson, 1990). The present 
study demonstrated that MPA and BPA rings, which had been precontracted 
with the a;-adrenoceptor agonist phenylephrine (PHE) underwent 
endothelium-dependent relaxations when exposed to either ATP or ADP. 
Vasorelaxant responses both to ATP and to ADP were prevented by 
pretreatment artery rings with the nitric oxide synthase inhibitor, l-NAME or 
by mechanical removal of the endothelium by rubbing. Concentration-
I
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dependent response curves to ATP and ADP were unaffected with 
pretreatment artery rings by a blocker of intracellular ATP-sensitive K+ 
channels, glibenclamide or the PDE inhibitor, theophylline and/or 
the p-adrenoceptor blocker, propranolol. The results obtained indicated
(i) ATP- or ADP-induced relaxations to be endothelium-dependent
(ii) ATP-sensitive channels were not involved in relaxant responses to ATP 
or ADP in MPA and BPA rings, and it is possible that relaxant responses to 
ATP or ADP were mediated by Pg purinoceptors. There were no significant 
differences between MPA and BPA rings in their responses to ATP, but, there 
were differences in response to ADP. MPA rings were more responsive than 
BPA rings to high concentrations of ADP (10"  ^to 10"^M).
Adenosine (AD) induced slowly-developing and sustained endothelium- 
independent relaxations in MPA and BPA rings. This effect of adenosine was 
antagonized by the P; receptor antagonist, theophylline, suggesting that 
adenosine produced this effect via P; receptors in these artery rings. 
Pretreatment of MPA and BPA rings with l-NAME or mechanical removal of 
the endothelium by rubbing did not affect relaxant responses to AD, indicating 
that relaxant responses to AD were endothelium-independent.
The effects of histamine (HIST) have been studied in different blood vessels 
and various species and two types of receptors for HIST (H; and Hg) are 
known to control vascular smooth muscle tone (Levie et al., 1982). The 
contribution of each receptor type varies in different species. HIST decreases 
coronary blood flow in rat at higher concentrations (Bartlet, 1963), whereas 
this amine increases coronary blood flow in the dog and cat (Altura & Halevy, 
1978). Harvey and Owen (1979) have shown that rat uterine vasculature is 
sensitive to HIST, which produced Hj- and Hg-mediated vasodilation when 
given intravenously to anaesthetized rats. Histamine is generally considered to
78
be a pulmonary vasoconstrictor, but it causes vasodilation when the pulmonary 
vascular tone is abnormally elevated (Tucker et al., 1975). It has also shown 
that vasodilatation to HIST in some species may be due to the release of 
endothelium-derived relaxing factor (EDRF) (Furchgott & Vanhoutte, 1989). 
The purpose of this study was (i) to determine the effect of HIST on the 
isolated pulmonary artery (MPA and BPA rings) of the rat (ii) to investigate 
the role of the endothelium in HEST-induced responses and (iii) to investigate 
the specificity of HIST-receptors in MPA and BPA rings. The response of 
pulmonary vessels to HIST has rarely been studied in rats. In this study HIST 
induced concentration-dependent relaxations in MPA and BPA rings, which 
had been precontracted with PHE. BPA rings v/ere apparently more responsive 
than MPA rings to HIST (1 0 “^  to IQ-^M), but no significant differences were 
seen in the maximum responses. l-NAME reduced relaxant responses to HIST, 
indicating that HIST-induced relaxations involved the synthesis of nitric oxide 
(NO). The present study indicated that HIST-induced vasorelaxant responses 
in these rings were mediated through H;-receptors. This hypothesis is further 
suggested by the fact that HIST concentration-response curves obtained in the 
presence of the H;-receptor antagonist, chlorpheniramine, were shifted to the 
right of the control. This result is consistent with that obtained by Tucker and 
colleagues (1975), who have shown that the H; histamine receptors mediate 
pulmonary vasodilator responses in the dog. Also, high concentrations of HIST 
(10"4 to lO'^M) produced small concentration dependent-contractile responses 
in resting MPA and BPA rings. This result is consistent with that obtained by 
Tucker and colleagues (1975), who have shown that the HIST is a pulmonary 
vasoconstrictor when the vascular tone is not elevated.
In some experiments, the effects of bradykinin (BK) and substance P (SP) were 
examined in MPA and BPA rings, which had been precontracted with PHE or 
5-HT and/or the thromboxane Ag mimetic, U46619. Neither BK nor SP had
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any effect in MPA and BPA rings, which had been precontracted with one of 
these agonists.
Physiological studies indicate that p-adrenoceptors induce vasodilatation in 
pulmonary and systemic vascular beds (Hyman & Kadowitz, 1986). Vascular 
smooth muscle relaxation mediated via P-adrenoceptors involves activation of 
adenylate cyclase and increases synthesis of cAMP (Scheid et al., 1979). 
However, recently, conflicting reports have suggested that the endothelium 
may be involved in p-adrenoceptor-mediated vasorelaxation and have 
implicated the L-Arg/NO pathway in this response. The results obtained in
j
%vitro, in canine coronary artery have indicated that isoprenaline-induced 
relaxation was either endothelium-independent (MacDonald et al., 1987;
Î
O'Rourke & Vanhoutte, 1990) or endothelium-dependent (Rubanyi & 
Vanhoutte, 1985b) and in rat thoracic aorta was completely endothelium- 
dependent, suggesting that the rise in adenosine 3' : S'-cyclic monophosphate 
(cAMP) could lead to the stimulation of NO synthase (Gray & Marshall, 
1992). These results were totally at variance with those of Béa and colleagues 
(1994), who suggested that NO was not directly involved in p-adrenoceptor- 
mediated relaxation in large epicardial canine coronary arteries, but the 
presence of a functional endothelium may facilate this relaxation, probably 
through the basal release of NO and consequently an increase in the basal 
content of cGMP in vascular smooth muscle. Other investigators have 
demonstrated that the nitrovasodilator, nitroprusside, and the p-adrenoceptor 
agonist, isoprenaline, interact synergistically, either to relax or to inhibit the
:
contraction of rat aortic smooth muscle (Maurice et al., 1991). Moreover, 
nitroprusside markedly increased the accumulation of cAMP caused by 
additional of isoproterenol to this tissue (Maurice & Haslam, 1990). Recently, 
evidence has suggested that effects of cAMP in vascular smooth muscle may be 
mediated, at least in part, by cGMP-dependent protein kinase (Jiang et al..
1
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1992; Lincoln & Cornwell, 1993). The present experiments demonstrated that 
the p-adrenoceptor agonist, isoprenaline (ISO) induced concentration- 
dependent relaxations both in endothelium-intact rings and in rings (MPA and 
BPA) without endothelium,which had been precontracted with PHE. Removal 
of endothelium or pretreatment of artery rings with l-NAME reduced 
submaximal relaxant responses to ISO, particularly to low concentrations, but 
had no effect on maximum relaxant responses to ISO. However, when 
l-NAME was added during maximum relaxation to ISO, a partial reversal of
the relaxation was observed and this effect of l-NAME was slightly inhibited 
by L-Arg (lO'^M). These results confirm the possibility, suggested by Béa and 
colleagues (1994) that NO is not required for p-adrenoceptor-mediated
relaxation, but the presence of fiinctional endothelium may facilate this 
relaxation, probably through the basal release of NO and consequently an
increase in the basal content of cGMP in vascular smooth muscle.
The p-adrenoceptor antagonist, propranolol (10"^M) abolished relaxant
responses to ISO (1 0 ”i® to 10"^M), and reduced the maximum induced-
relaxation by ISO (1 0 "%), indicating that relaxant responses were mediated
.via p-adrenoceptors in these artery rings. MPA rings were more responsive
than BPA rings in their response to this agonist, suggesting that p-
.adrenoceptor-mediated mechanisms may be more active in MPA rings than in
BPA rings.
4,3 Vascular effects o f atropine and the role o f the endothelium
Large doses of atropine cause vasodilation of the blood vessels in the skin 
(Bowman & Rand, 1980). This effect is apparently unconnected with the 
antimuscarinic activity of atropine and seems to be due to a direct action on the 
blood vessel. This direct vasodilator action of atropine gives rise to the 
characteristic “flush” which is caused by dilation of superficial blood vessels of
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the skin in the neck and face and is a sign of atropine toxicity (Bowman & 
Rand, 1980). This study investigated the effects of atropine in MPA and BPA 
rings with endothelium-intact or with denuded endothelium and in the presence 
of NO synthase inhibitor, N©-nitro-L-arginine methyl ester (l-NAME, 
SxlO '^^M, for 15-20min) when responses to acetylcholine (ACh, 1 0 "^M) were 
abolished. l-NAME had no effect on AT-induced relaxation. Paradoxically, 
when l-NAME (5xl0"'*M) was added during maximum relaxation to atropine 
(5xl0"%), the relaxant response to AT was completely reversed in 
endothelium-intact but not in rings with denuded endothelium, and this effect 
of l-NAME was inhibited by L-arginine (L-Arg, 2xlO"'^M). The vasorelaxant 
effect of AT was neither blocked by propranolol (PROP, 10"%) nor enhanced 
by isobutylmethylxanthine (EBMX, 10“% ). These results indicate that the 
ability of atropine to relax pulmonary artery rings (MPA and BPA) may be 
dependent upon the mechanism of action of the precontracting agonist and 
suggest that the vasorelaxant effect of atropine is not wholly mediated by the 
release of nitric oxide (NO).
4,4 Vascular effects o f electrical field stimulation (EFS)
Extrinsic physiological control of vascular smooth muscle cells is primarily 
achieved by sympathetic nerve-released noradrenaline (NA). Little is known 
about the role of the endothelium on the neural control of vascular smooth 
muscle. The endothelium has been shown to metabolise norepinephrine 
released from adrenergic nerves in dog pulmonary artery by transmural 
electrical stimulation (Rorie & Tyce, 1985). The vascular endothelium has an 
inhibitory effect on adrenergic nerve stimulation in the rabbit carotid artery 
(Tesfamariam et al., 1987) and rat caudal artery (Hynes et al., 1988). This 
inhibitory effect of the endothelium on contractile response to adrenergic nerve 
stimulation is believed to be due to the release of relaxing factors from
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endothelial cells (Tesfamariam et al., 1987; Cohen & Weisbrod, 1988). 
Recently, Liu and colleagues (1991) implicated NO as the factor responsible 
for the inhibition adrenergic neurogenic vasoconstriction to modulate 
adrenergic neural responses in guinea-pig pulmonary artery via a postjunctional 
mechanism and basal release of NO from endothelial cells. The present study 
demonstrated that electrical field stimulation (EFS) induced frequency- 
dependent contraction responses (FCR) in MPA rings. These FCRs were 
significantly reduced when stimulation was repeated, suggesting the possibility 
of exhaustion of NA stores, since there were no significant differences on 
contractile responses to NA (10"%) before or after stimulation. Tetrodotoxin 
(1 0 "% ) abolished the contractile responses to EFS, indicating that the FCRs 
were neuronally-mediated. Prazosin also inhibited contractile responses to 
EFS, suggesting that these responses were due to the activation a^- 
adrenoceptors by neural-released noradrenaline (data not shown). FCRs were 
enhanced by l-NAME (10"^M), but this was only significant with maximum 
responses to EFS (16 Hz), suggesting that the endothelium can modulate 
neurogenic responses by releasing endothelial-released relaxing factors, 
especially, endothelium-derived relaxing factor (EDRF/NO). Treatment with 
cocaine (10”<^ M), which is an inhibitor of neuronal NA uptake (Iverson, 1967), 
did not significantly increase contractile responses to EFS at all frequencies, 
but contractile responses were prolonged in comparison with time controls, 
suggesting that cocaine inhibited NA uptake.
4.5 Vascular effects o f cigarette smoke extract (CSE)
The purpose of the present study was to investigate the effect of CSE on the 
endothelium of pulmonary artery rings. The most important findings of this 
study were that the CSE (i) depressed contractile responses to PHE and
(ii) inhibited the endothelium-dependent-relaxant responses in MPA and BPA
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rings but not endothelium-independent relaxant responses. The results suggest 
that the endothelium may be affected by CSE in MPA and of BPA rings and 
this is consistent with evidence from other studies, which have demonstrated 
that components of CS reach the endothelium of pulmonary blood vessels in 
vivo. It has been demonstrated that the components of CS are rapidly absorbed 
into the bloodstream (Koch et al., 1980), The vasoactive compound, carbon 
monoxide (CO) reaches a peak concentration in systemic venous blood within 
a minute of cessation of smoking (Woodman et al., 1986; Zacny et al., 1987), 
and a similar rapid peak of nicotine concentration has also been demonstrated 
in the venous blood (Feyerabend et al., 1985). Zacny and colleagues (1987) 
demonstrated that the constituents of CS are actually present in recirculating 
blood for several hours after smoking. It has also been demonstrated that in 
smokers there is an increase in the uptake of small molecular weight 
compounds ( Jones et al., 1980). NO can also be found in high concentration in 
cigarette smoke (Norman & Keith, 1965). The present study demonstrated that 
incubation of resting rings with CS caused a slowly-developing contraction in 
some artery rings tested. This may be due to the effect of CO in CSE. It may 
also be due to inhibition of basally-release NO. It has been shown that the 
content of CO is high in cigarette smoke (First, 1984) and also inhalation of 
CO causes a vasoconstrictor response in the pulmonary circulation of the pig, 
but the mechanism of action of this remains unclear. Paradoxically, CS-induced 
bronchial vasodilator effects have been attributed to a combination of CO and 
NO (Alving et al., 1993). It has been suggested, that this effect may cause 
direct activation of soluble guanylate cyclase (Marks et al., 1991). It has been 
shown that cigarette smoke relaxes the pulmonary circulation of the pig 
isolated lung (Gilman et a l, 1981). The present study demonstrated that CSE 
(l-2ml) induced relaxations in MPA and BPA rings, which had been 
precontracted with PHE. These relaxations were unaffected by L-NAME 
(10"4 to 5xlQ-4M) whether the L-NAME was administered before or after
exposure to CSE. It does not seem likely that CSB-induced relaxations were 
caused by NO synthesis, through stimulation of specific endothelial cell 
receptors, since l-NAME failed to reverse this CSE-induced relaxant effect. 
Nor was it due to NOg, since, the absence ofNOg in firesh cigarette smoke has 
been demonstrated (Norman & Keith, 1965; Alving et al., 1993). The relaxant 
effects of CSE seem in this study is consistent to some extent with the results 
obtained by Holden and colleagues (1990), who found the CSE produced 
biphasic responses in isolated porcine intrapulmonary arteries, in which CSE 
produced relaxant responses at low concentrations (0 .0 0 1 -0 .0 1 %) and 
contractile responses at high concentrations (0.1-1%)., It has also been shown 
that the vasodilatory effects of NO were similar to those of filtered smoke in 
the pulmonary circulation (Alving et al., 1992). These workers concluded that 
the NO content of the gas phase of CS was likely to account for the dilatation 
of the pulmonary circulation. However, they observed that whole CS did not 
consistently relax the porcine pulmonary circulation, therefore, the particulate 
phase, including nicotine, must counteract the vasodilatory effect caused by 
NO, possibly by reflex mechanisms. This latter view was supported by the fact 
that vasodilator responses in the pulmonary circulation to whole CS were seen 
in the isolated porcine lung, where reflexes would be absent (Gilman et al., 
1981). It has also been shown that both CS and NO increase the levels of 
guanosine 3* :5-cyclic monophosphate in the lung tissue (Arnold et al., 1977). 
This study demonstrated that the high concentrations of CSE produced by 
administration of 2 ml of extract depressed concentration-dependent contractile 
responses to PHE. However since, nicotine, a major component of CS, had no 
such effect, and since aliquots of an aqueous extract of unbumed tobacco had 
no such effect it appears that this depression is not due to natural compound(s) 
in the cigarette, but may instead be due to some of the compound(s) produced 
on combustion. It is possible that the NO content of the CSE acts to increase 
cGMP levels and thus causes depression of the PHE-induced contractile
i
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effects. CSE reduced relaxant responses to ACh but not to SNP. These results 
suggest that the CSE might impair the vascular endothelium, which confirms
the hypothesis that smoking might impair endothelium-derived vascular 
relaxation because of its toxic effect on endothelial cells in human (Jacobs et 
al., 1993) and also consistent with the observation that CSE impaired the 
dilatation of hamster cheek pouch arterioles to ACh, without impairing the 
response to nitroglycerin (NG) (Rubinstein et al., 1991). These workers also 
reported that indomethacin prevented the CSE-induced impairment of 
vasodilatation in response to ACh but did not effect the dilatory response to 
NG, suggesting that the mechanism of impaired dilatation after CSE exposure 
may be related to the release of cyclooxygenase products. Also, Bakhle and 
colleagues (1979) demonstrated that CSE increases the perfusate concentration 
of PGs in isolated lung of rat, but the vascular effects of CSE were not 
mediated by PGs. Also, it has been reported that although CSE impairs the
production of dilator products produced via the cyclooxygenase pathway, it
does not appear that this is the primary mechanism by which CSE impairs
.ACh-induced vasodilation (Rubinstein et al., 1991). They have proposed that 
.the probable mechanism of impaired dilatation is related to the release of a
constrictor substance(s) produced via the cyclooxygenase pathway. Also, it has 
been reported that CSE inhibits the synthesis of prostacyclin (PGI2) in human, 
rabbit and rat vascular tissue (Jeremy et al., 1985). However, the nature of the 
constrictor substance(s) is not yet known. Also, it has been demonstrated that 
both the vasodilator and vasoconstrictor effects of CSE were inhibited by the 
removal of the endothelium, suggesting that the endothelium may be involved 
in the vascular response of intrapulmonary arteries during CS exposure 
(Holden et a/., 1990).
In conclusion, the results obtained in this study indicated that CSE impairs 
endothelium-dependent vasorelaxant responses of the pulmonary arteries.
Furthermore, such CSE-induced effects cannot be attributed to nicotine, which
!
is a major component of CS, nor are they due to a natural product in the 
cigarette, but rather are the result of combustion.
4.6 Vascular effects o f chronic heart failure due to experimental coronary 
artery ligation
Detailed studies on the responsiveness of vessels from chronic heart failure 
(CHF) patients are notoriously difficult to perform due to the practical and
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ethical difficulties involved in obtaining suitable tissues from disease and 
control subjects. Most of the current knowledge comes from animal models. 
The results obtained in this study were: 5-Hydroxytryptamine induced 
concentration-dependent contractions in MPA and BP A rings of the eight week 
either sham operated or heart failure (HF) rabbits. No significant differences 
were seen between concentration response curves obtained in rings from sham 
operated or HF rabbits to 5-HT. BPA rings were more responsive than MPA 
rings to 5-HT in both sham and HF rabbits. Noradrenaline (NA) also induced 
concentration-dependent contractions in artery rings from sham and from HF #
rabbits. There were no significant differences between contractile concentration 
response curves to NA obtained in rings from sham operated and HF rabbits. 
BPA rings were more responsive than MPA rings from both sham operated and 
HF rabbits. These results indicated that contractile responses were not different 
in artery rings from sham operated and HF rabbits.
Acetylcholine (ACh) induced concentration-dependent relaxations in both sham 
operated rabbits and in HF rabbits. There were significant differences between 
the responses in rings from sham operated rabbits and in rings from HF rabbits 
but only at the lowest concentration of ACh (10"^M). Whether or not the 
smaller inhibiting responses to ACh (10”^ M) seem in rings from HF rabbits was 
biologically significant and indicated that in these animals, the endothelium- 
dependent vasorelaxation mechanism is impaired, remains to be clarified- 
perhaps using different models of HF.
i
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In conclusion, this study has shown that in isolated segments of pulmonary 
artery, there is a basal release of nitric oxide (NO), which may be responsible 
for the low tone in the pulmonary vasculature. In addition, the basal release of 
NO is responsible for attenuating contractile responses to vasoconstrictors, 
such as phenylephrine (PHE), noradrenaline (NA) and angiotensin II (Ang II). 
This was suggested by the ability of the NO synthase inhibitor, L-NAME, to 
enhance contractile responses to these agonists. Another major finding was that 
the smaller, branch pulmonary artery was not only more responsive than the 
larger, main pulmonary artery to vasoconstrictors such as PHE, NA and Ang II 
and also more responsive to the endothelium-dependent vasodilators, 
acetylcholine (ACh), carbachol (CARB), and histamine (HIST) but less 
responsive to endothelium-independent vasodilators such as sodium 
nitroprusside (SNP) and isoprenaline (ISO). In addition, this study 
demonstrated that tachyphylaxis to the contractile responses of the pulmonary 
artery to 5-hydroxytryptamine (5-HI) occurred and this was partly due to the 
release by 5-HT of NO from the endothelium. The effects of an aqueous 
extract of cigarette smoke were also investigated in isolated rings of pulmonary 
artery. These experiments showed the cigarette smoke extract (CSE) inhibited 
vasodilator responses to ACh but not to SNP and did not potentiate contractile 
responses to vasoconstrictors and even inhibited these responses. This is an 
important observation, since it suggestes that a component of cigarette smoke 
can inhibit the agonist stimulated release of NO from the endothelium but does 
not affect either the basal release of NO or the ability of the vascular smooth 
muscle to relax to NO derived from SNP.
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